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This thesis contains several independent projects, covering two aspects of organic chemistry: 
natural product synthesis and investigation of new synthetic methodology. The first chapter 
contains the total synthesis of (±)-Lingzhiol, derivatives and their biological evaluation. The second 
chapter describes efforts towards the total synthesis of Gulmirecin B. The third chapter is about 


















Chapter I:  
Lingzhiol has an inhibitory effect on TGF-β-1 mediated Smad3 phosphorylation which is playing 
the main role in chronic kidney disease and diabetic problems. Besides biological activity, the 
structure of lingzhiol has a tetracyclic ring system and two consecutive quaternary carbons which 
are rather unusual. All this features attracted us to develop a synthesis for the polycyclic natural 
product (±)-Lingzhiol. The key steps consist of a Wittig olefination, an epoxide formation, 
intramolecular epoxide opening, and a benzylic oxidation.  
 
Chapter II:  
Gulmirecin A and B were isolated from the predatory bacterium Pyxidicoccus fallax HKI 727. They 
have strong activity against Staphylococcus species. Structurally, the gulmirecins are 12-membered 
macrolactones containing four stereocentres, two trisubstituted double bonds, and an α-
arabinofuranose moiety attached at the C-7 position. All these features attracted us to the synthesis 
of Gulmirecin B.  
Thesis  
Total synthesis of Lingzhiol 
Towards the total synthesis 
of Gulmirecin B 
Studies on spiroacetal 
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The key intermediate C8-C12 was prepared from L-malic acid. The C1-C7 aldehyde building block 
was synthesized from hexenoic acid using an Evans alkylation, a cross metathesis, and an 
asymmetric dihydroxylation as key steps.  
 
Chapter III: 
Here we studied a method for spiroacetal formation via photocatalysis under blue LED irradiation. 
Different synthetic approaches to spiroacetal formation have been reported in the literature. 
However, the visible light induced spiroacetal formation via an alkoxy radical is unknown. 
Therefore, we decided to investigate such transformations via alkoxy radical generation using 
hypervalent iodine(III) reagents under photochemical conditions. The starting material was 










Lingzhiol zeichnet sich durch eine hemmende Wirkung auf die durch TGF-β-1 vermittelte Smad3-
Phosphorylierung aus, die eine Hauptrolle bei chronischen Nierenerkrankungen sowie bei Diabetes 
spielt. Neben der interessanten biologischen Aktivität weist Lingzhiol eine beachtenswerte Struktur 
auf. Lingzhiol hat ein tetracyclisches Ringsystem und zwei aufeinanderfolgende quaternäre 
Kohlenstoffzentren, welche eher als ungewöhnlich anzusehen sind. All diese Eigenschaften haben 
uns motiviert, eine Synthese für das polycyclische Naturprodukt von (±)-Lingzhiol zu entwickeln. 
Die entscheidenden Schritte dieser Synthese umfassen dabei eine Wittig-Olefinierung, eine 




Gulmirecin A und B wurden aus dem räuberischen Bakterium Pyxidicoccus fallax HKI 727 isoliert. 
Sie weisen eine starke Aktivität gegen Staphylococcus-Erreger auf. Strukturell handelt es sich bei 
den Gulmirecinen um 12-gliedrige Makrolactone, die vier Stereozentren, zwei trisubstituierte 
Doppelbindungen und einen α-Arabinofuranose-Rest an der C-7-Position enthalten. Diese 
strukturelle Eigenschaften machen die Gulmirecine zu interessanten Zielen für die Totalsynthese. 
Das Schlüsselintermediat C8-C12 wurde aus L-Äpfelsäure hergestellt. Der C1-C7-Aldehyd-
Baustein wiederrum wurde aus Hexensäure unter Verwendung einer Evans-Alkylierung, einer 




Im Rahmen dieser Arbeit wurde eine neue Methode zur Synthese von Spiroacetalverbindungen 
durch Photokatalyse unter Bestrahlung mittels blauer LED-Lampen untersucht. In der Literatur 
wurden bereits verschiedene synthetische Ansätze zur Spiroacetal-Bildung beschrieben. Die durch 
sichtbares Licht induzierten Spiroacetal-synthesen über ein Alkoxy-Radikal sind allerdings bis 
heute unbekannt. Daher haben wir uns entschlossen, eine solche Umwandlung mittels 
Alkoxylradikalbildung unter Verwendung hypervalenter Iod(III)-Reagenzien unter 
photochemischen Bedingungen zu untersuchen. Das Ausgangsmaterial wurde mittels Swern-
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 Bacteria and fungus are vast sources of biologically active compounds. They played a vital 
role in the development of modern medicines. Fungi have been used widely in East Asian medicine 
for a range of human disease conditions such as diabetics, chronic kidney problems, stomach ulcers, 
liver rot, and hypertension etc. A mushroom, named Ganoderma lucidum, has been used in Chinese 
medicine to prevent diabetic and kidney diseases. Most of the fungi are growing on woody plants, 
sawdust, grain and wood logs (Figure 1). More than 450 species of Ganoderma were recorded in 
the Chinese Pharmacopoeia. Particularly, the Ganoderma lucidum and Ganoderma sinense were 
listed as most beneficial fungus. Ganoderma species are rich sources of terpenoids. Most of the 
isolated terpenoids from them belong to meroterpenoids, which contain polycyclic substructures 

















Figure 1. Naturally occurring mushroom in wood logs. 
 
Ganoderma meroterpenoids can be classified on the basis of chemical structures into three types1  
1. Monocyclic with exocyclic chain  
For examples: Fornicin D, Cochlearin H, Ganoleucin B etc.  
2. Polycyclic meroterpenoids 
For examples: Lingzhine C, Lingzhiol, Spiroaplanatumine D etc.   
3. Dimeric meroterpenoids   
For examples: Sinensilactam A, (±)-Ganoapplanin etc.  
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Based on medicinal utility, the group of Cheng extracted Lingzhiol from the naturally available 
Ganoderma lucidum.2 The extraction of 80 kg of the dried mushroom yielded 50 mg of racemic 
Lingzhiol (1-1). The enantiomers were separated using chiral HPLC, which provided pure 
enantiomers (–)-Lingzhiol and (+)-Lingzhiol (1-1). The isolated lingzhiol consists of an aromatic 
part and a terpene part. Structurally, lingzhiol has two phenolic groups, a tetracyclic ring system and 









Figure 2. Structure of (±)-Lingzhiol (1-1).  
1.1 Monocyclic meroterpenoids with exocyclic chain  
This kind of Ganoderma meroterpenoids has double bonds in the side chain. Due to that, redox 
reactions can take place at the allylic positions. For example, Fornicin D (1-2) and derivatives of 
Cochlearin H, G (1-3, 1-5), and Ganomycin E (1-8) display significant antioxidant activity.3 The 
compound Chizhine D (1-4) was isolated from Ganoderma lucidum and has shown a weak 
renoprotective effect.4 Ganoleucin B (1-6) was isolated from Ganoderma leuocontextum and it does 
not show any inhibitory activities against COX-1, COX-2, HMG.5 However, Ganomycin J (1-7) has 
shown strong inhibitory activity against HMG-CoA reductase with an IC50 value of 30.3 μM. The 
compounds (+)-Chizhine E and F (1-10, 1-9) were isolated from Ganoderma lucidum and 
individual enantiomers have shown inhibitory effect on monocyte chemoattractant protein-1(MCP-

















Figure 3. Structures of Ganoderma meroterpenoids with side chain. 
1.2 Polycyclic meroterpenoids  
These compounds have a polyunsaturated terpenoid part. It is supposed that free radical reactions 
driven by enzymes (or) light, lead to the formation of polycyclic structures (Figure 4). Lingzhine C 
(1-11) and (±)-Lingzhine B (1-12) were found to be potentially active against proliferation of neural 
stem cells (NSCs).6 Furthermore, most of these Ganoderma meroterpenoids were found be inactive 
against COX-2 in vitro studies, but only (+)-Ganotheaecoloid J (1-13) had shown COX-2 inhibitory 
activity.7 Biological evaluation of (+)-Cochlearin A (1-14) has shown a free radical scavenging 
activity.8 The spiroaplanatumines D, F (1-15, 1-16) were found to be JAK3 kinase inhibitores.9  
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Both enantiomers of (+)-Lingzhiol and (–)-Lingzhiol (1-1) have shown an inhibiting effect on TGF-
β1-mediated Smad3 phosphorylation.2 Cochlearol B (1-17), a novel meroterpenoid exhibits 
renoprotective activities.10 Whereas, Applanatumol A (1-18) and (+)-Applanatumol A (1-19) were 




Figure 4. Chemical structures of polycyclic Ganoderma meroterpenoids. 
1.3 Dimeric meroterpenoids 
Dimeric Ganoderma meroterpenoids are formed via intra/intermolecular cyclization reactions 
(Figure 5). Both enantiomers (+)-Sinensilactam A and (–)-Sinensilactam A (1-20) were found to 
inhibit Smad3 phosphorylation, which is an integral part in the cure of chronic kidney disease and 
diabetic nephropathy.12 Compound (±)-Ganoapplanin (1-21) has shown inhibitory activity against 
T-type voltage-gated calcium channels.13 (+)-Ganodilactone (1-22) which features two chains has 
shown pancreatic lipase inhibitory activity.14  
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In addition, Cochlearoid H-K (1-23 to 1-26) and Cochlearoid F-G (1-27, 1-28) were found to 
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1.4 Biological studies of Lingzhiol 
Cheng et al. have investigated biological properties of Lingzhiol and found an interesting biological 
activity against renal fibrosis and diabetic nephropathy.2 Diabetic nephropathy and renal fibrosis 
have been involved in liver failure and chronic kidney diseases. Pathogenic events contributing to 
renal fibrosis and diabetic nephropathy include oxidative stress,16 accumulation of extracellular 
matrix (ECM), chronic inflammation and activated TGF-β/Smads signaling pathways.17 The Smad2 
and Smad3 proteins are associated with renal fibrosis and inflammatory processes. TGF-β/Smad 
signaling plays an important role in the development of chronic kidney disease.18 Transforming 
Growth Factor β (TGF-β) is a cytokine protein belonging to the TGF superfamily. It is involved in 
the regulation of cell growth.19 TGF-β expression is affected in many ways, including high levels of 
glucose.20 There are many factors that could activate the TGF-β binding receptors such as pH 
medium, protease, reactive oxygen species (ROS), and integrins.21 The signaling pathway of TGF-β 
family members occurs through type I (TβRI) and type II (TβRII) serine/threonine kinase receptors. 
The activated TβRI phosphorylates Smad3, which release the anchoring protein SARA and permits 
formation of Smads heteromeric complexes. These substrates can form a complex with Smad4 




Figure 6. The TGF-β/Smad phosphorylation signaling pathway.  




2.1 Biosynthesis of Lingzhiol 
The biosynthesis of lingzhiol was proposed on the basis of a suggested biosynthesis of the related 
meroterpenoid (±)-Sinensilactam (1-20).12 Structurally, it is related to Lingzhiol. It was suggested 
that (±)-Sinensilactam (1-20) originates from 4-hydroxybenzoic acid (1-29) formed via the shikimic 
acid pathway23 and the monoterpene geranyl diphosphate (1-30). The geranylhydroquinone (1-31) 
was oxidized to generate intermediate 1-34. The hydroxide induced domino-Michael addition to the 
oxidation product 1-34 could lead to cyclopentane 1-35. Further, the biosynthesis involves the 
formation of intermediate 1-36 by the reaction of pyrrolidine with the aldehyde and hydroxyl 
function. The isomerization of iminium ion 1-36 to 1-37 involves a 1,3-hydride shift. Finally, the 
nucleophilic addition of the OH to the iminiumion followed by oxidation reactions would deliver 




Scheme 1. Biosynthetic pathway related to (±)-Sinensilactam (1-20).  
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A first biosynthesis proposal for (±)-Lingzhiol was reported by Cheng et al. in 2013. It has been 
proposed based on Fornicin (1-40)24 through a nucleophile substitution of benzene ring with a side 
chain allyl cation which would deliver macrocycle 1-42. Loss of a methyl cation and transannular 
cyclization forms the tetracycle 1-44 featuring a cyclopentene ring. Oxidation reactions and 




Scheme 2. A plausible biosynthesis pathway for (±)-Lingzhiol (1-1) by Cheng et al. 
 
An alternative plausible biosynthesis pathway was proposed by Birman et al.25 It was suggested that 
geranylhydroquinone 1-31 undergoes cyclization to produce enone 1-47. After conversion of 1-47 
into epoxy alcohol 1-48, a semipinacol rearrangement would produce aldehyde 1-49. Two further 


















Scheme 3. Biosynthesis proposed via semipinacol rearrangement by Birman et al. 
 
Our biosynthesis proposal is a modification of the pathway suggested for (±)-Sinensilactam for the 
formation of Lingzhiol (1-1).26 In order to get lingzhiol in this way, the epoxide must be established 
in the cyclopentane ring 1-52. We assumed that a related route to lingzhiol could involve the 
addition of hydroperoxide anion to the dicarboxylic acid 1-50. The resulting cyclopentane 
carboxylic acid 1-51 might undergo decarboxylation to deliver epoxide 1-52. A further step would 
be an intramolecular epoxide opening reaction with the aromatic ring as nucleophile that could lead 
to formation of Lingzhiol (1-1) (Scheme 4).    
  
 
Scheme 4. Modified biosynthesis of (±)-Sinensilactam 1-20 for (±)-Lingzhiol (1-1). 
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2.2 Previous syntheses of Lingzhiol 
Up to now, six total syntheses of Lingzhiol have been reported in the literature. The isolated pure 
enantiomers of (+)-Lingzhiol and (–)-Lingzhiol from Ganoderma lucidum were described by Cheng 
et al. in 2013.2 After that different groups have been investigating on the total synthesis of 
Lingzhiol (1-1). The first total synthesis was reported by Long et al.27 and utilized an Rh-catalyzed 
[3+2] cycloaddition reaction of chiral homopropargyl alcohol 1-54 to give the tricyclic enal 1-55 
through putative intermediates A and B. The key intermediate 1-54 was prepared from 5,8-
dimethoxytetralone (1-53) in 10 steps. The aldehyde 1-55 was treated with NaBH4 to induce lactone 
formation. Thereafter, allylic oxidation and reduction provided 1-56. The stereochemistry of 1-56 
was determined by NOE spectroscopy. Next steps involved benzylic oxidation reaction and 
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The second approach was reported by Qin et al. in 201528 and is outlined below. They have 
achieved the target molecule (±)-Lingzhiol (1-1) via an epoxy-arene cyclization reaction of epoxide 
1-62 in the presence of Lewis acid. They have tried a classical Wittig olefination on an 
oxocyclopentane carboxylate which did not work in their hands. Therefore, they have developed a 
route to endo-1-58 through Grignard addition and elimination to give a mixture of endo/exo-1-58 
(2.2:1). The major endo-1-58 was oxidized using OsO4/NMO and treated with acetic anhydride to 
give 1-60. Further, elimination with SOCl2, Et3N and cleavage of the acetate group using basic 
conditions gave 1-61 in 4 steps. The next step is epoxide formation using VO(acac)2, TBHB to give 
exclusively a single isomer of 1-62. In this approach ethyl 2-oxocylco-pentanecarboxylate (1-57) 




Scheme 6. Synthesis of (–)-Lingzhiol (1-1) by Long et al. 
 
Thereafter, Birman et al.25 and Xie et al.29 groups reported conceptually similar synthetic 
approaches. The Birman group described a racemic as well as enantioselective synthesis of (+)-
Lingzhiol through an acid-catalyzed semipinacol rearrangement of epoxyalcohol 1-66 to create the 
benzylic quaternary center of 1-67.  
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The tricyclic enone 1-65 was obtained from tetralone 1-64 via a Robinson annulation reaction. This 
was followed by reduction of the enone and epoxidation of 1-65 which delivered a high 
diastereoselectivity of 1-66. The glycidyl alcohol of 1-66 under goes on semipinacol rearrangement 
in the presence of TFA to produce aldehyde 1-67. Further, reduction of the aldehyde and 




Scheme 7. Synthesis of (±)-Lingzhiol (1-1) according to Birman et al. 
 
Furthermore, the same group has achieved the enantioselective synthesis of (+)-Lingzhiol (1-1) 
starting from known ketoester 1-6430 using an asymmetric catalytic Michael addition to MVK in the 
presence of scandium triflate and Bolm’s ligand 1-7131 which produced the Michael adduct (+)-1-
69 in 94% ee (Scheme 8). Thereafter, they have used their initially established procedures to get 












Scheme 8. Enantioselective synthesis of (+)-Lingzhiol (1-1) by Birman et al. 
 
Xie et al.29 have reported a similar synthesis like Birman25 via semipinacol rearrangement under 
acidic conditions. Only the difference was in key intermediate 1-63. The lactone 1-63 was treated 
with MOMCl followed by oxidization at the benzylic position with CrO3 to deliver tetracyclic 
lactone 1-74 in 45% yield. Further, the demethylation and MOM cleavage from 1-74 produced the 
target molecule (1-1) in 74% yield (Scheme 9). 
 
 
Scheme 9. Synthesis of (±)-Lingzhiol (1-1) by Xie et al. 
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The group of Qin et al.32 reported an enantioselective synthesis of (+)-Lingzhiol (1-1) in 17 steps. 
The intermediate 1-76 was obtained in high enantioselectivity (99% ee) via enzymatic resolution 
using baker’s yeast. Nucleophilic addition of an aryllithium species to 1-76 gave 1-78. This 
approach also involves a semipinacol rearrangement. The epoxy alcohol 1-78 obtained after 
rearrangement underwent an intramolecular Friedel-Crafts alkylation to close the B ring of 1-78. 
Hydroquinone functionalities in ring A of 1-79 were created via Baeyer-Villiger oxidation. 
Thereafter, the aryl ester 1-80 was hydrolyzed into hydroquinone, which underwent spontaneously a 




Scheme 10. Synthesis of (+)-Lingzhiol (1-1) by Qin et al. 
 
Recently, the Maier group demonstrated a Lingzhiol synthesis33 which utilizes a benzyl radical 
based cyclization approach. Tetralone 1-53 was reacted with diethyl carbonate to give ketoester 1-
64 in 90% yield. The ketoester 1-64 was reacted with acrolein to give aldehyde 1-81 in 81% yield. 
Subsequently, the aldehyde 1-81 was treated with Ohira-Bestmann reagent 1-82 in the presence of a 
mild base to provide the alkyne 1-83. Later, the keto group of 1-83 was converted into the 
corresponding spiro epoxide.  
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In the key step an intramolecular benzyl radical cyclization on to the alkyne using Cp2TiCl2/Zn 
produced polycycle 1-84. After oxidative cleavage of the double bond, reduction of the derived 
ketone gave a separable mixture (1:1) of two diastereomeric alcohols. Further, benzylic oxidation of 
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3. Goal of the research 
The aim of this project was to investigate the total synthesis of Lingzhiol and analogues for testing 
their biologically activity. According to literature search Lingzhiol has an inhibitory effect on TGF-
β-1 mediated Smad3 phosphorylation which is playing a main role in the chronic kidney disease 
and diabetes problems. Many methods have been reported in the literature. However, it is 
worthwhile to reinvestigate such species considering the developments in traditional medicine and 
the availability of more powerful analytical methods. Besides the interesting biological activity, the 
structure of lingzhiol has a tetracyclic ring system and two consecutive quaternary carbons are 
rather unusual. All the features attracted us to develop a synthesis for the polycyclic natural product 




Figure 7. Retrosynthetic plan for synthesis of (±)-Lingzhiol (1-1). 
 
Our general synthetic strategy for lingzhiol is outlined in Figure 7. Our initial plan was the 
formation of tetracycle 1-63 via intramolecular epoxide opening with the aromatic ring of 1-87 in 
the presence of Lewis acid. Alternatively, the spiro epoxide 1-62 was considered as another possible 
substrate.28 The ketoester 1-93 was initiated from the β-ketoester 1-57 and a subsequent Wittig 
olefination reaction could deliver the exo-methylene compound 1-89. After the crucial cyclization 
reaction to 1-63 benzylic oxidation25 and demethylation should give (±)-Lingzhiol (1-1). 
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4. Results and Discussion 
4.1 Synthesis of exo-double bond via Wittig olefination 
According to the retrosynthetic plan, we have synthesized the alkyl iodide 1-92 from commercially 
available 2,5-dimethoxyphenyl acetic acid (1-90) which was reduced using LiAlH4
34
 in THF to 
alcohol 1-91 in 98% yield. Subsequently, alcohol 1-91 was treated with Ph3P, I2 under Appel-type 





Scheme 12. Synthesis of 2-(2-iodoethyl)-1,4-dimethoxybenzene (1-92). 
 
The next step was alkylation of ethyl 2-oxocyclopentane-1-carboxylate (1-57) with 2-iodoethyl-1,4-
dimethoxybenzene (1-92) using K2CO3 as a base in DMF. This gave the alkylation product 1-93 in 
reasonable yield.36 During this reaction, 1-93a was formed as an elimination by-product.37 Both 
compounds were separated by column chromatography on silica gel. As we were not able to convert 
ketone 1-93 into epoxide 1-88 by a Corey-Chaykovsky reaction using NaH, DMSO,38 we wanted to 
prepare it by epoxidation of the corresponding alkene. Unfortunately, while working on this 
sequence, a similar synthetic approach was published by the Qin group.28 They reported that the 
Wittig olefination reaction does not work in their hand.28 But we have been able to find conditions 
for this crucial Wittig olefination reaction. Initially, we used a number of classical conditions such 
as 1) Ph3PCH3I (1.2 equiv), NaH (2.5 equiv), THF, 0 °C; 2) Ph3PCH3Br (2.5 equiv), t-BuOK (2.5 
equiv), toluene, 100 °C; 3) Ph3PCH3Br (1.2 equiv), n-BuLi (1.5 equiv), THF, –10 °C and also 
Takai-Lombardo methylenation39 but none of them gave the desired product exo-1-89. Eventually, 
we found that it is crucial to use around 3 equiv of methyl triphenylphosphonium bromide and 2.83 
equiv of potassium tert-butoxide, both of them from freshly opened bottles and using distilled THF. 
Under these conditions, this Wittig reaction works well and it’s reproducible easily. The maximum 
yield for this reaction was around 80% (Scheme 13). 
 
 





Scheme 13. Synthesis of exo-1-89 via Wittig olefination. 
 
Furthermore, the formation of exo-1-89 was proven by NMR and HRMS analysis. Particularly, the 
1H NMR spectrum shows two germinal vinyl protons as two triplets at δ values 5.03 and 5.10 ppm 
respectively (Figure 8). 
 
 






































Figure 8. Confirmation of Wittig olefination to give exo-1-89 by 1H NMR spectrum. 
 
4.2 Attempts for opening of epoxide under basic conditions  
The intermediate exo-1-89 was subjected for epoxide formation using m-CPBA (1.5 equiv), 
NaHCO3 (2 equiv) in CH2Cl2 which delivered spiro epoxide 1-88 as a 7:3 mixture of diastereomers. 
Since both isomers would converge to the same allylic alcohols. we have subjected the mixture of 
isomers for further epoxide opening reaction using basic condition to get allylic alcohol 1-94.  
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Initially, we have used a range of basic conditions for the opening of epoxide 1-88 (see Table 1).40 




Scheme 14. Attempts for opening of epoxide to get allyl alcohol 1-94. 
 
Table 1. Summary of basic conditions that were tried for opening of the epoxide 1-88 
 
Entry Reagents and conditions  Results 
1 LDA (6.0 equiv), THF, –78 °C to r.t., 6 h no reaction, SM was recovered 
2 DATMP (1.0 equiv), toluene, –78 °C to r.t., 8 h no reaction, SM was recovered 
3 TMSiI (1.1 equiv), DBN (2.1 equiv), CH3CN 
60 °C, 12 h 
no reaction, SM was recovered 
4 LiNEt2 (2.1 equiv), THF, –78 °C to r.t., 12 h no reaction, SM was recovered 
5 LDA (7.0 equiv), Et2O, –78 °C to r.t., 8 h no reaction, SM was recovered 
6 LDA (3.0 equiv), THF, HMPA (5 drops), –78 °C 
to r.t., 6h 
no reaction, SM was recovered 
Substrate 1-88 was dissolved in the solvent (0.05 M) prior to addition of the base; SM = starting 
material. 
 
4.3 Optimization of epoxide opening under acidic conditions 
With enough amount of epoxide 1-88 in hand, we investigated opening of epoxide 1-88 using 
different Lewis acids.41 However, it did not give an allylic alcohol 1-94. Therefore, we decided to 
use a range of Brønsted acids such as HCl, H2SO4, TFA, H3PO4 and acetic acid. Surprisingly, we 
observed allylic alcohol 1-94 only in low yield using HCl (1M in 1,4-dioxane).42 The reason for the 
low yield is decomposition of the substrate. This could be possible under strong acidic medium. In 
order to improve the yield, we investigated other weak acids such as TFA, acetic acid, and H3PO4. 
However, there was no product formation under these conditions (see the Table 2).  
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Interestingly, in the presence of H2SO4 (1 equiv, 2M in water) in CH2Cl2 at 0 °C for 15 min allyl 
alcohol 1-94 was formed in slightly higher yield (33%) (Scheme 15). 
 
 
Scheme 15. Synthesis of allyl alcohol 1-94 using acidic conditions. 
 
Table 2. Summary of acidic conditions that were tried for opening of the epoxide 1-88 to allylic 
alcohol 1-94 
 
Entry Reagents and conditions  Results 
1 Al(OiPr)3 (2.7 equiv), 2-propanol, 85 °C, 8 h no reaction, SM was recovered 
2 Al(OiPr)3 (5.0 equiv), toluene, 110 °C, 48 h no reaction, SM was recovered 
3 BF3·OEt2 (1.8 equiv), CH2Cl2, 0 °C, 12 h 1H NMR not comply 
4 Ti(OiPr)4 (2.5 equiv), CH2Cl2, 0 °C, 6 h no reaction, SM was recovered 
5 H3PO4 (1 drop), CH2Cl2, 0 °C to r.t., 1 h multiple spots on TLC 
6 AcOH (1 mL), H2O, 80 °C, 8 h no reaction, SM was recovered 
7 HCl (1M in dioxane), 0 °C to r.t., 2 h 20% yield of 1-94 
8 TFA (2.0 equiv), CH2Cl2, 0 °C to r.t., 12 h no reaction, SM was recovered 
9 H2SO4 (0.5 mL), CH2Cl2, 0 °C, 15 min 33% yield of 1-94 




The allylic alcohol 1-94 was treated with m-CPBA in the presence of NaHCO3 in CH2Cl2 to give an 
inseparable mixture of diastereomers of 1-87 in reasonable yield. We believed that it would be 
possible to separate the diastereomers after the cyclization of 1-63. Since only one of the isomer 
was expected to cyclize. Therefore, we have tested a range of Lewis acids41 (Table 3) on the 
mixture of 1-87. In this case, the aromatic ring would act as nucleophile and would undergo epoxide 
opening to get 1-63.  
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However, the desired Lingzhiol precursor 1-63 was not formed, which was confirmed by 1H NMR 
analysis. The NMR data showed the presence of three aromatic protons in all of the tested reactions 




Scheme 16. Intramolecular Friedel–Crafts alkylation reaction of epoxide 1-87. 
 
Table 3. Summary of conditions that were tried for cyclization of epoxides 1-87. 
 
Entry epoxide Reagents and conditions Results 
1 1-87 AlCl3 (0.2 equiv), CH2Cl2, 0 °C to r.t., 30 min no product formation 
2 1-87 BF3·Et2O (1 equiv), CH2Cl2, 0 °C, 20 min no product formation 
3 1-87 InCl3 (1 equiv), ClCH2CH2Cl, 90 °C, 20 min many spots on TLC 
4 1-87 Sc(OTf)3 (2 equiv), ClCH2CH2Cl, 90 °C, 30 min no product formation 
   The substrates were dissolved in the solvent ( 0.05M) prior to addition of the Lewis acid. 
4.4 Intramolecular Friedel-Crafts cyclization of epoxide  
We assumed that the unprotected allylic alcohol interfered with the cyclization process. Therefore, 
we have protected the allylic alcohol 1-94 using acetic anhydride and pyridine as a base to give allyl 
acetate 1-95 in 77% yield (Scheme 17). The 1-95 was treated with m-CPBA and NaHCO3 to give 1-
96 as a 1:1 mixture of diastereomers. Initially, we used a mixture of diastereomers 1-96 for the 
crucial cyclization reaction. But it did not work in my hands. At the same time, we have developed 
a suitable method for separation of the diastereomers to give pure compound 1-97a and 1-97b. 













Scheme 17. Intramolecular Friedel-Crafts cyclization of epoxides 1-96 and 1-97a/b. 
 
Thus, one diastereotopic proton of the CH2OAc group of 1-97a showed a weak cross peak with one 
H-1', whilst the other CH2OAc proton showed a weak cross peak with H-2' atom and a medium-
sized cross peak with a H-1' atom. There were no cross-peaks with the H-3. If one would assume 
that there is also no cross peak with the H-3 atom, then the CH2OAc and the aryl ethyl groups, 
which showed strong cross-peaks between the CH2OAc protons and both H-1' atoms, should adopt 
a cis orientation in diasteroisomer 1-97b. The problem here was that, in the spectrum of compound 
1-97b, the H-1' and H-3 atoms overlapped. Therefore, we were not completely sure about their 
relative stereochemistry (Figure 9). 
 
 
Figure 9. Key NOESY data of epoxide 1-97a and 1-97b. 
 
Nevertheless, both isomers of 1-97a and 1-97b were studied in the intramolecular Friedel-Crafts 
reaction using a range of Lewis acids, including AlCl3 (0.2 equiv), BF3·Et2O (1 equiv), InCl3 (1 
equiv), and Sc(OTf)3
33 (2 equiv) in CH2Cl2 at 0 °C or 1,2-dichloroethane at 90 °C (Table 4). 
However, the epoxides of 1-97a/b did not undergo the desired reaction to afford polycyclic 1-98. 
Although these cyclization reactions would correspond to an allowed 6-exo-tet transformation,43 
stereoelectronic effects still may have thwarted this cyclization mode.  
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Table 4. Summary of conditions that were tried for cyclization of epoxides 1-96 and 1-97a/b. 
 
Entry epoxide Reagents and conditions  Results 
1 1-96 & 1-97a/b AlCl3 (0.2 equiv), CH2Cl2, 0 °C, 30 min SM disappeared, no product 
formation 
2 1-96 & 1-97a/b BF3·Et2O (1 equiv), CH2Cl2, 0 °C, 1 h SM disappeared, no product 
formation 
3 1-96 & 1-97a/b InCl3 (1 equiv), ClCH2CH2Cl, 90 °C, 2 h SM disappeared, no product 
formation 
4 1-96 & 1-97a/b Sc(OTf)3 (2 equiv), ClCH2CH2Cl, 90 °C, 
1 h 
SM disappeared, no product 
formation 
The reactions were carried out both with the mixture 1-96 and individual diastereomers of 1-97a/b. 
 
4.5 Synthesis of tetracyclic lactone 
We could shorten the synthetic route of lingzhiol which was published by Qin et al.28 while our 
work was underway. But our approach can directly produce olefin exo-1-89 via classical Wittig 
olefination reaction without any addition and elimination reactions. Thus, the allylic oxidation of 
exo-1-89 with t-BuOOH in the presence of selenium dioxide delivered the allylic alcohol 1-61 as a 
single diastereomer. Furthermore, the epoxidation using m-CPBA gave spiro epoxide 1-62 in 79% 
yield. A further step involves an intramolecular Friedel-Crafts alkylation of 1-62 in the presence of 
BF3·Et2O in CH2Cl2 which gave tetracyclic lactone 1-63 as a white solid in 58% yield (Scheme 18). 
 
 
Scheme 18. Synthesis of tetracyclic lactone 1-63. 
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Initially, we have used a previously reported methods consisting of NBS, (PhCO2)2 in CCl4/Water; 
then MnO2, CH2Cl2 for the benzylic oxidation reaction.
27,28  Unfortunately, the crucial reaction did 
not work in our hands. Therefore, we have used the method of Birman and co-workers.25 The key 
intermediate 1-63 in hand, the secondary alcohol was protected using acetic anhydride, pyridine and 
a catalytic amount of DMAP in CH2Cl2 to give acetate 1-85-syn in quantitative yield. Subsequently, 
the acetate 1-85-syn was treated with O2, N-hydroxyphthalimide (NHPI), and AIBN in MeCN. 
After heating the mixture overnight the solvent was removed, and the crude phenone was directly 




Scheme 19. Synthesis of phenone 1-68. 
4.6 Completion of the total synthesis of (±)-Lingzhiol (1-1) 
After having a sufficient amount of tetracyclic 1-68 in hand, the next step was cleavage of the 
acetate group under acidic condition. For this reaction, we have used aqueous 3N HCl in MeOH at 
85 °C to give hydroxy ketone 1-100 in 96% yield. Further, the demethylation reaction of 1-100 
using AlCl3 (2.2 equiv) in the presence of t-BuSH provided the target molecule (±)-Lingzhiol (1-1) 
in 60% yield as a yellow solid (Scheme 20). The 1H NMR spectra showed two aromatic protons as 
two doublets at 7.22 ppm and 6.77 ppm and 13C, and HMBC spectra clearly indicated the presence 
of the lactone and four quaternary centers as well. Also, the spectra of Lingzhiol (1-1) matched with 




Scheme 20. Synthesis of (±)-Lingzhiol (1-1). 
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4.7 Synthesis of Lingzhiol derivatives 
We have developed a quite efficient route to get (±)-Lingzhiol (1-1) in nine steps. This encouraged 
us to make various derivatives as Lingzhiol analogues. They include desoxylingzhiol 1-101, 
obtained from tetracyclic lactone 1-63, quinone derivative 1-102 from desoxy 1-101 and 
monomethoxy derivative 1-103 as well as ketone 1-104 from tetracyclic lactone 1-63. All these 
compounds were submitted for preliminary screening. 
 
4.7.1 Synthesis of desoxylingzhiol 
 
Tetracyclic lactone 1-63 in hand, the next reaction involves the deprotection of the aryl methyl 
ethers using AlCl3 and t-BuSH in CH2Cl2. After heating the reaction mixture for overnight at 40 °C 
Desoxy-lingzhiol (1-101) was obtained in 74% yield (Scheme 21). However, we did not observe 




Scheme 21. Synthesis of desoxylingzhiol (1-100). 
 
4.7.2 Synthesis of quinone derivative 1-102 
 
It is well know that quinone derivatives are widely used in pharmaceutical industries. Because they 
are playing a main role in antibacterial activity.44 Based on this kind of results, we have oxidized the 
phenol derivative 1-101 using DDQ in CH2Cl2/Water (25:1) to give quinone 1-102 as a yellow solid 




Scheme 22. Synthesis of quinone derivative 1-102. 
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4.7.3 Synthesis of monomethoxy-deoxy derivative 1-103 
 
We have made monomethoxy 1-103 from the tetracyclic lactone 1-63 using BBr3 in CH2Cl2. 
Interestingly, we have observed that only one of the aryl methyl ethers was cleaved to afford 




Scheme 23. Synthesis of monomethoxy derivative 1-103. 
 
The 1D and 2D NMR spectra of 1-103 showed that 1-OMe was selectively cleaved at the C1 
position. 1H NMR spectra showed OMe signal as a singlet at 3.76 ppm and HMBC spectrum 
exhibited cross-peaks between the protons of OCH3 and carbon  at C4 (three-bond correlation) and 
C5 atoms (four-bond correlation). All of the carbon atoms and protons in this compound were fully 
assigned (Figure 10, 11). 
 





































































Figure 10. 1H NMR (400 MHz) spectrum of monomethoxy 1-103 in CD3OD (0.5 – 7.5 ppm). 
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Figure 11. HMBC spectrum of monomethoxy 1-103 in CD3OD. 
 
4.7.4 Synthesis of ketone derivative 1-104 
 
Finally, the ketone 1-104 was prepared easily by an oxidation reaction of 1-63 using IBX in DMSO. 
After heating the reaction mixture for 5 h at 80 °C ketone 1-104 was obtained as semisolid in 78% 
yield. Finally we have achieved five different compounds as Lingzhiol analogues for testing their 
biological activity (Scheme 24).  
 
 
Scheme 24. Synthesis of ketone derivative 1-104. 
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4.8 Biological Screening of Lingzhiol analogous 
4.8.1 Antibiotic activity 
 
In order to investigate structure activity relationship of Lingzhiol we have successfully synthesized 
a set of its analogues (Scheme 21-24).  They are desoxylingzhiol (1-101), quinone derivative 1-102, 
monomethoxy-lingzhiol (1-103) and ketone 1-104. The preliminary screening of these compounds 
against S. aureus (MRSA; RKI 11-02670), E. coli (DSM 1116), and p. aeruginosa (PA7; DSM 
24068) suggested that they are inactive up to concentrations of 100 μM. 
 
4.8.2 Antiproliferative activity    
 
The compounds were tested on two different cell lines. In the first method, Human T-lymphoid 
(Cem) cells were seeded in 96-well plates at 60,000 cells/well in the presence of different 
concentrations of the compounds. The cells were allowed to proliferate for 72 h and then counted in 
a Coulter counter. The 50% inhibitory concentration (IC50) was defined as the compound 
concentration required reducing cell proliferation by 50%. In a second method, human cervical 
carcinoma (HeLa) cells were seeded in 96-well plates at 15,000 cells/well in the presence of 
different concentrations of the compounds. After 4 days of incubation cell viability in the presence 
of the compounds was evaluated by the MTS method [(3-(4,5-dimethylthiazole-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, Promega)]. Briefly, medium was 
replaced by 50 μ of 0.02% MTS in PBS and incubated for 2 h at 37 °C. The optical density (OD) 
was determined at 490 nm and the IC50 was calculated. Finally, all the compounds were found to be 
inactive. The results are summarized in Table 5. 
 
4.8.3 Antiviral activity 
 
Also, these compounds were tested against the following viruses: Respiratory syncytial virus (RSV) 
strain Long, influenza virus A (subtype H1N1), influenza virus B, human coronavirus strain 229E, 
yellow fever virus (17D vaccine strain). The antiviral assays were based on inhibition of virus-
induced cytopathogenicity in human embryonic lung (HEL) fibroblasts, African green monkey cells 
(Vero), human cervical carcinoma cells (HeLa) or Madin-Darby canine kidney cells (MDCK). But 
there was no activity observed. Confluent cell cultures in microtiter 96-well plates were infected 
with the virus in the presence of varying concentrations of the test compounds. Viral 
cytopathogenicity was recorded as soon as it reached completion in the control virus-infected cell 
cultures that were not treated with the test compounds. Antiviral activity was expressed as the EC50 
or compound concentration required to reducing virus-induced cytopathogenicity by 50%. 
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4.8.4 Other activities 
 
Compounds active against yellow fever virus were subsequently tested against Zika virus (MR766 
strain) and dengue virus serotype-2 (New Guinea C strain). Antiviral activity against Zika virus was 
measured using the MTS assay. Inhibition of DENV-2 infection of Vero cells was evaluated using 
flow cytometry. Confluent monolayers were infected with DENV-2 in the presence of different 
concentrations of the test compounds. DENV antigen expression was analyzed 24 h after infection 
by flow cytometry (FACS Calibur, BD Biosciences), using a specific anti-DENV-2 antibody (clone 
3H5, Millipore). The EC50 value was determined as the compound concentration required to inhibit 
DENV-2 infection of Vero cells by 50%. Here also the results were found to be inactive.  
 








EC50 (μM) Cem Hela 
1-1 >10 >10 >10 
1-101 >10 >10 >10 
1-102 >10 >10 >10 
1-103 >10 >10 >10 
1-104 >10 >10 >10 
 




30                                                                                                                                          Conclusion 
 
 
5. Conclusion  
In overall summary, we have investigated two different approaches towards the total synthesis of 
(±)-Lingzhiol (1-1). The first approach was based on intramolecular Friedel-Crafts alkylation of 1-
95 and 1-96a/b using Lewis acids to get 1-63 as core molecule. In order to get key intermediate 1-
95, we started from commercially available 1-57 and alkyl iodide 1-92 (3 steps synthesis). A crucial 
reaction turned out to be the Wittig olefination to give exo-1-89. However, we have found 
appropriate conditions for this transformation of the ketone 1-93 to exo-1-89 in good yield. Further 
steps involved epoxide formation, an opening of epoxide to give an allylic alcohol which was 
converted to 1-96 and 1-97a/b (3 steps overall). Later, both isomers were used for the cyclization 
reaction using various Lewis acids. However, presumably owing to stereoelectronic effects the 





Scheme 25. Attempts at intramolecular Friedel-Crafts alkylation of epoxides 1-96 and 1-97a/b. 
These epoxides were prepared from the Wittig product exo-1-89. 
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A second approach was similar to the route published by Qin et al. However, the Wittig reaction to 
afford exo-1-89 allowed us to shorten the previously reported route. The key intermediate exo-1-89 
delivered spiro epoxide 1-62 as a single diastereomer. Further, an intramolecular cyclization 
provided polycycle 1-63 in 58% yield. A subsequent, benzylic oxidation on acetate 1-85-syn led to 
phenone 1-100. Finally, treatment of 1-100 with AlCl3 and t-BuSH delivered (±)-Lingzhiol (1-1) as 






Scheme 26. Synthesis of (±)-Lingzhiol (1-1) via spiro epoxide opening. 
 
Finally, we have made five different compounds such as 1-1, 1-101, 1-102, 1-103 and 1-104 as 
lingzhiol analogues for preliminary screening (Figure 12). All the compounds were tested with for 
biological activities such as antibiotic, antiviral and antiproliferative properties. The results are 






























6.1 Macrolides as antibiotic drugs 
 The discovery of antibiotics was one of the key achievements of modern medicine. 
Antibiotics have been used enormously to human health for treating various bacterial infections. 
Many antibiotics bind to the 50S subunit of the bacterial ribosome and prevent translocation of 
peptidyl-t-RNA.45 Still, natural products play a key role in the discovery of drugs against human 
diseases. For instance, naturally occurring macrolides and polyketides show interesting biological 
activities such as antibacterial, antifungal, prokinetic, and immunosuppressant properties. 
Macrolides usually have drug-like properties such as good solubility, tissue penetration, 
lipophilicity, and metabolic stability.46 They are classified by the size from 12-membered to 60-
membered lactones. Notably, 14-membered to 16-membered macrolides are most frequently used 
as antibiotics to treat skin and soft tissue infections.47 Penicillin G (2-1) was isolated from the 
Penicillium chrysogenum by Alexander Fleming in 1928. It showed antibacterial activity against 
Staphylococcus aureus due to the β-lactam ring.48 However, the antimicrobial spectrum of 
macrolides is broader than that of penicillins. Many macrocyclic based antibiotics are being used in 
the clinical practice. Among them, erythromycin (2-2) is a 14-membered macrolide that was 
isolated from the fungus Saccharopolyspora erythraea. It is used clinically for treatment of Gram-
positive bacterial infections.49 Clarithromycin (2-3) is a derivative of erythromycin and used for 
treatment of chronic bronchitis, and erysipelas.50 Telithromycin (2-4), a synthetic derivative of 
erythromycin featuring an alkyl and hetaryl containing side contain linked to the macrolactone via a 
cyclic carbamate is used for the treatment of community-acquired pneumonia (CAP).51 Fidaxomicin 
(2-5) was isolated from Dactylosporangium aurantiacum for the treatment of clostridium difficile 
associated diarrhea.52 Spiramycin (2-6) is a glycomacrolide antibiotic is used for the treatment of 
bacterial infections.53 Vancomycin (2-7), a peptide derivative where aryl ring of the side chains are 
cross-linked is mainly used for the treatment of Gram-positive bacterial infections such as 
methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus 












Figure 13. Examples of clinically used antibiotics. 
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6.2 Predatory bacteria 
Myxobacteria are a promising source for the discovery of novel antibiotics. They produce several 
natural products such as Salimyxins,55 Salimabromide,56 Jahnellamides,57 and Cystomanamides.58 
In recent years, further screening of various strains put forth novel antibiotics. Notably, predatory 
bacteria are a family of myxococcaceae that are able to feed on other microbes as sole nutrient 
source.59 Furthermore in 2014, Müller et al.60 reported that Disciformycin A (2-8) and B (2-9) were 
isolated from the Pyxidicoccus fallax stain AndGT8 (Figure 14). Structurally, Disciformycin A (2-
8) has a double bond at C2-C3 position and B (2-9) has a double bond between at C3-C4 position. 
Both of them showed antibacterial activity against Gram-positive bacteria. However, Disciformycin 
B (2-9) displays a more inhibitory efficiency than Disciformycin A (2-8) in the range 0.6 to 1.2 μg 
mL–1 against Staphylococcus aureus including vancomycin-resistant S. aureus (VRSA) and 
methicillin-resistant S. aureus (MRSA) strains.61 Moreover, these compounds don’t show any 




Figure 14. Disciformycin A (2-8) and B (2-9) were isolated by Müller et al.60 
 
Likewise, Gulmirecin A (2-8) and B (2-9) reported by Nett et al.62 were isolated from the 
Myxobacterium Pyxidicoccus fallax HKI 727. Structurally, Gulmirecins are related to 
Disciformycin A (2-8) and B (2-9). Interestingly, both families have an isovaleryl group at the C6 
position and α-arabinofuranose moiety which is attached to the macrolactone ring. The 
antimicrobial activity of Gulmircein A (2-10) and B (2-11) were not varying from Disciformycin A 
(2-8) and B (2-9). However, the minimum inhibitory concentration (MIC) value of Gulmirecin A 














































7.1 Biosynthesis of Gulmirecins 
The first biosynthesis proposals for Gulmirecins were reported by Nett et al. in 2014.62 It was 
suggested that these macrolides were produced by the polyketide synthase (PKS) pathway.63 The 
type I PKS process, a decarboxylative Claisen condensation takes place repeatedly between 
individual thioester monomers. Furthermore, linked monomers have several catalytic units with 
specific functions such as ketosynthase (KS), acyl transferase (AT), and acyl carrier protein (ACP) 
which are necessary to produce the β-ketoester intermediates.64 Gulmirecin consist of six gene 
sequences in the PKS modules (gulA–gulF), which assembly the carbon chain. The stereocentres 
are introduced at C-3, C-7, and C-11 positions by NADPH-based reduction. After the polyketide 
synthesis and macrolactonization, a cytochrome P450-based oxidation introduce the hydroxyl group 
at C6. The modules may contain further domains (KR, DH, ER) to introduces further functionality 
after the Claisen condensation steps (Figure 16). 
 
 
Figure 16. Biosynthesis of Gulmirecin A (2-10) according to Nett et al.62 
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The second biosynthesis proposals for Gulmirecins and Disciformycins were reported by 
Kirschning et al.65 in 2018. Structurally, Gulmirecins are quite similar to Disciformycins. 
Accordingly, the biosynthesis of the gulmirecins is similar. The main difference relates to the 
introduction of the C3 hydroxyl group. Whereas in the Nett proposal this originates from a C3 
ketone, in the Kirschning proposal 3-OH is introduced by oxidation. The intermediate 2-12 leads to 
macrolactone 2-13 by a thioesterase. Then, macrolactone 2-13 was oxidized to generate hydroxyl 
group at the C6 position. A further sequence involves an oxidation at C3 position and esterification 
at C6 position to furnish Gulmirecin A (2-10). Likewise, elimination of the hydroxyl group at C3 
could lead to Disciformycin A (2-8) and B (2-9), respectively (Figure 17).  
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7.2 Known syntheses of Gulmirecins and Disciformycins 
Gulmirecins and Disciformycins were described in a patent in 2016.66 It is reported that these 
compounds have antimicrobial activity against Gram-positive bacteria. A total synthesis of 
Disciformycin A (2-8) was described utilizing an Evans aldol reaction and Yamaguchi 
macrolactonization. The key intermediate vinyl iodide 2-1667 was obtained from readily available 
propargyl alcohol (2-14) in a two step sequence. Propargyl alcohol (2-14) was converted to allyl 
alcohol 2-15 using CuI and MeMgBr followed by quenching of the vinyl metal intermediate with I2. 
The resulting allyl alcohol 2-15 was treated with NaH, and PMBCl to furnish vinyl iodide 2-16 in 




Scheme 27. Synthesis of (Z)-1-(((3-iodo-2-methylallyl)oxy)methyl)-4-methoxybenzene (2-16).   
 
The required aldehyde 2-24 was prepared from (Z)-angelica acid methyl ester (2-17) in a 12 step 
sequence.69 Thus, ester 2-17 was converted into amide 2-18 by reduction/oxidation and aldol 
reaction. Treatment of amide 2-18 with DIBAL-H at –78 °C, followed by the addition of Wittig 
reagent 2-19 provided ester 2-20 quantitatively.70 Then, this ester 2-20 was transformed to aldehyde 
2-21 by reduction/oxidation and an Evans aldol reaction furnished amide 2-23 in 77% yield. The 
next steps involve protection of secondary alcohol, reductive cleavage of the auxiliary and Swern 

















Scheme 28. Synthesis of aldehyde 2-24 from (Z)-angelica acid methyl ester (2-17).  
 
Another key intermediate 2-25 was obtained from aldehyde 2-24 via Corey-Chaykovsky71 reaction 
and opening of the resulting epoxide with 2-16. Subsequently, protecting group manipulations 
delivered allyl alcohol 2-26. Oxidation of allyl alcohol 2-26 gave seco acid 2-27 in 96% yield. This 
seco acid 2-27 was subjected to Yamaguchi esterification72 using DIPEA, 2,4,6-trichloro benzoyl 
chloride to furnish macrolactone 2-28. Further, the secondary alcohol 2-29 was generated by 
debenzylation of 2-28.73 The next step involved installation of the 3-methylbutanoyl group at the C6 
hydroxy, which was achieved by Yamaguchi esterification of 2-28 with 3-methylbutanoyl chloride. 
This was followed by cleavage of the methylthiomethyl ether function at C5, Swern oxidation,74 
and TBAF mediated TBS ether cleavage which furnished macrolactone 2-30. Finally, 
Disciformycin A (2-8) was received by attaching the arabinose derivative 2-3175 followed by 












Scheme 29. Total synthesis of Disciformycin A (2-8) displayed in a patent 2016.66 
 
A second, total synthesis of Disciformycin A (2-8) and B (2-9) was reported by Fürstner et al.76 in 
2018 that is outlined below (Schemes 31-35). The key features of their synthesis are C-silyl 
building block 2-34 that can be easily functionalized at the C4 position and macrolactone formation 
via ring closing alkyne metathesis RCAM with formation of C8-C9 bond.77 The key intermediate 
vinyl TMS compound 2-34 was obtained from easily available (R)-3-hydroxy-2-methylpropanoate 
(2-32). This ester was converted to aldehyde 2-33 in a three step sequence. Thereafter, Corey-Fuchs 
and Schwartz’s reagent (Cp2Zr(H)Cl)
78 were applied to afford TMS alkene 2-34 regioselectively 
(Scheme 30).  
 
 






Scheme 30. Synthesis of C1-C4 building block featuring a vinyl silyl group 2-34.  
 
Another fragment, aldehyde 2-38 was efficiently prepared from (R)-isopropylideneglyceraldehyde 
(2-35) in a five step sequence. Thus, (R)-isopropylideneglyceraldehyde (2-35) was subjected to 
Carreira reaction protocol79 using propyne, 1R,2S-(–)-N-methylephedrine, and Zn(OTf)2. The 
resulting secondary alcohol was protected with TBSCl in the presence of imidazole to give TBS 
ether 2-36. Hydrolysis of the acetal under acidic conditions gave a diol which was converted to TES 
ether 2-37 by reacting it with TESCl in dichloromethane. A selective cleavage of the primary TES 





Scheme 31. Synthesis of intermediate 2-38 from (R)-isopropylideneglyceraldehyde (2-35). 
 
The section containing the side chain 2-42 was prepared from the commercially available (Z)-2-
methylbut-2-enoic acid. The derived Weinreb amide 2-39 was converted to alcohol 2-40 with 91% 
ee by Corey-Bakshi-Shibata reaction on the corresponding ketone.81 The resulting secondary 
alcohol 2-40 was converted to the TBS ether and after that lithiation using n-BuLi, and addition of 
MeI furnished alkyne 2-41 in 98% yield. TBAF mediated cleavage of silyl ether 2-41 delivered the 
corresponding alcohol 2-42 in 88% yield (Scheme 32). 
  






Scheme 32. Synthesis of key intermediate 2-42. 
 
Thereafter, key fragments 2-38 and 2-34 were coupled through metal-halogen exchange strategy.82 
Thus, vinyl iodosilane 2-34 was first treated with iPrMgCl·LiCl at –25 °C and the resulting 
Grignard reagent reacted with aldehyde 2-38 to furnish alcohol 2-43 in 69% yield.83 Further, 
oxidization of the secondary alcohol, removal of the PMB group, and oxidation of primary alcohol 
gave secoacid 2-45. Afterwards, the seco acid 2-45 was treated with EDCl, DMAP in the presence 
of alcohol 2-42 to deliver ester derivative 2-46 in 78% yield. After cleavage of TES ether, the 
isovalerate was attached at C6 position using CeCl3 as a catalyst
84 and macrocyclization (rcam) 
gave 2-49. Also, the authors described an alternative way to prepare lactone 2-49 where the rcam 
with molybdenum catalyst 2-47 was performed prior to attachment at the isovaleryl substituent 
(Scheme 33).  
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The formal trans hydromethylation of the triple bond proved quite challenging. First, the TMS 
group was removed from macrolactone 2-49 using AgF, HOAc in THF/MeOH/H2O.
85 Then, the 
TBS ether was cleaved under acidic medium to furnish propargyl alcohol 2-50 without acyl group 
migration. Alcohol 2-50 was converted to tributyltin derivate 2-51 in high regioselectivity using 
15mol% of [Cp*RuCl]4 as a catalyst.
86 Next, Stille coupling at C8 and glycosylation with arabinose 
derivative 2-52 at C7 position completed the target molecule Disciformycin B (2-9). Furthermore, 
Disciformycin B (2-9) was treated with Et3N in CH2Cl2/MeCN to afford Disciformycin A (2-8) in 




Scheme 34. Total synthesis of Disciformycin A (2-8) and B (2-9) by Fürstner et al.76 
 
Kirschning et al.65 described the total synthesis of the aglycon of Disciformycin B (2-9) in 2018. 
The required intermediate alkene 2-54 was synthesized from commercially available D-lactate (2-
53) in 4 steps (Scheme 35). Further steps involved an ozonolysis87 and Wittig olefination88 which 
gave ethyl ester 2-55 in 10:1 diastereoselectivity. The ester 2-55 was converted to the aldehyde by 
reduction/oxidation and following an Evans aldol protocol89 forming the C6-C7 bond, product 2-56 
was obtained with in good diastereoselectivity. Next, formation of Weinreb amide by using 
DIBAL-H, and N,O-dimethylhydroxylamine hydrochloride was followed by protection of the C7 
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alcohol to give compound 2-57. Towards macrolactone formation, allyl magnesium bromide was 
added to Weinreb amide 2-57 and stereoselective reduction of the resulting ketone using CBS-
reagent (2-58) together with BH3·DMS
90 furnished alcohol 2-90 in 95% yield.  
 
Scheme 35. Synthesis of alcohol 2-90 from D-lactate (2-53) by Kirschning et al.65 
 
Further synthetic sequence consisted of Sharpless dihydroxylation,91 periodate cleavage, and Wittig 
olefination88 which gave α,β-unsaturated ester 2-91. Protecting group manipulations and 
Yamaguchi lactonization92 resulted in macrolactone 2-92. After the PMB cleavage the obtained 
alcohol was oxidized and the derived ketone subjected to Wittig olefination to provide the aglycon 
of Disciformycin B (2-93) in 6:1 E/Z ratio. This synthesis requires around 23 steps (Scheme 36). 
 
 
Scheme 36. Synthesis of the aglycon of Disciformycin B (2-93) by Kirschning et al.65 
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8. Goal of the research 
The aim of our project was to develop a total synthesis of Gulmirecin B (2-11) for biological 
activity studies. Gulmirecin A (2-10) and B (2-11) were isolated from the predatory bacterium 
Pyxidicoccus fallax HKI 727 by Nett et al.62 They have strong antibacterial activity against 
Staphylococcus species. Structurally, the Gulmirecins are 12-membered macrolactones containing 
four stereocentres, two trisubstituted double bonds, and α-arabinofuranose attached at the C-7 
position. All these features attracted us to embark on a synthesis of Gulmirecin B (2-11). Our 
retrosynthetic plan for Gulmirecin B (2-11) is outlined in Figure 18. Our initial plan was to make 
the macrolactone 2-94 by using two key fragments, the organozinc reagent 2-95 (C1-C4 building 
block) and the Weinreb amide 2-96 (C5-C14 building block), which contains the crucial 
trisubstituted double bond at C8/C9. Intermediate 2-95 can be synthesized from 5-hexenoic acid via 
asymmetric alkylation.93 The C7-C8 bond formation to give 2-96 could be generated from ketone 2-
98 via enolization and cross-coupling. Ketone 2-98 in turn should be available from tartrate 
derivative 2-99 and the Grignard reagent 2-101 (C9-C14 fragment).94 The latter can be traced back 
to L-malic acid (2-102). Finally, Gulmirecin B (2-11) could be obtained by removal of the 
protecting group at C7 followed by attachment of the sugar moiety.  
 
 
Figure 18. Retrosynthetic plan for Gulmirecin B (2-11).  
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From a synthetic point of view, the most challenging step would be the formation of the (E)-
trisubstituted double bond between C8-C9 via cross-coupling. We were aware of the fact that vinyl 
triflate 2-97 could undergo an intramolecular Heck coupling to the C12/C13 double bond instead of 
the desired coupling with a methyl anion equivalent. To address these issues, we considered a 




Figure 19. Model studies with 5-bromopent-1-ene (2-103) towards the total synthesis of 
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9. Results and Discussion 
9.1 Model studies towards Gulmirecin B 
As discussed in the retrosynthetic analysis, we synthesized bis-Weinreb amide 2-99 from 
commercially available (–)-diethyl-D-tartarte (2-100) using a literature procedure.95 The starting 
material (–)-diethyl-D-tartarte was treated with acetone in the presence of BF3·OEt2 affording 
dimethoxy ester 2-104 in 75% yield.96 Thereafter, dimethyl ester 2-104 was treated with N,O-
dimethyl hydroxylamine and trimethyl aluminum (3M in toluene) at –10 °C, which gave us bis-
Weinreb amide 2-99 as a white solid in 68% yield. The next step was the controlled addition of 4-
pentenyl magnesium bromide (2-105) to bis-Weinreb amide 2-99 at 0 °C leading to the formation of 
mono keto with Weinreb-amide 2-106 in 80% yield. Mono additions of Grignard or organolithium 
reagent to bis-Weinreb amide 2-99 have been described in the literature.97 Further reactions aimed 
at the formation of a trisubstituted double bond at C5 position. The mono ketone 2-106 was 
enolized using LiHMDS in THF at –78 °C and the resulting enolate was trapped by addition of 
PhNTf2 to provide enol triflate 2-107 in 59% yield. Next step was the conversion of OTf to methyl 
group 2-108 via cross-coupling. Initially, we applied Kumada coupling conditions using MeMgBr 
in the presence of a palladium catalyst.98 Unfortunately, we did not receive 2-108. In parallel, we 
tried two different Suzuki conditions such as 1) MeBF3K (1.5 equiv), Pd(PPh3)4 in THF
99 and 2) 
(MeBO)3, K2CO3, Pd(PPh3)4 in 1,4-dioxane at 50 °C. However, the crucial cross coupling reaction 
did not work in our hands. In all the cases, we received only a complex mixture as shown by TLC 















Scheme 37. Model studies with 4-pentenyl magnesium bromide (2-105).  
 
We assumed that vinyl triflate 2-107 in the presence of Weinreb amide was not suitable for a cross 
coupling by palladium catalysis. Therefore, we decided to reduce the ketone and Weinreb amide 2-
106 simultaneously using NaBH4 in THF
94 which gave a mixture of secondary and primary 
alcohols (Scheme 38). First, primary alcohol was converted into TBS ether 2-109a, TIPS ether 2-
109b and trityl ether 2-109c using classical conditions.100 The next step was the oxidation of 
secondary alcohols 2-109a-c using DMP, NaHCO3 in CH2Cl2 which delivered ketones 2-110a-c in 
good yield. With ketones 2-110a-c in hand, we tested them for an enolization reaction using 
KHMDS or LiHMDS and addition of PhNTf2.
98 However, we observed that enolization doesn’t 
take place in the presence of silyl ether derivatives 2-110a-b. Interestingly, trityl ether 2-110c 
delivered OTf 2-111 using KHMDS in THF at –78 °C and addition of PhNTf2 in 56% yield. In 
order to prepare 2-112, vinyl triflate 2-111 was subjected for cross coupling using two different 
conditions such as 1) (MeBO)3, anhydrous K2CO3, Pd(PPh3)4 in THF at 40 °C for 1 h, and 2) 
CH3BF3K, Pd(PPh3)4 in THF at 55 °C for 20 min. In both cases, we found that coupling occurred 
with the terminal double bond to give intramolecular Heck coupling product 2-113 which was 
confirmed by 1H NMR and HRMS analysis (Figure 20). 
  







Scheme 38. Attempts at cross coupling of 2-111 to get diene 2-112 with a trisubstituted double 
bond. 
 
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5
Chemical Shift (ppm)



























































































Figure 20. 1H NMR spectrum of intramolecular Heck coupling product 2-113. 
 
Simultaneously, we did the enolization reaction without the double bond on the side chain (Scheme 
39). We used our initially established procedures for all the transformation to get 2-116. A freshly 
prepared solution of butylmagnesium bromide (2-119) was slowly added to bis-Weinreb amide 2-99 
to give mono ketone 2-114 in good yield. Further steps were oxidation of alcohol 2-115 and 
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enolization of 2-116 using standard conditions. Surprisingly, the desired vinyl triflate 2-118 could 
not be obtained. Eventually, we decided to prepare 2-118 via Grignard addition and subsequent 
elimination. Hence, 2-114 was treated with MeLi in THF at 0 °C to provide a mixture of tertiary 
alcohols. Then, elimination of water using Burgess reagent (MeO2CN
-SO2N
+Et3)
101 gave endo/exo 
2-117 (1:0.78) which was subjected for isomerization in the presence of Pd(OH)2, Cs2CO3
102 in 
CH3CN to give 2-118 in 58% yield. However, we could not implement this strategy with real 





Scheme 39. Studies related to the construction of the trisubstituted double bond with ketone 2-166 
lacking a terminal double bond. 
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9.2 Second retrosynthetic analysis featuring a Shapiro reaction 
Our second retrosynthetic plan was based on the formation of vinyllithium reagent 2-122 via 
Shapiro reaction.103 According to Shapiro reaction, the vinyllithium 2-122 could be obtained from 
sulfonylhydrazone 2-124 using sec-BuLi as a base. The required sulfonylhydrazone 2-124 can be 




Figure 21. The second retrosynthetic analysis for Gulmirecin B (2-1) based on a Shapiro reaction to 
form the C7-C8 bond. 
 
Before executing the above mentioned retrosynthetic plan, we aimed to make a model study with 
hydrazone derivative 2-126 instead of 2-124. These studies would allow us to develop a precursor 
2-124 towards Gulmirecin B (2-11). In order to prepare 2-126, we started with 2,4,6-
triisopropylbenzenesulfonyl chloride (2-127) which was treated with hydrazine hydrate under acidic 
condition affording 2,4,6-triisopropylbenzenesulfonylhydrazide104 as a white solid.  
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Immediately, 2,4,6-triisopropylbenzenesulfonylhydrazide was condensed with 6-methylhept-5-en-
2-one (2-128) in presence of aqueous HCl in CH3CN which gave us hydrazone 2-129 as a white 
solid.105 Hydrazone 2-129 was treated with 2.5 equiv of sec-BuLi in THF at –78 °C to generate the 
intermediate vinyllithium species which was added to bis-Weinreb amide 2-99 at –78 °C. 
Unfortunately, we obtained exo-2-131 instead of 2-130. The 1H NMR spectrum showed two singlet 
protons at 5.92 and 6.22 ppm and missed the CH3 group signal around at 1.45 ppm (Figure 22). It 
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Figure 22. 1H NMR spectrum of enone exo-2-131. 
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On the other hand, when we generated vinyllithium species 2-134 in situ from dimethylallyl 
bromide and the acetone sulfonylhydrazone106 2-132 and added the resulting vinyllithium species to 
bis-Weinreb amide 2-99 at –78 °C, the desired enone 2-130 was obtained. The 1H NMR clearly 
indicates a CH3 group signal at 1.40 as a singlet and there are no signals between 5.5 and 6.5 ppm 
(Figure 23). Since the third approach seemed more promising, we did not continue this approach 




Scheme 41. Synthesis of vinyllithium 2-134 using the 3,3-dimethylallyl bromide (2-133).  
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Figure 23. 1H NMR spectrum indicates the desired compound 2-130. 
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9.3 Third retrosynthetic analysis 
In order to make the C7-C8 bond formation, our revised retrosynthetic plan is based on the addition 
of vinyllithium 2-138 to Weinreb amide 2-142 to get ketone 2-136. In this case, further sequences 
consist of an oxidation/reduction to create a single configuration at C7. Alternatively, we 
considered the addition of vinyllithium 2-138 to aldehyde 2-143 to get alcohol 2-137. Depending on 
the stereoselectivity of this reaction, the resulting C7 secondary alcohol could be used for 
attachment of the sugar. The ketone 2-136 would lead to macrolactone 2-120 via Mitsunobu 




Figure 24. Third retrosynthetic plan towards Gulmirecin B (2-11).  
 
The key fragment C8-C14 2-139 can be synthesized from commercially available (S)-malic acid (2-
141). The vinyl bromide functionality would come from an alkyne precursor whereas the C12-C13 
double bond would be created by a Wittig reaction.108 The required C1-C7 fragment 2-142/143 can 
be generated from commercially available 5-hexen-1-ol (2-146) via Jones oxidation,109 asymmetric 
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9.3.1 Synthesis of C8-C14 Fragment 
Initially, we prepared the C8-C14 fragment 2-139 using (R)-malic acid. Later, we decided to use 
(S)-malic acid (2-141) due to its cheaper price as compared to (R)-malic acid. Ideally one would 
aim at ent-2-139 since with 2-139 the macrolactonization has to be performed under Mitsunobu 
condition.107 The starting material (S)-malic acid (2-141) was reduced using BH3·DMS and 
trimethyl borate to afford butanetriol 2-147.113 Due to the hydrophilic nature of butanetriol 2-147, it 
was used without any further aqueous workup and column chromatography. The crude 2-147 was 
treated with cyclohexanone in acidic medium113 which provided dioxolane 2-148 as colorless oil in 
58% yield after two steps. Thereafter, the terminal alcohol 2-148 was oxidized using IBX to give 
the corresponding aldehyde 2-149114 which was further subjected for Corey-Fuchs reaction115 using 





Scheme 42. Synthesis of dibromoalkene 2-150 starting from (S)-malic acid (2-141). 
 
Treatment of 2-150 with n-BuLi in THF at –78 °C was followed by quenching the intermediate 
acetylide with iodomethane to provide alkyne 2-140115 in 74% yield. Further, alkyne 2-140 was 
added to a suspension of in situ generated Cp2ZrHCl (Schwartz’s reagent)
116 from the combination 
of Cp2ZrCl2 and DIBAL-H (1M in hexane) at 0 °C for 30 min. To complete the hydrometalation the 
reaction mixture was kept for 1 h at 55 °C and subsequently quenched by addition of NBS in THF 
at 0 °C to give vinyl bromide 2-152 with good regioselectivity (4:1). The mixture of regioisomers 
was subjected for deprotection without any flash chromatography. The cleavage of acetal 2-152 was 
accomplished with a mixture of CH3COOH/H2O mixture
117 at r.t.  
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At this point, the regioisomers were separated by flash chromatography to afford diol 2-154 (minor) 
and 2-153 as a major isomer in 42% yield. Thereafter, two different protecting groups were used to 
extend the side chain at C12-C14. Thus, primary alcohol 2-153 was converted to trityl ether 2-155 
using trityl chloride, pyridine, DMAP in CH2Cl2 at r.t.
118 This was followed by protection of the 
secondary alcohol as TIPS ether 2-156 using TIPSOTf and 2,6-lutidine as base in 86% yield 




Scheme 43. Synthesis of C8-C12 fragment 2-156 starting from dibromoalkene 2-150. 
 
In order to introduce the C12-C13 double bond, the trityl ether 2-156 was selectively cleaved under 
reductive conditions using BF3·Et2O, Et3SiH in CH2Cl2
119 to afford primary alcohol 2-157 in 75% 
yield. The resulting primary alcohol 2-157 was oxidized using IBX in DMSO/CH2Cl2 at r.t. 
Subsequently, the aldehyde 2-158 was treated with CH3MgBr in THF to give 2-159 as a 
diasteromeric mixture (2:1) in 76% yield. The mixture of secondary alcohols 2-159 was oxidized 
using DMP to get methyl ketone 2-160 in 75% yield. Finally, methyl ketone 2-160 was subjected to 
Wittig olefination108 using ethyltriphenylphosphonium bromide, and KHMDS (1M THF) in THF at 
–78 °C to produce (Z)-trisubstituted olefin 2-139 (C8-C14 fragment) in high stereoselectivity and in 
66% yield (Scheme 44). 
  







Scheme 44. Synthesis of C8-C14 fragment (2-139) via Wittig olefination.  
 
Formation of Wittig product 2-139 was confirmed by 1H NMR analysis (Figure 26). Confirmation 
of (Z)-trisubstituted double bond at C12 position was possible through a NOESY experiment, where 
we observed a relatively strong cross peak between the 11-H and 14-H (Figure 27).  
 
 

























































































Figure 26. 1H NMR spectrum of C8-C14 fragment (2-139). 
  















































Figure 27. NOESY spectrum of C8-C14 fragment (2-139). 
 
9.3.2 Synthesis of C1-C7 Fragment 
We used 5-hexeonic acid (2-161) as a starting material to get key fragment C1-C7. However, 
commercially available 5-hexenoic acid (2-161) was slightly expensive. Therefore, we decided to 
make it by utilizing in-house chemicals. Initially, we synthesized 5-hexenoic acid (2-161) from 
easily available cyclohexanone using H2O2/FeSO4/CuSO4
 conditions. However, in the oxidative 
ring cleavage 2-161 was obtained in only 15-20% yield.120 Alternatively, Jones oxidization of 5-
hexene-1-ol (2-146) using CrO3, 2M H2SO4 at –10 °C affords 5-hexenoic acid (2-162) in 58% 
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yield.121 The next step was introduction of the stereocenter at the C2 position by asymmetric 
alkylation.110 We used (S)-4-benzyl-2-oxazolidinone (2-162) as a chiral auxiliary to secure a 
stereoselective methylation of 2-165. The chiral oxazolidinone (2-162) was treated with n-BuLi (2.5 
M in hexane) in THF at –78 °C followed by the addition of freshly prepared mixed anhydride to 
afford N-acylated oxazolidinone 2-163 in 54% yield.93 The mixed anhydride was prepared from 5-
hexeonic acid (2-161) and pivaloyl chloride using Et3N as a base. Thereafter, 2-163 was enolized 
using NaHMDS (2M in THF)110 at –78 °C and the formed sodium enolate intermediate 2-164 was 
quenched with iodomethane affording the methylated product 2-165 in 92% yield. After reductive 
cleavage of auxiliary from 2-165 using LiBH4 in THF and MeOH alcohol 2-166 was obtained as a 
volatile liquid together with the recovered Evans auxiliary 2-162 as well. Primary alcohol 2-166 
was protected using trityl chloride, pyridine, and DMAP acquiring trityl ether 2-167 in good yield 
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9.3.3 Cross metathesis and Sharpless dihydroxylation  
The cross metathesis reaction by ruthenium-based catalyst has proven to be one of the most 
powerful methods for the formation of carbon-carbon double bonds.122 Taking advantage of this 
strategy, trityl ether 2-167 and methyl acrylate (2-168) were subjected to the cross metathesis 
reaction using Grubb’s II catalyst in degassed toluene for 8 h at 80 °C. After completion of 
transformation, the black suspension was cooled to room temperature and the solvent was removed 
under reduced pressure. The crude product was directly loaded onto a silica column without any 
workup to afford metathesis product 2-169 as a colorless oil. The Sharpless asymmetric 
dihydroxylation has been developed as one of the most efficient methods for the preparation of 
enantiopure diols from olefins123 by utilizing osmium-catalyst. Asymmetric dihydroxylation 
reactions were performed using commercially available AD-mix α (or) AD-mix β. They contain a 
mixture of K2[OsO2(OH)4] (0.4 mol%), (DHQD)2PHAL (or) (DHQ)2PHAL (1 mol%), K3[Fe(CN)6] 
(3 equiv) and K2CO3 (3 equiv). Initially, we performed the asymmetric dihydroxylation with 2-169 
using AD-mix α (1.4 g needed for 1 mmol of starting material) in a mixture of t-BuOH/H2O at –10 
°C for overnight. However, there was only trace amount of product formation shown by TLC. We 
realized that MeSO2NH2 is required to increase the reaction rate due to the hydrolysis of osmate 
esters.123 Therefore, we used 2.5 equiv. of MeSO2NH2 and allowed the reaction to run for 1 day at 
r.t., which furnished diol 2-170 in high diastereoselectivity (Scheme 46).  
 
 
Scheme 46. Synthesis of diol 2-170 via cross metathesis and Sharpless dihydroxylation. 
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Diol 2-170 was protected using 2,2-dimethoxypropane under acidic medium to afford acetal 2-171 
in 86% yield. Even though, we observed a trace amount of trityl cleavage product during this 
reaction by TLC. Methyl ester 2-171 was converted into Weinreb amide 2-172 using N,O-dimethyl 
hydroxylamine and trimethylaluminum at –10 °C. Due to acidic medium, we received a mixture of 
2-172 and 2-173 as a protected and free diols respectively. Nevertheless, the resulting mixture was 
again treated with 2,2-dimethoxypropane in the presence of p-TSA to form the Weinreb amide 2-
172. In other hand, we considered that aldehyde 2-174 is a good electrophile for vinyllithium 2-138 
addition. Therefore, Weinreb amide 2-172 was reduced into corresponding aldehyde 2-174 with 




Scheme 47. Synthesis of aldehyde 2-174 via cross metathesis and Sharpless dihydroxylation. 
 
Due to the stability issue with trityl group, we decided to use a PMB protected alkene 2-175 for 
further transformations. Hence, primary alcohol 2-166 was treated with NaH, PMBCl, and TBAI 
that furnished PMB ether 2-175 in 75% yield. Further steps involved a cross metathesis, and 
Sharpless dihydroxylation which delivered methyl ester 2-177 in excellent yield.  
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After protection of the diol with 2,2-dimethoxypropane, the resulting methyl ester 2-178 was 
reduced using LiAlH4 in THF at r.t. gave alcohol 2-179 in 96% yield. Thereafter, alcohol 2-179 was 
oxidized using Swern oxidation providing the required aldehyde 2-180 as an oil which was used 




Scheme 48. Synthesis of aldehyde 2-180 with PMB ether. 
 
9.3.4 Studies on the coupling of C1-C7 and C8-C14 Fragments 
After this groundwork and the building blocks in hand, we focused to find suitable coupling 
conditions to assemble the available fragments 2-180 (C1-C7) and 2-139 (C8-C14). As discussed in 
the above retrosynthetic plan, our strategy involved two complementary approaches to assemble the 
vinyl bromide 2-139 and aldehyde 2-180 or 2-174 (Scheme 49). In the first attempt vinyllithium 2-
138 generated from vinyl bromide 2-139 using t-BuLi in THF at –78° C, was treated with Weinreb 
amide 2-172 to get ketone 2-181.125 However, the reaction was not successful in our hand (see the 
Table 6). It is assumed that Weinreb amide 2-172 is not such a good electrophile as an aldehyde 2-
180.  
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The second approach involves the addition of vinyllithium 2-138 to more electrophilic aldehyde 2-
180. Initially, we used a number of classical conditions for the halogen-metal exchange, such as 1) 
t-BuLi (1.3 equiv) in THF at –78 °C, 1.5 h and 2) t-BuLi (1.5 equiv), MgBr2 (1.5 equiv) in THF at –
78 °C for 2 h. In all cases, we received only debrominated product 2-183 which was confirmed by 
1H NMR spectrum (Figure 28). This is an indication that the metalation had worked. It might be 
that the vinylmetal species gets protonated by the aldehyde instead of the addition reaction. 
Nevertheless, two alternative procedures were employed such as (i) Nozaki−Hiyama−Takai−Kishi 
protocol126using CrCl2, NiCl2 in DMF/THF, (ii) Turbo Grignard
127 using iPrMgCl·LiCl in THF at 0 
°C. Even though both of these conditions were unsuccessful in our hands.  
 
 
Scheme 49. Reaction between building blocks 2-139 and 2-172, 2-174, 2-180. 
 
Table 6. Summary of reaction conditions that were tried for coupling of the building blocks.  
Entry Reagents and conditions  Results 
1 2-139 (1.0 equiv), t-BuLi (2.2 equiv), THF, –78 °C to 
r.t., 1 h. then added 2-172  
No product formation, 2-183 was 
isolated as major compound 
2 2-139 (1.0 equiv), sec-BuLi (1.5 equiv), THF, –78 °C 
to r.t., 45 min, then added 2-172 
No product formation, 2-183 was 
isolated 
3 2-139 (1.0 equiv), sec-BuLi (1.5 equiv), THF, –78 °C 
to r.t., 15 min, then added 2-174 
No product formation, 2-183 was 
isolated 
4 2-139 (1.0 equiv), i-PrMgCl·LiCl (1.25 equiv), THF,   
–78 °C to r.t., 3 h, then addition of 2-180 
No reaction, both SM were recovered 
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5 2-139 (2 equiv), 2-180 (1.2 equiv), CrCl2 (5 equiv), 
NiCl2 (1 equiv), DMF:THF (1:1 mL), r.t., 48 h 
No reaction, SM was recovered 
6 2-139 (1.0 equiv), n-BuLi (1.5 equiv), Et2O, –78 °C to 
r.t., 1 h, then added 2-180 at –78 °C 
No product formation, 2-183 was 
isolated 
7 2-139 (1.0 equiv), t-BuLi (1.52 equiv), THF, –78 °C 
to r.t., 1 h, then added 2-180 at –78 °C 
No product formation, 2-183 was 
isolated 
8 2-139 (1.0 equiv), t-BuLi (1.52 equiv), Et2O, –78 °C 
to r.t., 30 min, then added 2-180 at –78 °C 
No product formation, 2-183 was 
isolated 
9 2-139 (1.0 equiv), t-BuLi (1.5 equiv), MgBr2 (1.5 
equiv), THF, –78 °C , 2 h, then added 2-180 at –78 °C 
No product formation, 2-183 was 
isolated 
 
Substrate 2-139 was dissolved in the solvent (0.025M) prior to addition of the base; SM = starting 
material 






































































































Figure 28. 1H NMR spectrum of debrominated product 2-183. 
 
9.3.5 Synthesis of a C1-C12 Fragment  
At this point decided to introduce the C12-C13 (Z)-trisubstituted double bond at a late stage of the 
total synthesis. With vinyl bromide 2-156 that lacks the trisubstituted double bond in hand, we 
investigated the crucial coupling step with different conditions (Scheme 50). Initially, vinyl 
bromide 2-156 was treated with t-BuLi in THF at –78 °C to give vinyllithium 2-184 which was 
added to aldehyde 2-180. Notably, the desired alcohol 2-185 could be detected in the 1H NMR 
spectrum. However, the yield was very small.  
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Consequently, we tuned the coupling step and observed that upon treating vinyl bromide 2-156 with 
sec-BuLi (1.2 equiv) in THF at –78 °C and using 1.7 equiv of aldehyde 2-180, alcohol 2-185 was 
obtained as a 10:4 mixture of diastereomers in 40% yield. It is worth to mention that prior to 
formation of the vinyllithium species 2-184, the corresponding vinyl bromide 2-156 was needed to 
be dried completely by evaporating the solvents from a benzene/toluene solution and placing the 
concentrate under high vacuum for 1 h. Alcohol 2-185 was oxidized using DMP, NaHCO3 in 
CH2Cl2 which gave ketone 2-186 (C1-C12 fragment) as an oil in 71% yield. In order to complete 
the total synthesis of Gulmirecin B (2-1) the following steps would have to be performed: 1) 
selective reduction of ketone 2-186, 2) cleavage of PMB group and oxidation of the alcohol to the 
acid 3) macrolactonization by Mitsunobu protocol, and 4) introduction of the (Z)-trisubstituted 











Conclusion                                                                                  71 
 
 
10. Conclusion  
In summary, we investigated several approaches including model studies towards the total synthesis 
of Gulmirecin B (2-11). The first building block vinyl bromide 2-138 (C8-C14 fragment) was 
prepared from L-malic acid in 14 steps. The required aldehyde 2-149 was synthesized from (S)-
malic acid (2-141) via reduction of the acid, protection of the diol and oxidation of the alcohol 
function. A Corey-Fuchs reaction on aldehyde 2-149 and iodomethane addition gave alkyne 2-140. 
Further, alkyne 2-140 was subjected to hydrozirconation and addition of NBS furnished (E)-vinyl 
bromide 2-152 as a major regioisomer. Here, we used two different appropriate protecting groups 
for chain extension at the C12 position. After cleavage of the acetal, the primary and secondary 
alcohols were differentiated by protecting them with TrCl and TIPSOTf, which led to 2-155. 
Thereafter, the trityl ether 2-155 was removed, the obtained alcohol oxidized to the aldehyde which 
upon reaction with MeMgBr led to a secondary alcohol. Oxidation of this alcohol to the methyl 
ketone and Wittig olefination delivered the required diene 2-139 (C8-C14 fragment) featuring the 
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The second building block C1-C7 fragment 2-180 was made by asymmetric alkylation, cross 
metathesis, Sharpless dihydroxylation, and Swern oxidation. The amide derivative 2-165 was 
received from commercially available hex-5-en-1-ol (2-146) via Jones oxidation and Evans 
alkylation. Thereafter, reductive cleavage of the auxiliary gave a primary alcohol which was 
converted to PMB ether 2-175. Further key steps involved a cross metathesis and Sharpless 
dihydroxylation to afford diol 2-177. Then, reduction of methyl ester and Swern oxidation delivered 




Scheme 52. Summary of the synthesis of C1-C7 fragment (2-180). 
 
Several reaction conditions were investigated for the coupling of C8-C14 fragment (2-139) and C1-
C7 fragment (2-180). While metalated fragment 2-138 did not add to Weinreb amide 2-172 nor the 
aldehyde 2-174 or 2-180, the addition of the vinyllithium derivative of truncated building 2-156 


















































11.1 Photoredox catalysis 
 Visible light-mediated photoredox catalysis is a research field attracted by organic chemist 
due to its broad utility in organic transformations as well as for green chemistry.128 This method is a 
more mild, safe, cost-effective, and environmentally friendly approach to promoting radical-based 
organic transformations.129 Visible light irradiation of photocatalysts/chromophores enables one to 
convert solar energy to chemical energy by single-electron transfer (SET).130 According to literature 
reports, a wide range of Ru/Ir polypyridyl complexes and various organic dyes are used as efficient 
catalysts in this field (Figure 30).131 Furthermore, Ru(bpy)3
2+ and related complexes have been 
utilized in different applications such as water splitting, organic light-emitting diodes, and proton-
coupled electron transfer.132 Upon irradiation of Ru(bpy)3
2+ with visible light, an electron is 
transferred from the metal-centered t2g orbital to ligand-centered π* orbital. This transition is called 
metal to ligand charge transfer (MLCT) and results in an excited triplet state. This lifetime of this 
triplet state is 1100 ns which allow the photocatalyst to engage in single electron transfer reaction 
with organic molecules. Also, photocatalysts have the dual nature of the excited state as being both 












Figure 30. Chemical structures of most commonly used photoredox catalysts. 
 
11.2 Hypervalent iodine(III) reagents used in photocatalysis 
In recent years, hypervalent iodine(III) reagents have been used in organic synthesis for various 
oxidative transformations of organic molecules.133 They display an ionic reactivity due to high 
electrophilicity and they also have the tendency to form radicals. Organic iodine(III) reagents can 
be classified based on the ligands attached to the iodine atom.134 The most commonly used 
photoredox activating hypervalent iodine(III) reagents are displayed in Figure 31. Among the 
hypervalent iodine(III) reagents, five membered ring containing benziodoxoles have higher stability 
than acyclic derivatives. Besides having oxidizing ability, hypervalent iodine(III) reagents are used 
for cross-coupling reactions with more efficiency than transition-metal catalysis.135  
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In addition, the hypervalent iodine(III) compounds can generate radicals or electrophilic cationic 
species under thermal conditions.136 The utilization of hypervalent iodine(III) reagents in visible-
light photoredox catalysis is demonstrated in many synthetic methods. For example 
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12. Literature  
12.1 General methods for spiroacetal formation  
A variety of synthetic strategies are available for the synthesis of spiroacetal including  
   (i) Intramolecular hydrogen abstraction 
   (ii) Cycloisomerization 
   (iii) Oxa-Michael addition 
   (iv) Furan oxidation 
   (v) Cycloaddition 
   (vi) Dehydration of ketodiols  
 
12.1.1 Intramolecular hydrogen abstraction 
 
Intramolecular hydrogen abstraction is a powerful method in the area of spiroacetal synthesis.138 
The active alkoxy radical 3-26 is formed through the homolytic cleavage of an O–I bond of ether 3-
25 via photochemical conditions. The required acetyl hypoiodite (AcOI) is formed in situ from the 
reaction between lead tetraacetate and iodine. The alkoxy radical of 3-26 undergoes an 
intramolecular hydrogen abstraction to form a carbon radical adjacent to the oxygen of 3-27 which 
is further oxidized by iodine to form oxocarbenium ion 3-28. The subsequent attack of the alcohol 
to the electrophilic center of 3-28 affords spiroacetal derivative 3-29 (Scheme 54). Occasionally, 




Scheme 54. Synthesis of spiroacetal derivatives 3-29 via intramolecular hydrogen abstraction.  
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12.1.2 Metal-catalyzed cycloisomerization 
 
An alternative method for the synthesis of spiroacetal derivatives 3-29 is based on metal-catalyzed 
cycloisomerization139 of alkyne diols 3-30 as shown in Scheme 55. The alkynediol 3-30 is activated 
by transition metal catalyst to form complex 3-31. Then, the terminal alcohol attacks the alkyne in 
an endo-mode to give cyclic enol ether 3-32. After protonolysis of 3-32, the resulting intermediate 




Scheme 55. Synthesis of spiroacetal 3-29 via metal-catalyzed cycloismerization.  
 
12.1.3 Oxa-Michael addition 
 
Another possibility to make the spiroacetal derivatives like 3-36 is via Oxa-Michael addition140 as 
described in Scheme 56. In this case, treatment of ketone 3-34 with a suitable base may lead to 
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12.1.4 Furan oxidation 
 
Furan derivatives can be easily transformed into spiroacetals by oxidation.141 The mechanism 
involves [4+2]-cycloaddition between furan derivative 3-37 and singlet oxygen to result in 
cycloadduct 3-38. Then, the terminal alcohol attacks the quaternary center to form a spirocyclic 
hydroperoxide 3-39 which undergoes a dehydration to afford the spirolactone derivative 3-40. This 
can be easily transformed into the corresponding spiroacetal by reduction of the alkene as well as 








A very common method for synthesis of spiroacetal relies on a hetero Diels Alder reaction.142 This 
protocol is used in the synthesis of various spiroacetal based natural products. The mechanism 
involves a [4+2]-cycloaddition reaction between electron‐poor alkene 3-41 and the dienophile 3-42 
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12.1.6 Dehydration of ketodiols  
 
The treatment of ketodiols 3-45 with acid143 induces the formation of protonated hemiacetal 3-46 
which eliminates a water molecule to form a highly reactive oxocarbenium species 3-47. 
Nucleophilic addition of the terminal alcohol to the electrophilic center of oxocarbenium 3-47 




Scheme 59. Synthesis of spiroacetal 3-48 by dehydration of ketodiols 3-45.  
 
12.2 Inspiration from previous work   
Chen et al.144 utilized hypervalent iodine(III) reagents for generation of alkoxy radicals in the 
presence of a photocatalyst under visible light irradiation (Scheme 60). It is an example for visible 
light induced alkoxy radical mediated C-H bond activation. According to their mechanism, the 
alcohol derivative 3-49 was treated with hypervalent iodine(III) reagents to form complex 3-52 in 
situ. Then, photocatalytic conditions reduced the complex to provide alkoxy radical 3-51 which can 
make new bond formation by intramolecular hydrogen abstraction. We thought that the same 
strategy could be used to promote spiroacetal formation through an alkoxy radical using 
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13. Goal of the research 
The aim of our project was to develop a new method for the synthesis of spiroacetal compounds via 
photocatalysis under blue LED irradiation. Spiroacetals are important structural components which 
can be found in many biologically active natural products. They are present in some sex 
pheromones, microtubule stabilizing agents (MSAs), and polyketide antibiotics.145 Different 
synthetic approaches towards spiroacetal formation have been reported in the literature. However, 
the visible-light induced spiroacetal formation via alkoxy radical is unknown. Chen and co-workers 
developed a visible light induced alcohol oxidation to generate alkoxy radicals using hypervalent 
iodine(III) reagents.144 Taking advantage of this strategy, we decided to investigate the spiroacetal 
formation via alkoxy radical generation using hypervalent iodine(III) reagents under photochemical 




Scheme 61. Synthesis of spiroacetal 3-53 by employing a photocatalysis strategy.  
 
A plausible mechanism for spiroacetal formation is displayed in Figure 32. The alcohol 3-52 would 
react with hypervalent iodine(III) reagent (diacetoxyiodo)benzene to form intermediate (RO-I) 3-54 
in situ. Then, single electron transfer of an electron from the excited Ru(II)* to the O-I bond would 
give alkoxy radical 3-55, iodobenzene and acetate. Subsequently, the generated alkoxy radical 3-55 
activates the C-H bond of the tetrahydropyran at C2 position by intramolecular hydrogen 
abstraction. The resulting stabilized C-centered radical species 3-56 further undergoes an oxidation 
process by Ru(III) which leads to the oxocarbenium ion 3-57. Finally, the terminal alcohol attacks 
the electrophilic center of oxocarbenium 3-57 to afford spiroacetal 3-53.   
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14. Results and Discussion 
14.1 Synthesis of 3-(tetrahydro-2H-pyran-2-yl)propan-1-ol  
According to our plan, 3-(tetrahydro-2H-pyran-2-yl)propan-1-ol (3-52) was prepared in four steps. 
The synthetic sequence involves Swern oxidation, Wittig-Horner reaction, hydrogenation, and 
reduction of the enoate. Initially, we performed a DMP oxidation of (tetrahydro-2H-pyran-2-
yl)methanol (3-58) to give aldehyde 3-59, which was used for the next step without any 
chromatography. Subsequently, aldehyde 3-59 was treated with methyl 
(dimethoxyphosphoryl)acetate (3-60) using NaH as a base to furnish Wittig-Horner product, (E)-
α,β-unsaturated ester 3-61 in 50% yield.146 However, we received around 10% of (Z)-α,β-
unsaturated ester (3-61) as a minor product. An alternative method to make the (E)-α,β-unsaturated 
ester (3-61) is by an one-pot synthetic strategy.147 Thus, the (tetrahydro-2H-pyran-2-yl)methanol (3-
58) was subjected to Swern oxidation and subsequently we added methyl 2-(triphenyl-λ5-
phosphanylidene)acetate (3-62) in THF at –78 °C which afforded (E)-α,β-unsaturated ester (3-61) 
with 73% yield (Scheme 62).  
 
 
Scheme 62. Synthesis of (E)-α,β-unsaturated ester 3-61. 
 
These (Z) and (E)-α,β-unsaturated ester 3-61 was reduced under hydrogenation conditions using 
Pd/C in MeOH to afford saturated methyl ester 3-63 in 68% yield. Treatment of saturated methyl 
ester 3-63 with LiAlH4 in THF gave required 3-(tetrahydro-2H-pyran-2-yl)propan-1-ol (3-52) as a 










Scheme 63. Synthesis of starting material 3-(tetrahydro-2H-pyran-2-yl)propan-1-ol (3-52). 
 
14.2 Investigation of spiroacetal/aminol formation under visible light 
irradiation  
The required [Ru(bpy)3](PF6)2 (3-1) and Ir{dF(CF3)ppy}2(dtbbpy)]PF6 (3-5) catalysts were 
synthesized using literature procedures.148 Based on the above proposal, we started our investigation 
with 3-(tetrahydro-2H-pyran-2-yl)propan-1-ol (3-52) and benziodoxole derivatives (BI-OH, BI-
OAc)144 using DCE/H2O as solvents to give complex mixture 3-64 in situ, which was subsequently 
reduced by [Ru(bpy)3]
2+ under blue LED irradiation. However, all conditions were unsuccessful in 
our hand, only starting material was recovered (Table 7, entry 1-3) (Scheme 64).  
 
 
Scheme 64. Attempts at spiroacetal formation using cyclic hypervalent iodine(III) reagents under 
blue LED light irradiation. 
 
Thus, further experiments were performed. Alcohol 3-52 was reacted with various non-cyclic 
iodine(III) reagents, such as PhI(OAc)2, and PhI(CO2CF3)2 in the presence of [Ru(bpy)3]
2+ under 
blue LED irradiation. However, none of them gave the desired product (entry 4,5). We also 
employed alternative photocatalyst, iridium complex Ir{dF(CF3)ppy}2(dtbbpy)]PF6. Again, the 
alcohol 3-52 was treated with PhI(OAc)2 (1.5 equiv) in CH3CN and stirred for 3 h, before 
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irradiation in presence of Ir{dF(CF3)ppy}2(dtbbpy)]PF6 (0.01 equiv) using blue LED irradiation for 
overnight. In a further attempt alcohol 3-52 was reacted with PhI(CO2CF3)2 in the presence of the 
Ir(III) species under blue LED light for 8 h. In both cases, we received only the starting material 
back. These results indicate that the alkoxy radical or the R-O-IX2 3-64/3-65 intermediate did not 




Scheme 65. Spiroacetal formation using non-cyclic hypervalent iodine(III) reagents under blue 
LED light irradiation. 
 
Table 7. Summary of conditions that were tried for formation of spiroacetal  
 
Entry Reagents and conditions Results 
1 BI-OH (1.0 equiv), Ru(bpy)3Cl2 (0.02 equiv), 
DCE/H2O, 20 °C, 8 h 
No reaction; SM was observed 
2 BI-OH (1.0 equiv), [Ru(bpy)3](PF6)2 (0.02 
equiv), DCE/H2O, 20 °C, 2 days  
No reaction; SM was observed 
3 BI-OAc (1.2 equiv), [Ru(bpy)3](PF6)2 (0.02 
equiv), cyclohexane, 20 °C, 24 h 
No reaction; SM was observed 
4 PhI(OAc)2 (1.2 equiv), [Ru(bpy)3](PF6)2 (0.02 
equiv), DCM/H2O, 20 °C, 8 h 
No reaction; SM was observed 
5 PhI(OCF3)2 (1.0 equiv), [Ru(bpy)3](PF6)2 
(0.02 equiv), DCE, 20 °C, 24 h 
No reaction; SM was observed 
6 PhI(OAc)2 (1.0 equiv), Ir{dF(CF3)ppy}2 
(dtbbpy)]PF6 (0.01 equiv), CH3CN, 20 °C, 1 d 
No reaction; SM was observed 
7 PhI(OCF3)2 (1.0 equiv), 
Ir[df(CF3)ppy)2(dtbpy)]PF6 (0.01 equiv), DCE, 
20 °C, 8 h 
No reaction; SM was observed 
Substrate 3-52 was dissolved in the solvent ( 0.035M); SM = starting material 
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Also, we performed sprioaminal formation using the amide 3-66 (Scheme 66). Thus, methyl ester 
3-63 was treated with ammonia (2N in MeOH) at 85 °C for 24 h to give amide 3-66 in good yield. 
Further the amide 3-66 was reacted with non-cyclic iodine(III) reagents, such as PhI(OAc)2, 
PhI(CO2CF3)2 in the presence of [Ru(bpy)3]
2+ or Ir{dF(CF3)ppy}2(dtbbpy)]PF6 under blue LED 




Scheme 66. Attempts at spiroaminal formation using hypervalent iodine(III) reagents under blue 
LED light irradiation. 
 
Table 8. Summary of conditions that were tried for formation of spiroaminal derivative 3-76 
 
Entry Reagents and conditions Results 
1 PhI(OAc)2 (1.2 equiv), [Ru(bpy)3](PF6)2 (0.02 
equiv), DCM, 20 °C, 24 h 
No reaction; SM was observed 
2 PhI(OCF3)2 (1.0 equiv), [Ru(bpy)3](PF6)2 
(0.02 equiv), EtOAc, 20 °C, 24 h 
No reaction; SM was observed 
3 PhI(OAc)2 (2.0 equiv), Ir{dF(CF3)ppy}2 
(dtbbpy)]PF6 (0.01 equiv), CH3CN, 20 °C, 2 
days 
No reaction; SM was observed 
4 PhI(OCF3)2 (1.5 equiv), 
Ir[df(CF3)ppy)2(dtbpy)]PF6 (0.01 equiv), 
cyclohexane, 20 °C, 16 h 
No reaction; SM was observed 










In summary, 3-(tetrahydro-2H-pyran-2-yl)propan-1-ol (3-52) was synthesized from commercially 
available (tetrahydro-2H-pyran-2-yl)methanol (3-58) involving a Swern oxidation, hydrogenation 
and reduction. We used a range of hypervalent iodine(III) reagents for spiroacetal 3-53 and 
spiroaminal 3-67 formation in the presence of a photocatalyst under blue LED irradiation. 




Scheme 67. Summary of spiroacetal 3-53 and spiroaminal 3-67 formation via photocatalysis under 
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16. Experimental Sections 
16.1 General Remarks 
16.1.1 Chemicals and working techniques 
 
All the chemicals were purchased from TCI, Aldrich, and Acros. All reagents were used without 
further purification unless otherwise stated. All solvents were distilled and dried prior to use by 
standard methodology except for those, which were reagent grades. The applied petroleum ether 
fraction had a boiling point of 40-60 °C. Anhydrous solvents were obtained as follows: THF, 
diethyl ether and toluene by distillation from sodium and benzophenone; dichloromethane and 
chloroform by distillation from calcium hydride; acetone by distillation from phosphorous 
pentoxide. Absolute triethylamine, pyridine and diisopropylethylamine were distilled over calcium 
hydride prior to use. Unless and otherwise mentioned, all the reactions were carried out under a 
nitrogen atmosphere.  Compounds that are not described in the experimental part were synthesized 
according to the literature. 
 
16.1.2 NMR spectroscopy 
 
All the spectra were measured on a Bruker Avance III HD spectrometer, which operated at 400 
MHz for 1H and 100 MHz for 13C nuclei, respectively. 1H (400 MHz) and 13C NMR (100 MHz): 
spectra were recorded at 295 K either in CDCl3 or [D4] MeOH; chemical shifts are calibrated to the 
residual proton and carbon resonance of the solvent: CDCl3 (δ H = 7.25 ppm, δ C = 77.0 ppm), [D4] 
MeOH (δ H = 2.49 ppm, δ C = 39.5 ppm). Data are reported as follows: chemical shift 
(multiplicity: s = singlet, d = doublet, t = triplet, ddd = doublet of doublet of doublet, dt = doublet of 
triplet, td = triplet of doublet, m = multiplet, br = broadened, J = coupling constant (Hz), 
integration, peak assignment in italic form). 
 
16.1.3 Mass spectrometry 
 
High–resolution mass spectra (HRMS) were recorded on a Bruker maXis 4G instrument with 
electron spray ionization (ESI) and a TOF mass detector (mass range: 50-20000 m/z, mass 
accuracy: 600 ppb RMS error). Some of the mass spectra were also measured on an Agilent 1100 
series LC-MSD. Analytical HPLC-MS: HP 1100 Series connected with an ESI MS detector Agilent 
G1946C, positive mode with fragmentor voltage of 40 eV, column: Nucleosil 100–5, C–18 HD, 5 
mm, 70 × 3 mm Machery Nagel, eluent: NaCl solution (5 mM)/acetonitrile, gradient: 0/10/15/17/20 
min with 20/80/80/99/99% acetonitrile, flow: 0.6 mL min-1.  
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High resolution mass (HRMS) are reported as follows: (ESI): calcd mass for the related compound 
followed by found mass. 
 
16.1.4 Polarimetry  
 
Optical rotations were measured on a JASCO Polarimeter P–1020. They are reported as follows: 
[α]temperature D (concentration, solvent). The unit of c is g/100 mL. Anhydrous CH2Cl2 or CHCl3 
were used as solvents. For the measurement the sodium D line = 589 nm was used. 
 
16.1.5 Chromatographic Methods 
 
High performance liquid chromatography (HPLC) analysis was performed on a Hewlett–Packard 
1100 Series instrument equipped with a quaternary pump, using a Eurocell Knauer (250 × 4.6 mm). 
UV absorption was monitored at 220 nm or at 254 nm. Hexanes/isopropanol (65/25) mixture was 
used for elution (0.8 mL/min). Flash column chromatography was performed using flash silica gel 
(40–63 µm, 230–400 mesh ASTM) from Macherey–Nagel. Analytical thin layer chromatography 
(TLC) and preparative thin layer chromatography were performed on precoated silica gel 60 F254 
plates (Merck) or Polygram Sil G/UV254 (Macherey Nagel). The compounds were visualized by 
UV254 light and the chromatography plates were developed with an aqueous solution of 
molybdophosphorous acid or an aqueous solution of potassium permanganate (heating with the heat 
gun). For preparation of the molybdate solution 20 g ammonium molybdate [(NH4)6Mo7O24·4H2O] 
and 0.4 g Ce(SO4)2·4H2O were dissolved in 400 mL of 10% H2SO4. The potassium permanganate 
solution was prepared from 2.5 g KMnO4 and 12.5 g Na2CO3 in 250 mL H2O. 
 
16.1.6 IR spectroscopy 
 




Photochemical reactions were performed using the Kessill A160WE Tuna blue LED light. Two 
lamps were fixed around 10 cm away from the reaction vial (8 mL). Then, a cooling fan pointing 
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16.2 Experimental procedures 






t-BuOOH (5.5 m in n-decane, 6.4 mL, 35.2 mmol) was added to a solution of SeO2 (0.26 g, 2.35 
mmol) in CH2Cl2 (30 mL) and the mixture was stirred for 30 min. Then, a solution of alkene exo-1-
89 (3.75 g, 11.80 mmol) in CH2Cl2 (10 mL) was added dropwise and the resulting suspension was 
stirred at r.t. for 8 h and then diluted with a saturated solution of Na2S2O3 (20 mL). The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 50 mL). The combined organic 
layers were washed with an aqueous solution of NaHCO3 (10 mL) and a saturated solution of NaCl 
(25 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The 
residue was purified by flash chromatography (petroleum ether/ethyl acetate, 2:1) to give allyl 
alcohol 1-61 (2.99 g, 76% yield) as a white solid.  
Rf = 0.58 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 6.75–6.66 (m, 3H; 
ArH), 5.34 (d, J = 1.8 Hz, 1H; 2-CH2), 5.32 (d, J = 2.0 Hz, 1H; 2-CH2), 4.50–4.46 (m, 1H; H-3-H), 
4.17–4.12 (m, 2H; CO2CH2CH3), 3.76 (s, 3H; OCH3), 3.75 (s, 3H; OCH3), 2.60–2.50 (m, 2H; H-2', 
H-4), 2.45 (td, J = 4.9, 12.3 Hz, 1H; H-5), 2.20 (dt, J = 13.3, 4.9 Hz, 1H; H-4), 2.10–2.02 (m, 1H; 
H-1'), 1.80–1.67 (m, 3H; H-2', H-1', H-5), 1.27 (t, J = 7.2 Hz, 3H; CO2CH2CH3); 13C NMR (100 
MHz, CDCl3): δ = 175.1 (CO2Et), 156.8 (C-2), 153.5 (Ar), 151.6 (Ar), 131.6 (C-1''), 116.2 (C-6''), 
111.2 (CH2), 110.9 (Ar), 110.6 (2-CH2), 75.7 (C-3), 61.0 (CO2CH2CH3), 55.9 (OCH3), 55.7 
(OCH3), 54.9 (C-1), 39.5 (C-4 or C-5), 34.1 (C-1'), 30.7 (C-5 or C-4), 26.2 (C-2'), 14.1 
(CO2CH2CH3); HRMS (ESI): calcd for C19H26O5 [M+Na]
















NaHCO3 (0.81 g, 9.50 mmol) was added to a solution of allyl alcohol 1-61 (2.3 g, 6.88 mmol) in 
CH2Cl2 (40 mL) at 0 °C and a solution of meta-chloroperbenzoic acid (2.0 g, 11.9 mmol) in CH2Cl2 
(20 mL, pre-dried with anhydrous Na2SO4) was added dropwise at the same temperature. After 
stirring for 6 h at r.t., a saturated solution of Na2SO3 (25 mL) was added and the mixture was stirred 
for a further 15 min. The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 
× 50 mL). The combined organic layers were washed with a saturated solution of NaHCO3 (20 
mL), dried over Na2SO4, filtered, and concentrated under reduced pressure The crude product was 
purified by flash chromatography (petroleum ether/ethyl acetate, 2:1) to give epoxide 1-62 (1.9 g, 
79% yield) as a brown solid.  
Rf = 0.54 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 6.75–6.67 (m, 3H; 
ArH), 4.16–4.11 (m, 3H; CO2CH2CH3, H-7), 3.76 (s, 3H; OCH3), 3.74 (s, 3H; OCH3), 3.10 (d, J = 
4.4 Hz, 1H; H-2), 2.83 (d, J = 4.5 Hz, 1H; H-2), 2.66–2.57 (m, 2H; CH2), 2.35 (td, J = 12.2, 5.0 Hz 
1H; H-6 or H-5), 2.23–2.10 (m, 2H; CH2), 1.80–1.63 (m, 3H; CH2, H-1'), 1.26 (t, J = 7.1 Hz, 3H; 
CO2CH2CH3); 13C NMR (100 MHz, CDCl3): δ = 171.7 (CO2Et), 153.4, 151.5 (C-2'',C-5''), 131.0 
(C-1''), 116.2 (C-6''), 111.1, 111.1 (C-3'', C-4''), 70.4 (C-7), 68.1 (C-3), 60.8 (CO2CH2CH3), 55.8 
(OCH3), 55.6 (OCH3), 52.2 (C-4), 47.4 (C-2), 36.8 (CH2), 32.8 (CH2), 28.0 (CH2), 26.0 (CH2), 14.2 
(CO2CH2CH3); HRMS (ESI): calcd for C19H26O6 [M+Na]
+ 373.1621 ; found: 373.1621. 
 
Lingzhiol derivative (1-63)25 
 
 
BF3·Et2O (0.46 mL, 3.25 mmol) was added to a solution of epoxide 1-62 (1.90 g, 5.42 mmol) in 
CH2Cl2 (45 mL) at 0 °C and the mixture was stirred for 40 min at 0 °C. Then, the reaction mixture 
was treated with a saturated aqueous solution of NaHCO3 (15 mL), the layers were separated, and 
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the aqueous layer was extracted with CH2Cl2 (2 × 25 mL). The combined organic layers were 
washed with a saturated solution of Na2CO3 (25 mL) and a saturated solution of NaCl (12 mL), 
dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The crude product 
was purified by flash chromatography (petroleum ether/ethyl acetate, 1:1) to give tetracyclic lactone 
1-63 (0.96 g, 58% yield) as a white solid.  
Rf = 0.36 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 6.74–6.67 (m, 2H; 
ArH), 5.20 (d, J = 9.9 Hz, 1H; H-8'), 4.15–4.12 (m, 1H; H-6'), 4.10 (d, J = 9.7 Hz, 1H; H-8'), 3.81 
(s, 3H; OCH3), 3.78 (s, 3H; OCH3), 3.05 (dt, J = 17.2, 4.5 Hz, 1H; H-1'), 2.46 (ddd, J = 18.0, 13.4, 
4.4 Hz, 1H; H-1'), 2.23–2.18 (m, 1H; H-4'), 2.10 (dt, J = 13.4, 4.4 Hz, 1H; H-2' or H-5'), 1.92–1.81 
(m, 2H; H-4', H-2'), 1.65 (dd, J = 13.0, 4.6 Hz, 1H; H-4' or H-5'), 1.57–1.48 (m, 1H; H-2'); 13C 
NMR (100 MHz, CDCl3): δ = 182.2 (C-9'), 151.3, 151.2 (C-1, C-4), 129.4 (C-3), 126.2 (C-2), 
108.7, 108.2 (C-5, C-6), 81.8 (C-6'), 71.0 (C-8'), 55.9 (OCH3), 55.8 (OCH3), 53.6 (C-7'), 52.7 (C-
3'), 32.4 (C-4' or C-5'), 30.1 (C-5' or C-4'), 26.7 (C-1'), 18.5 (C-2'); IR (ATR): n˜=3455, 2953, 2360, 







N-hydroxyphthalimide (NHPI; 106 mg, 0.65 mmol) and AIBN (21 mg, 0.13 mmol) were added to a 
solution of naphthalene derivative 1-99 (90 mg, 0.26 mmol) in CH3CN (8 mL). Oxygen gas was 
bubbled through the mixture using a long steel needle and the mixture was stirred at 85° C for 12 h 
in a preheated oil bath. The mixture was cooled to r.t., and the solvent was removed under reduced 
pressure (without any workup). The crude product was directly purified by flash chromatography on 
silica gel (petroleum ether/ethyl acetate, 1:1) to give phenone 1-68 (33 mg, 35% yield) as a white 
solid.  
Rf = 0.21 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 7.07 (d, J = 9.2 Hz, 
1H; ArH), 7.01 (d, J = 9.2 Hz, 1H; ArH), 5.47 (br s, 1H; H-6'-H), 5.01 (d, J = 10.3 Hz, 1H; H-8'), 
4.30 (d, J = 10.4 Hz, 1H; H-8'), 3.84 (s, 3H; OCH3), 3.82 (s, 3H; OCH3), 2.84 (d, J = 12.8 Hz, 1H; 
H-2'), 2.81 (d, J = 12.8 Hz, 1H; H-2'), 2.53–2.45 (m, 1H; H-4' or H-5'), 2.12 (s, 3H; C(=O)CH3), 
1.98–1.91 (m, 1H; H-5' or H-4'), 1.73–1.62 (m, 2H; H-4', H-5'); 13C NMR (100 MHz, CDCl3): δ = 
98                                                    Experimental Section 
 
 
194.1 (C-1'), 179.4 (C-9'), 170.0 (C(=O)CH3), 152.3, 150.3 (C-1, C-4), 130.2 (Ar), 122.9 (Ar), 
117.0 (Ar), 112.5 (Ar), 81.6 (C-6'), 71.1 (C-8'), 56.5 (OCH3), 55.9 (OCH3), 55.2 (C-7'), 52.8 (C-3'), 
44.3 (C-5' or C-4'), 31.8 (C-4' or C-5'), 31.5 (C-2''), 21.3 (C(=O)CH3); HRMS (ESI): calcd for 
C19H20O7 [M+Na]





NaHCO3 (91 mg, 1.07 mmol) was added to a solution of allyl alcohol 1-94 (0.120 g, 0.35 mmol) in 
CH2Cl2 (5 mL) at 0 °C, followed by the dropwise addition of a solution of meta-chloroperbenzoic 
acid (0.18 g, 1.07 mmol) in CH2Cl2 (3 mL, pre-dried with anhydrous Na2SO4) at the same 
temperature. After the addition was complete, the mixture was stirred for a further 6 h at r.t. Then, a 
saturated solution of Na2SO3 (5 mL) was added and the mixture was stirred for a further 15 min. 
The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 × 10 mL). The 
combined organic layers were washed with a saturated solution of NaHCO3 (10 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 1:1) to give a mixture of two epoxides 1-87 (74 mg, 
59% combined yield, d.r = 1:1) as a colorless oil.  
Rf = 0.47 (petroleum ether/ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 6.76–6.66 (m, 3H, 
ArH), 4.32 (d, J = 12.7 Hz, 0.5H, CH2OH), 4.22–4.14 (m, 2H, CO2CH2CH3), 3.90 (d, J = 12.8 Hz, 
0.5H, CH2OH), 3.80 (d, J = 11.7 Hz, 1H, CH2OH), 3.77–3.74 (m, 6H, (2 × OCH3), 3.60 (s, 0.5H, 
H-5), 3.53 (s, 0.5H, H-5), 2.70–2.50 (m, 2H, CH2), 2.45 (dt, J = 12.5, 5.0 Hz, 0.5H, CH2), 2.25–
2.20 (m, 0.5H, CH2), 2.11–1.75 (m, 5H, CH2), 1.60–1.52 (m, 0.5H, CH2), 1.30–1.24 (m, 3H, 
CO2CH2CH3); 13C NMR (100 MHz, CDCl3): δ = 175.0 (CO2Et), 174.4 (CO2Et), 153.4 (Ar), 151.6 
(Ar), 151.4 (Ar), 131.6 (Ar), 130.6 (Ar), 116.3 (Ar), 116.1 (Ar), 111.1 (Ar), 111.1 (Ar), 70.3 (C-1), 
69.4 (C-1), 61.9 (C-5), 61.2 (C-5), 60.9 (CO2CH2CH3), 58.8 (CH2OH), 58.5 (CH2OH), 55.9 
(OCH3), 55.6 (OCH3), 55.0 (C-1), 54.3 (C-1), 34.1 (CH2), 33.1 (CH2), 30.4 (CH2), 28.2 (CH2), 26.4 
(CH2), 26.2 (CH2), 25.3 (CH2), 14.3 (CO2CH2CH3); HRMS (ESI): calcd for C19H26O6 [M+Na]
+ 
373.1621; found: 373.1621. 
 
 
Experimental Section                                                                                 99 
 
 
Ethyl 4-(2,5-Dimethoxyphenethyl)-1-oxaspiro[2.4]heptane-4-carboxylate (1-88) 
 
 
NaHCO3 (0.81 g, 9.74 mmol) was added to a solution of alkene exo-1-89 (1.55 g, 4.87 mmol) in 
CH2Cl2 (40 mL) at 0 °C, followed by the dropwise addition of a solution of meta-chloroperbenzoic 
acid (1.26 g, 7.30 mmol) in CH2Cl2 (20 mL, pre-dried with anhydrous Na2SO4) at the same 
temperature. After the addition was complete, the mixture was stirred for 5 h at r.t. Then, a saturated 
solution of sodium sulfite (Na2SO3; 25 mL) was added and the mixture was stirred for a further 15 
min. The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 × 40 mL). The 
combined organic layers were washed with a saturated solution of NaHCO3 (20 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 4:1) to give a mixture of two epoxides 1-88 (1.0 g, 
61% yield, d.r.= 7:3) as a white solid.  
Rf = 0.58 (petroleum ether/ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 6.75–6.64 (m, 3H, 
ArH), 4.16–4.10 (m, 2H, CO2CH2CH3), 3.76 (s,3H, OCH3), 3.74 (s, 3H, OCH3), 3.02 (d, J = 4.8 Hz, 
0.7H, H-2, major), 2.01 (d, J = 4.6 Hz, 0.3H, H-2, minor), 2.81 (d, J = 4.8 Hz, 0.3H, H-2, minor), 
2.72 (d, J = 4.6 Hz, 0.7H, H-2, major), 2.67–2.44 (m, 2H, CH2), 2.34 (dt, J = 12.1, 4.8 Hz, 1H, H-
1'), 2.14–1.95 (m, 2H, CH2), 1.90–1.72 (m, 3H, CH2, H-6 or H-2'), 1.70–1.62 (m, 2H, CH2), 1.30–
1.25 (m, 3H, CO2CH2CH3); 13C NMR (100 MHz, CDCl3): δ = 175.0 (CO2Et, minor), 172.2 
(CO2Et, major) 153.5, 151.6 (C-2'', C-5''), 131.8 (Ar), 131.5 (Ar), 116.2 (Ar), 116.1 (Ar), 111.2 (C-
3'' or C-4''), 111.0 (C-4''or C-3''), 68.8 (C-3 or C-4), 60.7 (CO2CH2CH3), 60.5 (CO2CH2CH3), 55.9 
(OCH3), 55.7 (OCH3), 54.9 (C-4 or C-3, minor), 54.4 (C-4 or C-3, major), 49.9 (C-2, minor), 48.9 
(C-2), 35.2 (CH2), 32.4 (CH2), 26.1 (CH2), 22.2 (CH2), 21.6 (CH2), 14.2 (CO2CH2CH3); HRMS 
(ESI): calcd for C19H26O5 [M+Na]
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Ethyl 1-(2,5-Dimethoxyphenethyl)-2-methylenecyclopentane-1-carboxylate (exo-1-89) 
 
 
Anhydrous potassium tert-butoxide (1.97 g, 17.61 mmol) was added to a solution of methyl 
triphenylphosphonium bromide (6.62 g, 18.53 mmol) in dry THF (50 mL) at 0 °C. The resulting 
yellow suspension was stirred for 30 min at 0 °C and then for 1 h at r.t. Then, the mixture was re-
cooled to 0 °C and a solution of ketoester 1-93 (1.98 g, 6.17 mmol) in THF (30 mL) was added 
dropwise. The resulting yellow mixture was stirred at r.t. for 8 h and the reaction mixture was 
diluted with cold water (50 mL). The layers were separated and the aqueous layer was extracted 
with ethyl acetate (3×30 mL). The combined organic layers were washed with a saturated solution 
of NaCl (15 mL), dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. 
The residue was purified by flash chromatography (petroleum ether/ethyl acetate, 10:1) to give 
alkene exo-1-89 (1.55 g, 79% yield) as a colorless liquid.  
Rf = 0.44 (petroleum ether/ethyl acetate, 8:2); 1H NMR (400 MHz, CDCl3): δ = 6.75–6.72 (m, 2H, 
ArH), 6.70–6.66 (m, 1H, ArH), 5.10 (t, J = 2.0 Hz, 1H, 2-CH2), 5.03 (t, J = 2.0 Hz, 1H, 2-CH2), 
4.15 (m, 2H, CO2CH2CH3), 3.76 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 2.61 (dt, J = 12.9, 4.5 Hz, 1H, 
H-2'), 2.50–2.37 (m, 4H, H-3, H-2', H-4, H-5), 2.21 (td, J = 13.1, 4.8 Hz, 1H, H-1'), 1.82–1.68 (m, 
4H, H-1', H-4, H-5, H-3), 1.26 (t, J = 7.1 Hz, 3H, CO2CH2CH3); 13C NMR (100 MHz, CDCl3): δ = 
175.1 (CO2Et), 155.1 (C-2), 153.4, 151.6 (C-2'', C-5''), 132.0 (C-1''), 116.1 (Ar), 111.2, 110.8 (C-3'', 
C-4''), 107.5 (2-CH2), 60.5 (CO2CH2CH3), 56.4 (C-1), 55.9 (OCH3), 55.6 (OCH3), 39.1 (CH2), 34.9 
(C-1'), 33.8 (CH2), 26.6 (C-2'), 24.1 (C-3), 14.1 (CO2CH2CH3); HRMS (ESI): calcd for C19H26O4 





To a solution of LiAlH4 (4.0 g, 100 mmol) in THF (150 mL) at 0 °C was added a solution of 2,5–
dimethoxyphenyl acetic acid (10.0 g, 50.9 mmol) in dry THF (50 mL). Thereafter, the resulting 
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suspension was stirred at 45 °C for 8 h. The reaction mixture was cooled to 0 °C and quenched by 
adding H2O (10 mL) and 15% aqueous NaOH (5 mL). The white suspension was filtered through 
celite and washed with hot ethyl acetate (2 × 50 mL). The obtained filtrate was dried over 
anhydrous Na2SO4, filtered and concentrated under reduced pressure to give crude alcohol 1-91 (9.1 
g, 98%) as a colorless oil which was subjected for the next step without purification.  
Rf = 0.25 (petroleum ether/ethyl acetate, 9:1); 1H NMR (400 MHz, CDCl3): δ = 6.78−6.70 (m, 3H, 
ArH), 3.80 (t, J = 6.5 Hz, 2H, CH2), 3.76 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 2.85 (t, J = 6.5 Hz, 
2H, CH2), 2.33 (s, 1H, OH); 13C NMR (100 MHz, CDCl3): δ = 153.4, 151.7 (C-2', C-5'), 128.2 (C-
1'), 117.0 (Ar), 111.5, 111.2 (C-3', C-4'), 62.6 (C-1), 55.8 (OCH3), 55.5 (OCH3), 34.1 (C-2). HRMS 
(ESI): calcd for C10H14O3 [M+Na]





Iodine (23.0 g, 90.6 mmol) was added portionwise to a solution of imidazole (16.8 g, 247 mmol) 
and triphenylphosphine (23.7 g, 90.6 mmol) in CH2Cl2 (100 mL) at 0 °C. The resulting suspension 
was stirred for 5 min at the same temperature and then a solution of alcohol 1-91 (15.0 g, 82.4 
mmol) in CH2Cl2 (50 mL) was added dropwise. After the addition was complete, the flask was 
covered with aluminum foil to protect it from light and the reaction mixture was stirred at r.t. for 4 
h. The reaction mixture was diluted with a saturated aqueous solution of Na2S2O3 (70 mL). The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (2 ×100 mL). The 
combined organic layers were washed with a saturated solution of NaCl (25 mL), dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The crude product was 
purified by flash chromatography (petroleum ether/ethyl acetate, 10:1) to give alkyl iodide 1-92 
(20.0 g, 83% yield) as a brown oil.  
Rf = 0.3 (petroleum ether/ethyl acetate, 9:1); 1H NMR (400 MHz, CDCl3): δ = 6.77–6.76 (m, 2H, 
ArH), 6.71–6.70 (m, 1H, ArH), 3.78 (s, 3H; OCH3) 3.76 (s, 3H, OCH3), 3.34 (t, J = 7.8 Hz, 2H, 
CH2), 3.15 (t, J = 8.3 Hz, 2H, CH2); 13C NMR (100 MHz, CDCl3): δ = 153.3, 151.6 (C-1, C-4), 
130.0 (C-2), 116.5 (C-3), 112.2, 111.3 (C-5, C-6), 55.8 (OCH3), 55.7 (OCH3), 35.7 (C-1'), 4.8 (C-
2'); HRMS (ESI): calcd for C10H13IO2 [M+Na]
+ 314.9853; found: 314.9850. 
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Ethyl 1-(2,5-Dimethoxyphenethyl)-2-oxocyclopentane-1-carboxylate (1-90)28 
 
 
A solution of ethyl 2-oxocyclopentanecarboxylate (2.87 g, 18.04 mmol) and anhydrous K2CO3 (6.2 
g, 53.06 mmol) in DMF (50 mL) was stirred for 15 min at r.t. A solution of alkyl iodide 1-92 (6.2 g, 
21.2 mmol) in DMF (15 mL) was added and the mixture was stirred for 12 h at 75 °C. Then, the 
reaction was cooled to r.t., diluted with water (50 mL) and poured onto ethyl acetate (50 mL). The 
layers were separated and the aqueous layer was extracted with ethyl acetate (3 × 50 mL). The 
combined organic layers were washed with saturated solution of NaCl (50 mL), dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 10:1) to give ketoester 1-93 (3.70 g, 63% yield) as a 
colorless oil. Styrene 1-93a was formed as a minor product (0.85 g, 24% yield, based on alkyl 
iodide) as colorless oil. (Rf = 0.78)  
Rf = 0.52 (petroleum ether/ethyl acetate, 9:1); 1H NMR (400 MHz, CDCl3): δ = 6.74–6.66 (m, 3H, 
ArH), 4.20–4.12 (m, 2H, CO2CH2CH3), 3.75 (s, 3H, OCH3), 3.74 (s, 3H, OCH3), 2.64–2.50 (m, 3H, 
H-1', H-2', H-3), 2.45–2.37 (m, 1H, H-4), 2.31–2.16 (m, 2H, H-5, H-2'), 2.05–1.93 (m, 3H, H-5, H-
3, H-4), 1.78 (ddd, J = 13.4, 11.6, 4.8 Hz, 1H, H-1'), 1.26 (t, J = 7.1 Hz, 3H, CO2CH2CH3); 13C 
NMR (100 MHz, CDCl3): δ = 214.7 (C-2), 170.8 (CO2Et), 153.5, 151.6 (C-2'', C-5''), 131.0 (C-1''), 
116.1 (C-6''), 111.4, 111.1 (C-3'', C-4''), 61.3 (CO2CH2CH3), 60.6 (C-1), 55.8 (OCH3), 55.7 (OCH3), 
37.9 (C-3), 34.0 (C-1'), 32.6 (CH2), 25.8 (C-2'), 19.6 (CH2), 14.1 (CO2CH2CH3); HRMS (ESI): 
calcd for C18H24O5 [M+Na]
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Ethyl 1-(2,5-Dimethoxyphenethyl)-2-(hydroxymethyl)cyclopent-2-ene-1-carboxylate (1-94) 
 
 
An aqueous solution of H2SO4 (2 m, 1 mL, 2.0 mmol) was added to a stirring solution of spiro 
epoxide 1-88 (0.7 g, 2.1 mmol) in CH2Cl2 (40 mL) at 0 °C and the stirring was continued for a 
further 15 min at the same temperature. Then, the reaction mixture was treated with a saturated 
aqueous solution of NaHCO3 (10 mL) at 0 °C. The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 × 20 mL). The combined organic layers were washed with a saturated 
solution of Na2CO3 (15 mL), a saturated solution of NaCl (10 mL), dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The crude alcohol was purified by flash 
chromatography (petroleum ether/ethyl acetate, 1:1) to give allyl alcohol 1-94 (0.231 g, 33% yield) 
as a white solid.  
Rf = 0.46 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 6.75–6.67 (m, 3H, 
ArH), 5.90 (br s, 1H, H-3), 4.25–4.24 (m, 2H, CH2OH), 4.17–4.10 (m, 2H, CO2CH2CH3), 3.76 (s, 
3H, OCH3), 3.75 (s, 3H, OCH3), 2.57–2.50 (m, 2H, CH2), 2.48–2.40 (m, 2H, CH2), 2.38–2.31 (m, 
1H, H-2'), 2.18–2.10 (m, 1H, H-4), 2.07–2.00 (m, 1H, H-1'), 1.86 (dt, J = 12.1, 4.7 Hz, 1H, H-4), 
1.26 (m, 3H,CO2CH2CH3); 13C NMR (100 MHz, CDCl3): δ = 176.8 (CO2Et), 153.5, 151.6 (C-2'', 
C-5''), 144.1 (C-2), 131.5 (C-3), 131.3 (C-1''), 116.3 (C-6''), 111.1 (C-3''), 111.0 (C-4''), 60.9 (C-1), 
60.4 (CO2CH2CH3), 59.7 (CH2OH), 55.8 (OCH3), 55.7 (OCH3), 36.4 (C-4), 33.8 (C-1'), 30.3 (C-2'), 
25.9 (C-5), 14.2 (CO2CH2CH3); HRMS (ESI): calcd for C19H26O5 [M+Na]
+ 357.1672; found: 
357.1675. 
 
Ethyl 2-(Acetoxymethyl)-1-(2,5-dimethoxyphenethyl)cyclopent-2-ene-1-carboxylate (1-95) 
 
 
Acetic anhydride (0.158 g, 1.55 mmol) was added to a stirring solution of allyl alcohol 1-94 (0.26 g, 
0.77 mmol) in pyridine (5 mL) at r.t. and the mixture was stirred for a further 8 h. The reaction 
mixture was diluted with water (15 mL) and extracted with CH2Cl2 (2 × 15 mL). The combined 
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organic layers were washed with HCl (1 m, 15 mL), dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The crude product was purified by flash chromatography 
(petroleum ether/ethyl acetate, 3:1) to give allyl acetate 1-95 (0.225 g, 77% yield) as a yellow solid.  
Rf = 0.71 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 6.75–6.66 (m, 3H, 
ArH), 5.87 (br s, 1H, H-3), 4.72 (br s, 2H, CH2OAc), 4.15–4.10 (m, 2H,CO2CH2CH3), 3.76 (s, 3H, 
OCH3), 3.74 (s, 3H, OCH3), 2.61–2.50 (m, 2H, H-1', H-5), 2.48–2.34 (m, 3H, H-5, H-4, H-2'), 2.15 
(dt, J = 13.4, 5.1 Hz, 1H, H-2'), 2.10–2.01 (m, 4H, OAc, H-1'), 1.80 (dt, J = 13.1, 4.5 Hz, 1H, H-4), 
1.25 (t, J = 7.1 Hz, 3H, CO2CH2CH3); 13C NMR (100 MHz, CDCl3): δ = 175.1 (CO2Et), 170.7 
(C=O, Ac), 153.4 (Ar), 151.6 (Ar), 139.4 (C-2), 131.9 (C-1''), 131.5 (C-3), 116.2 (C-6''), 111.0 (C-
3'' or C-4''), 111.0 (C-4'' or C-3''), 61.2 (CH2OAc), 60.6 (CO2CH2CH3), 60.2 (C-1), 55.8 (OCH3), 
55.6 (OCH3), 35.9 (C-4 or C-5), 33.4 (C-5 or C-4), 30.7 (C-1'), 25.9 (C-2'), 20.9 (O(C=O)CH3), 
14.2 (CO2CH2CH3); HRMS (ESI): calcd for C21H28O7 [M+Na]
+ 399.1778; found: 399.1780. 
 
Ethyl rel-(1S, 2S, 5S)-1-(Acetoxymethyl)-2-(2,5-dimethoxyphenethyl)-6-oxabicyclo[3.1.0] 
hexane-2-carboxylate (1-97a) and Ethyl -(1R, 2S, 5R)-1-(Acetoxymethyl)-2-(2,5-
dimethoxyphenethyl)-6- oxabicyclo[3.1.0]hexane-2-carboxylate (1-97b) 
 
 
NaHCO3 (0.17 g, 2.04 mmol) was added to a solution of compound 1-95 (0.22 g, 0.58 mmol) in 
CH2Cl2 (10 mL) at 0 °C and a solution of meta-chloroperbenzoic acid (0.35 g, 2.04 mmol) in 
CH2Cl2 (5 mL, pre-dried with anhydrous Na2SO4) was added dropwise at the same temperature. 
After the addition was complete, the mixture was stirred for a further 5 h at r.t. Then, a saturated 
solution of Na2SO3 (15 mL) was added and the mixture was stirred for a further 15 min. The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (2 × 15 mL). The combined 
organic layers were washed with a saturated solution of NaHCO3 (10 mL), dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 1:1) to give compound 1-97a (37 mg, 16% yield) as 
a white solid and compound 1-97b (36.4 mg, 16% yield) as a white solid.  
Compound 1-97a: Rf = 0.22 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 
6.72–6.65 (m, 2H; ArH), 6.64–6.57 (m,1H; ArH), 4.45 (d, J = 12.6 Hz, 1H; CH2OAc), 4.25 (d, J = 
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12.6 Hz, 1H; CH2OAc), 4.10 (q, J = 7.3 Hz, 2H; CO2CH2CH3), 3.70 (s, 3H; OCH3), 3.69 (s, 3H; 
OCH3), 3.47 (s, 1H; H-5), 2.58–2.52 (m, 2H; H-1'), 2.23–2.16 (m, 1H; H-2'), 1.97 (s, 3H; OAc), 
1.96–1.89 (m, 3H; H-3, H-4), 1.56–1.48 (m, 1H; H-4), 1.23 (t, J = 7.1 Hz, 3H; CO2CH2CH3); 13C 
NMR (100 MHz, CDCl3): δ = 174.1 (CO2CH2CH3), 170.4 (C=O, Ac), 153.4, 151.6 (C-2'', C-5''), 
131.7 (C-1''), 116.1 (C-6''), 111.1, 111.0 (C-3'', C-4''), 67.6 (C-5), 62.3 (C-1), 61.4 (CO2CH2CH3), 
60.9 (CH2OAc), 55.9 (OCH3), 55.7 (OCH3), 54.5 (C-2), 32.8 (C-4), 30.6 (C-3), 26.6 (C-1'), 26.2 
(C-2'), 20.7 (O(C=O)CH3), 14.1 (CO2CH2CH3); HRMS (ESI): calcd for C21H28O7 [M+Na]
+ 
415.1727; found: 415.1723. 
 
Compound 1-97b: Rf = 0.19 (petroleum ether/Ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 
6.76–6.68 (m, 3H; ArH), 4.71–4.63 (m, 2H; CH2 OAc), 4.22–4.17 (m, 2H; CO2CH2CH3), 3.76 (s, 
3H; OCH3), 3.75 (s, 3H; OCH3), 2.67 (td, J = 12.6, 4.0 Hz, 1H; H-2'), 2.43 (td, J = 12.6, 5.0 Hz, 
1H; H-2'), 2.14–2.06 (m, 3H; H-1', H-3, H-4), 2.03 (s, 3H; OAc), 1.92–1.90 (m, 1H; H-4), 1.80–
1.72 (m, 2H; H-1', H-3), 1.30 (t, J = 7.1 Hz, 3H; CO2CH2CH3); 13C NMR (100 MHz, CDCl3): δ = 
173.8 (CO2Et), 170.5 (O(C=O)CH3), 153.5 (C-5''), 151.5 (C-2''), 130.7 (C-1''), 116.3 (C-6''), 111.3 
(C-3''), 111.0 (C-4''), 67.4 (C-1), 61.2 (C-5), 61.0 (CO2CH2CH3), 60.3 (CH2OAc), 55.69 (OCH3), 
55.66 (OCH3), 54.8 (C-2), 33.9 (C-1'), 27.7 (C-4), 26.2 (C-3), 25.2 (C-2'), 20.8 (OAc), 14.2 
(CO2CH2CH3); HRMS (ESI): calcd for C21H28O7 [M+Na]





A solution of alcohol 1-63 (0.30 g, 0.98 mmol) in CH2Cl2 (15 mL) was treated with acetic 
anhydride (0.3 mL, 2.95 mmol), pyridine (0.3 mL, 2.95 mmol), and DMAP (37 mg, 0.29 mmol) at 
0 °C and the mixture was stirred for 8 h at r.t. Then, the mixture was diluted with CH2Cl2 (20 mL) 
and washed with HCl (1 m, 5 mL). The aqueous layer was further extracted with CH2Cl2 (30 mL) 
and the combined organic layers were washed with a saturated solution of NaCl (20 mL), dried over 
anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The crude product was 
purified by flash chromatography (petroleum ether/ethyl acetate, 1:1) to give acetate 1-85 (0.34 g, 
99% yield) as a white solid.  
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Rf = 0.63 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 6.70–6.66 (m, 2H; 
ArH), 5.46 (br s, 1H; H-6'), 4.91 (d, J = 4.8 Hz, 1H; H-8'), 4.10 (d, J = 4.0 Hz, 1H; H-8'), 3.78, (s, 
3H; OCH3), 3.76 (s, 3H; OCH3), 3.10 (dd, J = 17.9, 4.5 Hz, 1H; H-1'), 2.43 (ddd, J = 17.6, 13.3, 4.4 
Hz, 1H; H-1'), 2.37–2.31 (m, 1H; H-4' or H-5'), 2.20 (ddd, J = 17.4, 13.7, 4.2 Hz, 1H; H-2'), 2.11 (s, 
3H; C(=O)CH3), 2.01–1.93 (m, 1H; H-4' or H-5'), 1.76–1.52 (m, 3H; H-2', H-5', H-4'); 13C NMR 
(100 MHz, CDCl3): δ = 182.5 (C-9'), 170.2 (C(=O)CH3), 151.4, 150.7 (C-1, C-4), 127.2 (Ar), 125.7 
(Ar), 109.0 (Ar), 108.3 (Ar), 82.2 (C-6'), 72.2 (C-8'), 55.8 (OCH3), 55.4 (OCH3), 54.9 (C-7' or C-
3'), 51.6 (C-3' or C-7'), 32.2 (CH2), 31.3 (CH2), 27.4 (CH2), 21.3 (C(=O)CH3), 18.3 (C-1'); HRMS 
(ESI): calcd for C19H22O6 [M+Na]





A mixture of acetate 1-85-syn (33 mg, 0.09 mmol) in MeOH (5 mL) and an aqueous solution of 
HCl (3 m, 5 mL) was heated at 85° C for 8 h. Then, the mixture was cooled to r.t. and the MeOH 
was removed under vacuum. The residue was diluted with water (25 mL) and then extracted with 
CH2Cl2 (2 × 20 mL). The combined organic layers were washed with a saturated solution of NaCl 
(2 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product 
was purified by flash chromatography (petroleum ether/ethyl acetate, 1:1) to give alcohol 1-100 (28 
mg, 96% yield) as light brown solid.  
Rf = 0.12 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 7.10 (d, J = 9.1 Hz, 
1H; ArH), 6.90 (d, J = 9.1 Hz, 1H; ArH), 5.30 (d, J = 10.0 Hz, 1H; H–8'), 4.26–4.21 (m, 2H; H-8', 
H-6'), 3.87 (s, 3H; OCH3), 3.84 (s, 3H; OCH3), 2.84 (d, J = 13.0 Hz, 1H; H-2'), 2.80 (d, J = 13.0 Hz, 
1H; H-2'), 2.40–2.34 (m, 1H; H-4' or H-5'), 1.95–1.88 (m, 1H; H-5' or H-4'), 1.81–1.74 (m, 1H; H-
5'), 1.58–1.50 (m, 1H; H-4'); 13C NMR (100 MHz, CDCl3): δ = 194.7 (C-1'), 179.5 (C-9'), 152.6 
(C-1), 150.1 (C-4), 134.0 (C-3), 122.4 (C-2), 117.0 (C-5), 111.6 (C-6), 81.6 (C-6'), 70.2 (C-8'), 56.5 
(OCH3), 56.4 (OCH3), 53.5 (C-3'), 53.4 (C-7'), 44.1 (C-5'), 32.2 (C-4'), 31.5 (C-2'); HRMS (ESI): 
calcd for C17H18O6 [M+Na]












t-BuSH (3 mL) was added to a solution of AlCl3 (234 mg, 1.76 mmol) in CH2Cl2 (8 mL) at 0 °C 
and the mixture was stirred for 15 min at 0 °C. Subsequently, a solution of aryl ether 1-100 (28 mg, 
0.08 mmol) in CH2Cl2 (5 mL) was added at the same temperature and the resulting suspension was 
heated at reflux for 12 h. Then, the mixture was cooled to 0 °C and treated with a saturated solution 
of NaH2PO4 (6 mL). The layers were separated and the aqueous layer was extracted with ethyl 
acetate (2 × 10 mL). The combined organic layers were washed with a saturated solution of NaCl, 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was 
purified by flash chromatography (petroleum ether/ethyl acetate, 1:1) to give (±)-Lingzhiol (1-1) 
(15.3 mg, 60% yield) as a yellow solid.  
Rf = 0.18 (petroleum ether/ethyl acetate, 1:1 ); 1H NMR (400 MHz, (CD3)2CO): δ = 11.57 (s, OH), 
8.88 (s, OH), 7.20 (d, J = 8.9 Hz, 1H; ArH), 6.77 (d, J = 8.9 Hz, 1H; ArH), 5.20 (d, J = 9.7 Hz, 1H; 
H-8'), 4.87 (s, 1H; H), 4.64 (t, J = 4.3 Hz, 1H; H-6'), 4.45 (d, J = 9.7 Hz, 1H; H-8'), 3.10 (d, J = 16.0 
Hz, 1H; H-2'), 2.80 (d, J = 16.0 Hz, 1H; H-2'), 2.46–2.41 (m, 1H; H-5' or H-4'), 1.81–1.68 (m, 3H; 
H-4', H-5'); 13C NMR (100 MHz, (CD3)2CO): δ = 202.4 (C-1'), 180.1 (C-9'), 156.4 (Ar), 148.0 (Ar), 
129.2 (Ar), 127.6 (Ar), 118.0 (Ar), 116.5 (Ar), 80.8 (C-6'), 71.0 (C-8'), 56.2 (C-7'), 52.6 (C-3'), 42.4 
(C-2'), 33.8 (C-5' or C-4'), 33.3 (C-4' or C-5'); IR (ATR): n˜= 2356, 2330, 1756, 1644, 1463, 1267, 





t-BuSH (5 mL) was added to a solution of AlCl3 (613 mg, 4.65 mmol) in CH2Cl2 (15 mL) at 0 °C 
and a solution of aryl ether 1-63 (70 mg, 0.23 mmol) in CH2Cl2 (5 mL) was added at the same 
temperature. The resulting suspension was heated at reflux for 12 h, cooled to 0 °C, and treated with 
a saturated solution of NaH2PO4 (10 mL). The layers were separated and the aqueous layer was 
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extracted with ethyl acetate (2 × 20 mL), washed with a saturated solution of NaCl, dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 1:1) to give lingzhiol analogue 1-101 (47 mg, 74% 
yield) as an off white solid.  
Rf = 0.17 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CD3OD): δ = 6.53–6.48 (m, 2H; 
ArH), 5.23 (d, J = 9.8 Hz, 1H; H-8'), 4.38 (t, J = 3.4 Hz, 1H; H-6'), 4.16 (d, J = 9.9 Hz, 1H; H-8'), 
3.01 (ddd, J = 17.1, 7.3, 4.3 Hz, 1H; H-1'), 2.46 (ddd, J = 17.2,13.1, 4.3 Hz, 1H;H-1'), 2.34–2.26 
(m, 1H; H-4' or H-5'), 2.10 (td, J = 13.1, 4.0 Hz, 1H;H-2'), 2.01–1.90 (m, 1H; H-5' or H-5'), 1.67–
1.50 (m, 3H; H-5', H-4', H-2'); 13C NMR (100 MHz, CD3OD): δ = 186.0 (C-9'), 149.4 (C-4), 148.2 
(C-1), 126.7 (C-3), 125.7 (C-2), 114.4 (Ar), 114.1 (Ar), 80.9 (C-6'), 74.1 (C-8'), 57.0 (C-7'), 52.8 
(C-3'), 34.6 (C-5' or C-4'), 32.4 (C-4' or C-5'), 29.1 (C-2'), 19.6 (C-1'); IR (ATR): n˜ = 3364, 2947, 







Water (0.2 mL) and 2,3-dichlor-5,6-dicyano-1,4-benzoquinone (DDQ; 51 mg, 0.22 mmol) were 
added to a stirring solution of hydroquinone 1-101 (25 mg, 0.09 mmol) in CH2Cl2 (5 mL) at r.t. The 
resulting suspension was stirred at r.t for 4 h. The reaction mixture was diluted with a saturated 
solution of NaHCO3, the layers were separated, and the aqueous layer was extracted with CH2Cl2 (2 
× 10 mL). The combined organic layers were washed with a saturated solution of NaCl, dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 1:1) to give quinone 1-102 (16.4 mg, 66% yield) as 
a yellow solid. 
Rf = 0.37 (petroleum ether/ethyl acetate, 1:1 ); 1H NMR (400 MHz, CDCl3): δ = 6.84–6.77 (m, 2H; 
ArH) 5.10 (d, J = 10.1 Hz, 1H; H-8'), 4.01 (t, J = 7.9 Hz, 1H; H-6'), 3.90 (d, J = 10.2 Hz, 1H; H-8'), 
3.30 (s, OH), 2.77 (td, J = 9.3, 4.8 Hz, 1H; H-1'), 2.41–2.32 (m, 1H; H-1'), 2.25–2.20 (m, 1H; H-4' 
or H-5'), 2.13–2.01 (m, 2H; H-2', H-5'), 1.80–1.71 (m, 2H; H-4', H-2'), 1.68–1.58 (m, 1H; H-5' or 
H-4'); 13C NMR (100 MHz, CDCl3): δ = 188.9 (C=O), 185.8 (C=O), 180.0 (C-9'),143.9 (Ar), 142.6 
(Ar), 136.9 (Ar), 136.6 (Ar), 79.5 (C-6'), 69.0 (C-8'),53.0 (C-3' or C-7'), 52.8 (C-7' or C-3'), 31.7 (C-
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5'), 30.3 (C-4'), 25.5 (C-2'),18.8 (C-1'); IR (ATR): n˜=3730, 3444, 2360, 1758, 1653, 1302,1267, 
1024, 739 cm–1; HRMS (ESI): calcd for C15H14O5 [M+Na]





BBr3 (1 m in CH2Cl2, 0.32 mL, 0.32 mmol) was added to a solution of aryl ether 1-63 (20 mg, 0.06 
mmol) in CH2Cl2 (5 mL) at 0 °C. The resulting mixture was stirred at r.t. for 2 h and then diluted 
with a saturated solution of NaHCO3. The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were washed with a saturated 
solution of NaCl, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified by flash chromatography (petroleum ether/ethyl acetate, 1:1) to give phenol 1-
103 (10 mg, 52% yield) as a yellow solid.  
Rf = 0.25 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CD3OD): δ = 6.68–6.63 (m, 2H; 
ArH), 5.17 (d, J = 9.7 Hz, 1H; H-8'), 4.24 (t, J = 7.1 Hz, 1H; H-6'), 4.10 (d, J = 9.5 Hz, 1H; H-8'), 
3.76 (s, 3H; OCH3), 3.05 (ddd, J = 17.2, 4.4, 2.5 Hz, 1H; H-1'), 2.46 (ddd, J = 16.9, 12.5, 4.4 Hz, 
1H; H-1'), 2.37–2.30 (m, 1H; H-4'), 2.11–2.06 (m, 1H; H-2'), 2.01–1.90 (m, 1H; H-4'), 1.65–1.56 
(m, 2H; H-2', H-5'), 1.47–1.37 (m, 1H; H-5'); 13C NMR (100 MHz, CD3OD): δ = 186.2 (C-9'), 
152.3 (C-4), 149.5 (C-1), 128.3 (C-3), 126.6 (C-2), 114.2 (C-6), 110.4 (C-5), 81.1 (C-6'), 74.4 (C-
8'), 57.7 (C-7'), 56.1 (OCH3), 52.8 (C-3'), 35.1 (C-5'), 32.7 (C-4'), 29.4 (C-2'), 19.8 (C-1'); IR 
(ATR): n˜= 3436, 2360, 1748, 1267, 1026, 740, 677 cm–1; HRMS (ESI): calcd for 
C16H18O5[M+Na]





A mixture of alcohol 1-63 (25 mg, 0.082 mmol) and 2-iodoxybenzoic acid (46 mg, 0.16 mmol) in 
DMSO (5 mL) was stirred for 5 h at 80 °C. A saturated solution of NaHCO3 (3 mL) was added and 
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the mixture was extracted with ethyl acetate (2 × 10 mL). The combined organic layers were 
washed with a saturated solution of NaCl (4 mL), dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The crude product was purified by flash chromatography (petroleum 
ether/ethyl acetate, 1:1) to give ketone 1-104 (19.4 mg, 78% yield) as a semi-solid.  
Rf = 0.68 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 6.74 (s, 2H; ArH), 
5.10 (d, J = 10.2 Hz, 1H; H-8'), 4.40 (d, J = 10.2 Hz, 1H; H-8'), 3.78 (s, 6H; 2 × OCH3), 3.02 (td, J 
= 8.8, 4.5 Hz, 1H; H-1'), 2.58 (ddd, J = 16.9, 11.6, 4.9 Hz, 1H; H-1'), 2.44–2.27 (m, 3H; H-4', H-5'), 
2.17–2.18 (m, 2H; H-2', H-4'), 1.80 (ddd, J = 18.2, 13.7, 4.9 Hz, 1H; H-2'); 13C NMR (100 MHz, 
CDCl3): δ = 210.3 (C-6'), 180.6 (C-9'), 152.8 (Ar), 150.9 (Ar), 126.5 (Ar), 121.4 (Ar), 109.8 (Ar), 
109.8 (Ar), 72.8 (C-8'), 56.6 (C-7' or C-3'), 56.2 (OCH3), 55.8 (OCH3), 49.7 (C-3' or C-7'), 36.0 (C-
5'), 26.0 (C-2' or C-4'), 25.9 (C-4' or C-2'), 18.7 (C-1'); IR (ATR): n˜=3389, 2945, 2837, 2360, 
1755, 1476, 1261, 1024, 676 cm–1; HRMS (ESI): calcd for C17H18O5 [M+Na]






To a mixture of N,O-dimethylhydroxylamine hydrochloride (1.78 g, 18.3 mmol) in CH2Cl2 (20 mL) 
at –20 °C was added a solution of trimethylaluminum (2.0 M in hexane, 9.1 mL, 18.3 mmol) over 5 
min. Then the mixture was stirred for 30 min at the same temperature before the dropwise addition 
of diethyl ester 2-104 (1.0 g, 4.1 mmol) in CH2Cl2 (5 mL). After addition, the cooling bath was 
removed and the mixture stirred for 2 h at r.t. Thereafter, the reaction mixture was carefully 
quenched with aqueous 1N HCl solution (10 mL) at 0 °C. Then, the layers were separated and the 
aqueous layer was extracted with CH2Cl2 (2 × 15 mL). The combined organic layers were washed 
with saturated NaCl solution (20 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was purified by flash chromatography (petroleum ether/ethyl acetate, 6:4) to 
give bis-weinreb amide 2-99 (0.86 g, 76%) as a colorless oil.  
Rf = 0.26 (petroleum ether/ethyl acetate, 1:1); []D 
20 = +13.2 (c = 2.15, CH2Cl2), 1H NMR (400 
MHz, CDCl3): δ = 1.49 (s, 6H, 2 × CH3), 3.20 (s, 6H, 2 × CH3), 3.67 (s, 6H, 2 × OCH3), 5.14 (s, br, 
2H, 4-H, 5-H); 13C NMR (100 MHz, CDCl3): δ = 26.6 (2 × (CH3)2), 32.4 (2 × (CH3)2), 61.6 (2 × 
(OCH3), 74.9 (C-4, C-5), 112.9 (C-2), 170.0 (2 × C=O); HRMS (ESI):  calculated for 
[C16H19NO3+Na]
+: 296.1257; found: 296.1257.   
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Diethyl (4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate (2-104)96 
 
 
To a stirred solution of R-(+)-diethyl tartrate (5.0 g, 24.24 mmol) in acetone (50 mL) was added 
dropwise BF3·OEt2 (4.1 mL, 15.8 mmol) at r.t. The resulting yellow mixture was stirred for 3 h at 
r.t. During the reaction time the yellow mixture turned to red brown color. Thereafter, the reaction 
mixture was quenched with aqueous NaHCO3 (15 mL) and extracted with ethyl acetate (2 × 40 
mL). The combined organic layers were washed with NaCl solution (35 mL), dried over Na2SO4 
and concentrated under reduced pressure. The residue was purified by fractional distillation to give 
protected dimethyl tartrate 2-104 (4.5 g, 75%) as a yellow oil.  
Rf = 0.72 (petroleum ether/ethyl acetate, 5:5); []D
20 = +47.5 (c = 2, CH2Cl2); Lit
149 αD
20
 = +48.8 
(c = 1, MeOH; 1H NMR (400 MHz, CDCl3): δ = 1.30 (t, J = 7.1 Hz, 6H, (CO2CH2CH3)2), 1.48 (s, 
6H, C(CH3)2), 4.26 (q, J = 7.1, 14.2 Hz, 4H, (CO2CH2CH3)2), 4.74 (s, 2H, 4-H, 5-H); 13C NMR 
(100 MHz, CDCl3): δ = 13.9 (2 × CO2CH2CH3), 26.2 (2 × CH3), 61.7 (2 × CO2CH2CH3), 76.5 (C-4, 
C-5), 113.6 (C-2), 169.5 (2 × CO2CH2CH3); HRMS (ESI):  calculated for [C11H18O6+Na]
+: 





To a mixture of magnesium turnings (0.52 g, 21.7 mmol) in THF (5 mL) was added under argon 
atmosphere a solution of 5-bromo-1-pentene 2-105 (1.94 g, 13.0 mmol) in dry THF (6 mL) at 0 °C. 
After addition, the reaction mixture was stirred for 1 h at 45 °C. The resulting Grignard solution 
was added dropwise to a solution of bis-weinreb amide 2-99 (2.4 g, 8.68 mmol) in THF (8 mL) at 0 
°C. The resulting mixture was stirred for further 30 min at 0 °C, before saturated NH4Cl (10 mL) 
solution was added. The layers were separated and the aqueous layer was extracted with ethyl 
acetate (2 × 15 mL). The combined organic layers were washed with NaCl solution (25 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by flash 
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chromatography (petroleum ether/ethyl acetate, 6:4) to give ketoamide 2-106 (2.0 g, 80%) as a 
colorless oil.  
Rf = 0.46 (petroleum ether/ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 1.42 (s, 3H, CH3), 
1.47 (s, 3H, CH3), 1.67–1.73 (m, 2H, 3'-H), 2.07 (q, J = 14.6, 7.1 Hz, 2H, 4'-H), 2.54–2.74 (m, 2H, 
2'-H), 3.21 (s, 3H, CH3), 3.70 (s, 3H, OCH3), 4.79–4.80 (m, 1H, 5-H), 4.95–5.03 (m, 3H, 6'-H, 4-
H), 5.70–5.80 (m, 1H, 5'-H); 13C NMR (100 MHz, CDCl3): δ = 22.0 (C-3'), 26.2 (CH3), 26.6 (CH3), 
32.4 (CH3), 32.9 (C-4'), 38.4 (C-2'), 61.6 (OCH3), 73.9 (C-4), 82.2 (C-5), 112.7 (C-2), 115.3 (C-6'), 
137.7 (C-5'), 169.7 (C=O), 206.1 (C-1'); HRMS (ESI):  calculated for [C14H23NO5+Na]
+: 
308.14684; found: 308.14674.   
 
(Z)-1-((4S,5S)-5-(Methoxy(methyl)carbamoyl)-2,2-dimethyl-1,3-dioxolan-4-yl)hexa-1,5-dien-1-
yl trifluoromethanesulfonate (2-107) 
 
 
To a solution of hexamethyldisilazane (0.2 mL, 0.94 mmol) in THF (2 mL) at 0 °C was added n-
BuLi (2.5 M in hexane, 0.3 mL, 0.52 mmol). The mixture was stirred for 30 min before the addition 
of amide 2-106 (0.15 g, 0.52 mmol) dissolved in THF (3 mL) at –78 °C. After addition, the reaction 
mixture was stirred for 1 h at –78 °C. Then, PhNTf2 (0.28 g, 0.78 mmol) in THF (2 mL) solution 
was added at –78 °C. Again the resulting yellow mixture was stirred another 1 h at the same 
temperature and at r.t. for 30 min. The reaction mixture was quenched with saturated NH4Cl 
solution (8 mL) and the layers were separated. The aqueous layer was extracted with ethyl acetate 
(2  8 mL). The combined organic layers were washed with saturated NaCl solution (5 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure. The cured triflate was purified by 
flash chromatography (petroleum ether/ethyl acetate, 6:4) to give vinyl triflate 2-107 (0.13 g, 60%) 
as a colorless oil.  
Rf = 0.64 (petroleum ether/ethyl acetate, 7:3); 1H NMR (400 MHz, C6D6): δ = 1.24 (s, 3H, CH3), 
1.47 (s, 3H, CH3), 1.58–1.71 (m, 2H, 3'-H), 2.06–2.15 (m, 2H, 4'-H), 2.46–2.51 (m, 1H, 4-H), 2.64–
2.75 (m, 1H, 5-H), 2.82 (s, 3H, CH3), 3.24 (s, 3H, OCH3), 4.05–5.08 (m, 2H, 6'-H), 5.66–5.76 (m, 
1H, 5'-H), 6.07 (s, br, 1H, 2'-H); 13C NMR (100 MHz, CDCl3): δ = 25.5 (CH3), 26.3 (CH3), 28.3 
(CH3), 32.5 (C-4'), 61.3 (OCH3), 74.6 (C-5), 115.4 (C-4), 116.3 (C-2'), 117.2 (C-2), 120.4 (C-6'), 
138.0 (C-5'), 148.3 (C=O), 167.1 (C-1'); HRMS (ESI):  calculated for [C15H22F3NO7S+Na]
+: 
440.0961; found: 440.0961.   






To a stirred solution of amide 2-106 (1.92 g, 6.73 mmol) in THF (40 mL) at 0 °C was added NaBH4 
(0.63 g, 16.65 mmol) portionwise over 10 min. After addition, the cooling bath was removed and 
the reaction mixture stirred at r.t. for 8 h. Then, the reaction mixture was quenched with aqueous 
NaOH solution (2.0 M, 15 mL). The aqueous phase was extracted with ethyl acetate (2  30 mL) 
and the combined organic layers were washed with saturated NaCl solution (35 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude was purified by flash 
chromatography (petroleum ether/diethyl ether, 6:4) to give a 1:1 mixture of alcohol 2-108 (1.32 g, 
85%) as a colorless oil.  
Rf = 0.46 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 1.39 (s, 3H, CH3), 
1.41 (s, 3H, CH3), 1.44–1.51 (m, 3H, 3'-H), 1.61–1.64 (m, 2H, 2'-H), 2.06–2.09 (m, 2.5H, 4'-H), 
3.60–3.84 (m, 4H, CH2OH, 1'-H, 4-H), 4.03–4.05 (m, 1H, 5-H), 4.94–5.03 (m, 2H, 6'-H), 5.75–5.85 
(m, 1H, 5'-H); 13C NMR (100 MHz, CDCl3): δ = 24.7 (C-3'), 24.9 (C-3'), 27.0 (CH3), 27.2 (CH3), 
32.8 (C-2'), 33.5 (C-4'), 33.7 (C-4'), 63.9 (CH2OH), 63.1 (CH2OH), 70.3 (C-1'), 71.6 (C-1'), 77.6 
(C-5), 78.6 (C-5), 79.9 (C-4), 80.5 (C-4), 108.8 (C-6'), 109.2 (C-6'), 114.7 (C-2), 114.8 (C-2), 138.4 
(C-5'); HRMS (ESI):  calculated for [C12H22O4+Na]
+: 253.1410; found: 253.1410. 
 
General procedure for synthesis of TBS, TIPS ether derivatives (2-109a and 2-109b) 
 
 
To a solution mixture of alcohol 2-108 (0.19 g, 0.85 mmol) in CH2Cl2 (8 mL) were added imidazole 
(0.07 g, 1.04 mmol) and TBSCl (0.15 g, 1.04 mmol) at 0 °C. The white suspension was stirred for 2 
h at r.t. Then the reaction mixture was diluted with water (5 mL) and the aqueous layer was 
extracted with CH2Cl2 (2 × 4 mL). The combined organic layers were washed with saturated NaCl 
solution (5 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
material was purified by flash chromatography (petroleum ether/ethyl acetate, 60:40) to give silyl 
ethers 2-109a and 2-109b (d.r = 6:4) as a colorless oils.  
 







To a mixture of secondary alcohols 2-109 (0.30 g, 1.30 mmol) in CH2Cl2 (10 mL) were added 
DMAP (16 mg, 0.13 mmol), pyridine (0.1 mL, 1.30 mmol) and trityl chloride (0.36 g, 1.30 mmol) 
at 0 °C. Then the reaction mixture was stirred for 8 h at r.t. before it was diluted with water (10 mL) 
and the aqueous layer extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were 
washed with saturated NaCl solution (10 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The crude ether was purified by flash chromatography (petroleum ether/ethyl 
acetate, 8:2) to give trityl ether 2-109c (0.50 g, 81%) as colorless oil.  
Rf = 0.71 (petroleum ether/ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 1.35–1.44 (m, 9H, 
(CH3)2), 1.58–1.60 (m, 1.6H, 2'-H), 1.97–2.02 (m, 2H, 4'-H), 3.22–3.32 (m, 2H, 1'-H, 1''-H), 3.49–
3.54 (m, 0.5H, 4-H), 3.69–3.70 (m, 0.7H, 4-H), 3.78–3.83 (m, 1H, 5-H), 4.90–4.98 (m, 2H, 6’-H), 
5.69–5.82 (m, 1H, 5'-H), 7.21–7.31 (m, 10H, ArH), 7.42–7.47 (m, 6H, ArH); 13C NMR (100 MHz, 
CDCl3): δ = 24.8, (C(CH3), 25.1 (C(CH3), 29.7 (C-3’), 32.5 (C-2'), 33.1 (C-4'), 33.5 (C-4'), 65.4 (C-
1''), 70.3 (C-1'), 73.1 (C-3'), 73.2 (C-2'), 73.7 (C-4'), 74.3 (C-5), 82.0 (C-4), 114.9 (C-6'), 127.2 (C-
2), 127.2, 127.9, 128.6 (3 × Ar C), 138.3 (C-5'), 138.4 (C-5'), 146.8 (Ar C).  
 
General procedure for synthesis ketones (2-110a and 2-110b) 
 
 
To a solution of the secondary alcohol 2-109a,b (0.18 g, 0.52 mmol) in CH2Cl2 (6 mL) at 0 °C were 
added DMP (0.44 g, 1.04 mmol) and NaHCO3 (0.065 g, 0.78 mmol). The resulting mixture was 
stirred for 3 h at r.t. Then the reaction mixture was diluted with water (10 mL) and extracted with 
CH2Cl2 (2 × 5 mL). The combined organic layers were washed with saturated NaCl solution (5 
mL), dried over Na2SO4, filtered and concentrated under reduced pressure. The crude ketones were 
purified by flash chromatography (petroleum ether/ethyl acetate, 8:2) to give ketone 2-110a and 2-
110b as colorless oils.  






To a solution of secondary alcohol 2-109c (0.90 g, 1.90 mmol) in CH2Cl2 (20 mL) were added 
DMP (1.20 g, 2.85 mmol) and NaHCO3 (0.40 g, 4.76 mmol) at 0 °C. The reaction mixture was 
stirred for 5 h at r.t. Then the reaction mixture was diluted with water (25 mL) and the aqueous 
layer was extracted with CH2Cl2 (2 × 25 mL). The combined organic layers were washed with 
saturated NaCl solution (25 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The crude ketone was purified by flash chromatography (petroleum ether/ethyl acetate, 
85:15) to give ketone 2-110c (0.74 g, 82%) as a colorless oil.  
Rf = 0.52 (petroleum ether/ethyl acetate, 9:1); []D 
20 = –1.5 (c = 1, CH2Cl2), 1H NMR (400 MHz, 
CDCl3): δ = 1.38 (s, 3H, CH3), 1.44 (s, 3H, CH3), 1.58–1.65 (m, 2H, 3'-H), 1.96–2.01 (m, 2H, 4'-H), 
2.48–2.58 (m, 2H, 2'-H), 3.24 (dd, J = 4.9, 10.1 Hz, 1H, 1''-H), 3.32 (dd, J = 3.8, 10.2 Hz, 1H, 1''-
H), 4.05–4.09 (m, 1H, 5-H), 4.14–4.17 (m, 1H, 4-H), 4.89–4.97 (m, 2H, 6'-H), 5.64–5.75 (m, 1H, 
5'-H), 7.16 (m, 10H, ArH), 7.40–7.43 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 21.9 (C-3’), 
26.4 (C(CH3)2, 27.0 (C(CH3)2, 32.9 (C-4'), 38.0 (C-2'), 64.1 (C-1''), 76.7 (C-5), 81.9 (C-4), 86.8 







To a solution of ketone 2-110c (0.10 g, 0.21 mmol) in THF (3 mL) at –78 °C was added a solution 
of KHMDS (1.0 M in THF, 0.42 mL, 0.21 mmol) dropwise over 5 min. The reaction mixture was 
stirred further 2 h at the same temperature, before it was treated with a solution of PhNTf2 (0.11 g, 
0.31 mmol) in THF (2 mL) at –78 °C for 45 min. Then the cooling bath was removed and the 
reaction mixture stirred for 30 min at r.t. Thereafter, the solvent was removed under reduced 
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pressure. The crude material purified by flash chromatography short column (petroleum ether/ethyl 
acetate, 7:3) to give triflate 2-111 (72 mg, 56%) as a colorless oil.  
Rf = 0.56 (petroleum ether/ethyl acetate, 8:2); 1H NMR (400 MHz, CDCl3): δ = 1.42 (m, s, 3H, 
CH3), 1.45 (s, 3H, CH3), 1.96–2.05 (m, 2H, 3'-H), 2.13–2.31 (m, 2H, 4'-H), 3.18 (dd, J = 4.0, 10.2 
Hz, 1H, 1''-H), 3.30 (dd, J = 4.4, 10.2 Hz, 1H, 1''-H), 4.01–4.05 (m, 1H, 5-H, ), 4.45 (d, J = 8.2 Hz, 
1H, 6'-H), 4.95–5.03 (m, 2H, 4-H, 6'-H), 5.50 (t, J = 7.3 Hz, 1H, 2'-H), 5.60–5.72 (m, 1H, 5'-H), 
7.19–7.27 (m, 10H, ArH), 7.38–7.41 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 24.8 (C-4'), 
26.4 (CH3), 27.0 (CH3), 32.1 (C-3'), 32.6 (C-4'), 62.6 (C-1''), 77.4 (C-5), 75.7 (C-4), 78.9 (C-1'), 
86.8 (CPh3), 110.5 (C-2), 115.9 (C-6'), 125.6 (C-2'), 127.8, 128.6, 128.7 (3 × Ar C), 136.5 (C-5'), 
143.6 (Ar C); HRMS (ESI): calculated for [C32H33F3O6S+Na]






To a mixture of triflate 2-111 (20 mg, 0.03 mmol) in THF (2 mL) were added trimethylboroxine (6 
mg, 0.05 mmol), anhydrous K2CO3 (18 mg, 0.13 mmol), and Pd(PPh3)4 (7 mg, 0.01 mmol) at 40 °C 
and the mixture was stirred for 1 h. The reaction mixture was cooled to r.t., and diluted with water 
(3 mL) and poured onto EtOAc (5 mL). The layers were separated and the organic layer washed 
with saturated NaCl solution (2 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The crude material was purified by flash chromatography (petroleum ether/ethyl acetate, 
80:20) to give diene 2-113 (10 mg, 66%) as a colorless oil.  
Rf = 0.56 (petroleum ether/ethyl acetate, 9:1); 1H NMR (400 MHz, CDCl3): δ = 1.47 (s, 3H, 
C(CH3)2), 1.48 (s, 3H, C(CH3)2), 2.35–2.40 (m, 2H, 4'-H), 2.53–2.60 (m, 2H, 3'-H), 3.15 (dd, J = 
10.1, 4.3 Hz, 1H, 1''-H), 3.32 (dd, J = 10.3, 4.0 Hz, 1H, 1''-H), 4.05–4.10 (m, 1H, 5-H), 4.67 (s, 1H, 
=CH2), 4.76 (d, J = 8.4 Hz, 1H, 4-H), 4.84 (s, 1H, =CH2), 6.17 (s, 1H, 2'-H), 7.20–7.27 (m, 10H, 
ArH), 7.40–7.45 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 27.0 (C(CH3)2), 27.2 (C(CH3)2), 
30.1 (C-4'), 39.5 (C-3'), 63.4 (C-1''), 74.3 (C-4 or C-5), 80.0 (C-5 or C-4), 86.3 (CPh3), 101.8 (C-
=CH2), 109.0 (C-2), 126.7, 127.6, 128.8 (3 × Ar C), 132.0 (C-2'), 138.2 (C-5'), 143.8 (Ar C), 151.1 
(C-1'); HRMS (ESI): m/z [M + Na]+ calcd for C31H32O3: 475.22437; found: 475.22433. 
 






To magnesium turnings (0.26 g, 20.87 mmol) in THF (10 mL) was added under argon atmosphere a 
solution of 1-bromobutane (0.5 mL, 4.70 mmol) in dry THF (5 mL) at 0 °C. After addition, the 
reaction mixture was stirred for 1 h at 45 °C. The resulting Grignard solution was added dropwise 
to a solution of bis-Weinreb amide 2-99 (1.0 g, 3.66 mmol) in THF (8 mL) at 0 °C.  The resulting 
mixture was stirred for further 1 h at 0 °C, before saturated NH4Cl (15 mL) solution was added. The 
layers were separated and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The 
combined organic layers were washed with saturated NaCl solution (15 mL), dried over Na2SO4, 
filtered and concentrated under reduced pressure. The crude ketone was purified by flash 
chromatography (petroleum ether/ethyl acetate, 65:45) to give ketoamide 2-114 (0.70 g, 72%) as a 
colorless oil.  
Rf = 0.5 (petroleum ether/ ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 7.3 Hz, 
3H, 5'-H), 1.30–1.34 (m, 2H, CH2), 1.41 (s, 3H, CH3), 1.47 (s, 3H, CH3), 1.52–1.60 (m, 2H, CH2), 
2.55–2.70 (m, 2H, CH2), 3.21 (s, 3H, CH3), 3.70 (s, 3H, OCH3), 4.80 (d, J = 5.2 Hz, 1H, 4-H or 5-
H), 5.02 (d, J = 5.1 Hz, 1H, 5-H or 4-H); 13C NMR (100 MHz, CDCl3): δ = 13.1 (CH3), 22.2 (CH2), 
26.5 (C(CH3)2), 26.7 (C(CH3)2), 28.3 (CH3), 32.5 (CH2), 39.0 (CH2), 61.7 (OCH3), 73.8 (C-4 or C-





To a stirred solution of amide 2-114 (0.70 g, 2.56 mmol) in THF (40 mL) at 0 °C was added NaBH4 
(0.24 g, 6.40 mmol) portionwise. After addition, the reaction mixture was stirred at r.t. for 6 h. 
Then, the reaction mixture was quenched with aqueous NaOH solution (2.0 M, 8 mL). The aqueous 
phase was extracted with ethyl acetate (2  10 mL) and the combined organic layers were washed 
with saturated NaCl solution (15 mL), dried over Na2SO4, filtered, and concentrated under reduced 
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pressure. The crude secondary alcohol was used further without any flash chromatography. To the 
crude secondary alcohols (0.54 g, 2.30 mmol) in CH2Cl2 (10 mL) were added DMAP (5.6 mg, 0.04 
mmol), pyridine (5 mL) and trityl chloride (0.83 g, 2.30 mmol) at 0 °C. Then the reaction mixture 
was stirred for 12 h at r.t., before it was diluted with water (15 mL) and the aqueous layer was 
extracted with CH2Cl2 (2 × 15 mL). The combined organic layers were washed with a saturated 
NaCl solution (10 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
crude alcohols was purified by flash chromatography (petroleum ether/ethyl acetate, 60:40) to give 
secondary alcohols 2-115 (0.67 g, 56%, after two steps, d.r = 1:1) as colorless oil. 
Rf = 0.64 (petroleum ether/ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 0.78–0.83 (m, 3H, 
5'-H), 1.18–1.23 (m, 5H, 3'-H, 2'-H), 1.35–1.38 (m, 7H, (C(CH3)2), 1.95–1.97 (m, 0.3H, 1'-H), 
2.16–2.17 (m, 0.5H, 1'-H), 3.15–3.30 (m, 2H, CH2), 3.44–3.50 (m, 0.5H, 4-H), 3.65–3.68 (m, 0.6H, 
5-H), 4.06–4.10 (m, 1.5H, 1''-H), 7.17–7.27 (m, 11H, ArH), 7.40 –7.43 (m, 5H, ArH); 13C NMR 
(100 MHz, CDCl3): δ = 13.9 (C-5'), 14.1 (C-5'), 22.6 (CH2), 27.0 (C(CH3)2), 27.1 (C(CH3)2), 27.8 
(C(CH3)2), 32.2 (CH2), 34.3 (CH2), 60.4 (C-1'), 64.3 (C-1''), 64.7 (C-1''), 71.2 (CH2), 76.5 (C-5 or 
C-4), 80.6 (C-4 or C-5), 81.4 (C-5 or C-4), 87.1 (CPh3), 108.7 (C-2), 109.2 (C-2), 127.1, 127.8, 
128.8, 143.4 (4 × Ar C). 
 




To a solution of secondary alcohols 2-115 (0.66 g, 1.43 mmol) in CH2Cl2 (10 mL) were added 
DMP (1.2 g, 2.86 mmol) and NaHCO3 (0.36 g, 4.30 mmol) at 0 °C. The reaction mixture was 
stirred for 5 h at r.t. before it was diluted with water (15 mL) and the aqueous layer was extracted 
with CH2Cl2 (2 × 10 mL). The combined organic layers were washed with a saturated NaCl solution 
(20 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude ketone 
was purified by flash chromatography (petroleum ether/ethyl acetate, 80:20) to give ketone 2-116 
(0.37 g, 56%) as a colorless oil.  
Rf = 0.54 (petroleum ether/ ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 0.84 (t, J = 7.3 Hz, 
3H, 5'-H), 1.20–1.28 (m, 2H, CH2), 1.40 (s, 3H, (C(CH3)2), 1.44–1.50 (m, 5H, (C(CH3)2), CH2), 
2.50–2.54 (td, J = 7.3, 3.1 Hz, 2H, CH2), 3.24 (dd, J = 10.3, 4.9 Hz, 1H, 1''-H), 3.34 (dd, J = 10.2, 
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3.8 Hz, 1H, 1''-H), 4.16–4.18 (m, 1H, 5-H), 4.24–4.26 (m, 1H, 4-H), 7.16–7.28 (m, 10H, ArH), 
7.41–7.43 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 13.8 (C-5'), 22.2 (C-4'), 25.0 (C-3'), 
26.4 (C(CH3)2), 27.6 (C(CH3)2), 38.5 (C-2'), 64.1 (C-''), 77.4 (C-5), 81.2 (C-4), 86.8 (CPh3), 110.8 






To a solution of ketone 2-116 (100 mg, 0.27 mmol) in THF (2 mL) at 0 °C was added CH3Li (1.6 
M in Et2O, 0.13 mL, 0.54 mmol) dropwise. After addition, the yellow suspension was stirred for 30 
min at r.t. Then, the reaction was quenched with saturated NH4Cl solution (2 mL) and the layers 
were separated. The aqueous layer was extracted with ethyl acetate (3 × 5 mL). The combined 
organic layers were washed with statured NaCl solution (5 mL), dried over Na2SO4, filtered, and 
concentrated under reduced pressure. To the crude alcohol (85 mg, 0.17 mmol, d.r = 1:1) in CH2Cl2 
(2 mL) was added Burgess reagent (18 mg, 0.08 mmol). The resulting mixture was heated at 40 °C 
for 8 h. Then, the reaction mixture was cooled to room temperature, diluted with water (3 mL) and 
poured onto ethyl acetate (2 × 5 mL). The layers were separated and the organic layer washed with 
saturated NaCl solution (5 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The crude material was purified by flash chromatography (petroleum ether/ethyl acetate, 
6:4) to give endo/exo-2-177 (40 mg, 51%, 1:0.78) as a colorless oil.  
Rf = 0.44 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 0.76 (t, J = 7.3 Hz, 
3H, 6'-H, endo-major), 0.84 (t, J = 7.3 Hz, 2.5 H, 6'-H, exo-minor), 1.24–1.27 (m, 4H, 5'-H), 1.42–
1.44 (m, 10H, (C(CH3)2), 1.57 (s, 3H, 1'-H), 1.86–2.00 (m, 3.5H, 4'-H), 3.10–3.14 (m, 2H, 1''-H), 
3.20–3.30 (m, 2H, 1''-H), 3.86–3.90 (m, 1.7H, 5-H (or) 4-H), 4.25 (d, J = 8.6 Hz, 1H, 4-H (or) 5-H), 
4.35 (d, J = 8.4 Hz, 5-H (or) 4-H), 4.83 (s, 0.7H, exo-minor), 4.95 (s, 0.7H, exo-minor), 5.35 (t, J = 













To a stirred solution of endo-2188 and exo-2-177 (20 mg, 0.04 mmol) in CH3CN (2 mL) were 
added Pd(OH)2 (2 mg) and Cs2CO3 (14 mg, 0.04 mmol). The suspension was kept under hydrogen 
atmosphere (balloon) for 8 h at r.t. Then, the reaction mixture was filtered through celite and the 
filtrate concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 70:30) to give endo-2-118 (10 mg, 55%) as a 
colorless oil.  
Rf = 0.6 (petroleum ether/ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 0.78 (t, J = 7.3 Hz, 
3H, 6'-H), 1.18–1.28 (m, 2H, 5'-H), 1.42–1.44 (m, 6H, C(CH3)2), 1.57 (s, 3H, 1'-H), 1.88–1.97 (m, 
2H, 4'-H), 3.10 (dd, J = 10.1, 4.6 Hz, 1H, 1''-H), 3.24 (dd, J = 10.1, 3.9 Hz, 1H, 1''-H), 3.86–3.90 
(m, 1H, 5-H (or) 4-H), 4.25–4.27 (m, 1H, 4-H (or) 5-H), 5.35 (t, J = 8.5 Hz, 1H, 3'-H), 7.17–7.27 
(m, 10 ArH), 7.42–7.46 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 11.2 (C-6'), 13.8 (C-1'), 
22.3 (C-5'), 26.5 (C(CH3)2), 26.7 (C(CH3)2), 30.7 (C-4'), 63.5 (C-1''), 79.6 (C-5), 81.2 (C-4), 86.6 





To a solution of 6-methyl-5-heptaen-2-one (0.5 mL, 3.35 mmol) in CH3CN (10 mL) were added 
2,4,6-triisopropylbenzenesulfonyl hydrazide (1.0 g, 3.35 mmol) and concentrated hydrochloric acid 
(0.3 mL) at r.t. The reaction mixture was stirred for 3 h at r.t. Then the white solid was filtered off, 
and washed with diethyl ether (30 mL) to afford hydrazone 2-129 (1.0 g, 73%) as a white solid.  
Rf = 0.38 (CH2Cl2/MeOH); 1H NMR (400 MHz, CDCl3): δ = 1.23–1.27 (m, 18H, (CH(CH3)2)3), 
1.47 (s, 3H, CH3), 1.51 (s, 3H, CH3), 1.75 (s, 3H, CH3), 2.07–2.12 (m, 2H, CH2), 2.18–2.22 (m, 2H, 
CH2), 2.87–2.90 (m, 1H, CH(CH3)2)3), 4.20–4.25 (m, 2H, CH(CH3)2)3), 4.86 (t, J = 7.1 Hz, 1H, 4-
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H), 7.15 (s, 2H, ArH); 13C NMR (100 MHz, CDCl3): δ = 15.3 (CH3), 17.5 (CH3), 23.5 (CH3), 24.5 
(CH3), 24.7 (2 × CH3), 25.5 (CH3), 29.8 (CH3), 34.1 (CH(CH3)2)3), 38.7 (C-3), 122.7 (C-5), 123.6 
(2 × Ar C), 131.4 (C-6), 132.3 (Ar C), 151.3, 153.1 (2 × Ar C); HRMS (ESI): m/z [M + Na]+ calcd 






Hydrazone 2-129 (100 mg, 0.24 mmol) was dissolved in THF (2 mL) under an argon atmosphere 
and the reaction flask was cooled to –78 °C. Then, sec-BuLi (1.4 M in cyclohexane, 0.5 mL, 0.70 
mmol) was added dropwise and the reaction mixture stirred for 30 min at –78 °C. Then, the cooling 
bath was removed and the mixture was allowed to warm over 15 min until the nitrogen gas evolved 
(reaction mixture turned dark brown to yellow solution). Then, the solution was again re-cooled to –
78 °C, before addition of bis-Weinreb amide 2-99 (70 mg, 0.24 mmol) in THF (1 mL). Later, the 
reaction mixture was warmed to room temperature and stirred for 1 h. The reaction mixture was 
quenched with saturated NH4Cl solution (2 mL). The layers were separated and the aqueous layer 
was extracted with ethyl acetate (2 × 5 mL). The combined organic layers were washed with 
saturated NaCl solution (2 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was purified by flash chromatography (petroleum ether/ethyl acetate, 30:70) 
to give ketone exo-2-131 (60 mg, 76%) as a colorless oil. 
Rf = 0.62 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 1.40 (s, 3H, CH3), 
1.50 (s, 3H, CH3), 1.57 (s, 3H, CH3), 1.66 (s, 3H, CH3), 2.10–2.12 (m, 2H, 4'-H), 2.30–2.32 (m, 2H, 
3'-H), 3.20 (s, 3H, OCH3), 3.66 (s, 3H, CH3), 5.10 (t, J = 7.1 Hz, 2H, 5'-H), 5.22 (d, J = 4.7 Hz, 1H, 
5-H or 4-H), 5.31 (d, J = 4.7 Hz, 1H, 4-H or 5-H), 5.92 (s, 1H, 2'-CH2), 6.22 (s, 1H, 2'-CH2); 13C 
NMR (100 MHz, CDCl3): δ = 17.7 (CH3), 25.6 (CH3), 26.4 (2 × CH3), 26.6 (C-4'), 26.7 (CH3), 31.2 
(C-3'), 61.5 (OCH3), 74.3 (C-4 or C-5), 78.6 (C-5 or C-4), 113.0 (C-2), 123.3 (C-5'), 127.8 (2'-CH2), 
132.4 (C-6'), 146.4 (C-2'), 170.2 (C=O), 196.4 (C=O); HRMS (ESI): m/z [M + Na]+ calcd for 
C17H27NO5: 348.17814; found: 348.17819. 
 
 






To a solution of acetone(2,4,6-triisopropylbenzyl)sulfonylhydrazone (0.20 g, 0.60 mmol) in THF (5 
mL) at –78 °C was added sec-BuLi (1.4 M in cyclohexane, 0.9 mL, 1.30 mmol). The mixture was 
stirred for 30 min at the same temperature. After that l-bromo-3-methyl-2-butene (0.1 mL, 0.75 
mmol) was added at –78 °C and the mixture stirred for 2 h. An additional portion of sec-BuLi (1.4 
M in cyclohexane, 0.47 mL, 0.66 mmol) was added and the reaction stirred at –78° C another 20 
min. Later, the cooling bath was removed and the reaction mixture was allowed to warm over 15 
min until the nitrogen gas evolved. Then, the solution was re-cooled to –78 °C before addition of 
bis-Weinreb amide 2-99 (68 mg, 0.24 mmol) in THF (1 mL). The resulting mixture was stirred for 
another 1 h at –78 °C and warmed to room temperature within another 2 h. Finally, the reaction 
mixture was quenched with saturated NH4Cl solution (5 mL). The layers were separated and the 
aqueous layer was extracted with ethyl acetate (2 × 10 mL). The combined organic layers were 
washed with saturated NaCl solution (8 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The crude ketoamide was purified by flash chromatography (petroleum 
ether/ethyl acetate, 60:40) to give ketoamide 2-135 (0.12 g, 61%) as a colorless oil. 
Rf = 0.62 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 1.40 (s, 3H, CH3), 
1.50 (s, 3H, CH3), 1.64 (s, 3H, CH3), 1.71 (s, 3H, CH3), 1.82 (s, 3H, CH3), 2.30 (t, J = 7.1 Hz, 2H, 
4'-H), 3.20 (s, 3H, OCH3), 3.65 (s, 3H, CH3), 5.12 (t, J = 7.2 Hz, 1H, 5'-H), 5.21 (d, J = 5.0 Hz, 1H, 
5-H or 4-H), 5.30 (d, J = 5.1 Hz, 1H, 4-H or 5-H), 6.80 ( t, J = 7.0 Hz, 1H, 3'-H); 13C NMR (100 
MHz, CDCl3): δ = 11.5 (CH3), 18.0 (CH3), 25.6 (CH3), 26.4 (CH3), 26.6 (CH3), 28.4 (CH3), 32.4 
(C-4'), 61.5 (OCH3), 74.5 (C-4 or C-5), 78.0 (C-5 or C-4), 112.7 (C-2), 120.0 (C-5'), 134.0 

















To a solution of ethyltriphenylphosphonium bromide (0.61 g, 1.65 mmol) in THF (5 mL) was 
added KHMDS (1.0 M in THF, 1.66 mL, 1.65 mmol) dropwise at –78 °C. The resulting yellow 
suspension was stirred for 45 min at the same temperature. Thereafter, a solution of ketone 2-160 
(0.27 g, 0.74 mmol) in THF (2 mL) was added dropwise at –78 °C. After complete addition, the 
resulting yellow mixture was stirred for 1 h at –78 °C and then brought to r.t. The reaction mixture 
was diluted with water (10 mL) and the layers were separated. The aqueous layer was extracted 
with ethyl acetate (2 × 10 mL). The combined organic layers were washed with saturated NaCl 
solution (8 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue 
was purified by flash chromatography (petroleum ether/ethyl acetate, 75:15) to give vinyl bromide 
2-139 (0.185 g, 66%) as a colorless oil.  
Rf = 0.88 (petroleum ether/ethyl acetate, 9:1); []D
19 = +15.07 (c = 1.44, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 1.03–1.05 (m, 21H, Si(CH(CH3)2)3), 1.55 (dd, J = 6.9, 1.4 Hz, 3H, 1-H), 1.67 (t, 
J = 1.4 Hz, 3H, 3-CH3), 2.19–2.35 (m, 5H, 8-H, 5-H), 4.66 (dd, J = 8.0, 6.1 Hz, 1H, 4-H), 5.22–
5.28 (m, 1H, 2-H), 5.75 (dt, J = 8.3, 1.3 Hz, 1H, 6-H); 13C NMR (100 MHz, CDCl3): δ = 12.3 
(Si(CH(CH3)2)3), 13.2 (C-1), 17.5 (3-CH3), 17.9 (Si(CH(CH3)2)3), 18.0 (Si(CH(CH3)2)3), 23.3 (C-8), 
36.5 (C-5), 69.0 (C-4), 120.3 (C-2), 120.6 (C-7), 128.5 (C-6), 137.3 (C-3). 





To a stirred solution of dibromide 2-150 (9.5 g, 27.9 mmol) in THF (80 mL) at –78 °C was added a 
solution of n-BuLi (2.5 M in THF, 27.9 mL, 69.8 mmol) over 15 min. The reaction mixture was 
stirred at –78 °C for 2 h, before iodomethane (7.0 mL, 112 mmol) was added dropwise. After 
addition, the reaction mixture was stirred at r.t. for 30 min. Then the reaction mixture was diluted 
with saturated NH4Cl solution, the layers were separated and the aqueous layer was extracted with 
ethyl acetate (3 × 35 mL). The combined organic layers were washed with saturated NaCl solution, 
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dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash chromatography (petroleum ether/ethyl acetate, 9:1) to give alkyne 2-140 (4.0 g, 74%) as a 
colorless oil.  
Rf = 0.75 (petroleum ether/ethyl acetate, 9:1); []D
22 = +33.01 (c =0.73, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 1.33–1.40 (m, 2H, CH2), 1.52–1.63 (m, 8H, (CH2)4), 1.75 (t, J = 2.5 Hz, 3H, 
CH3), 2.28–2.36 (m, 1H, 1'-H), 2.44–2.50 (m, 1H, 1'-H), 3.73 (dd, J = 8.2, 6.2 Hz, 1H, 3-H), 4.06 
(dd, J = 8.3, 6.0 Hz, 1H, 3-H), 4.14–4.20 (m, 1H, 2-H); 13C NMR (100 MHz, CDCl3): δ = 3.4 (4'-
H), 23.7 (CH2), 23.9 (C-1'), 24.1, 25.1, 35.1, 36.5 (4 × CH2), 68.5 (C-3), 74.1 (C-2), 74.5 (C-2'), 
77.4 (C-3'), 110.0 (C-5); HRMS (ESI): m/z [M + Na]+ calcd for C12H18O2: 217.1199; found: 
217.1199. 
 
(S)-Butane-1,2,4-triol (2-147)113  
 
 
A mixture of BH3·SMe2 complex (47.2 mL, 0.552 mol) and trimethyl borate (61.6 mL, 0.553 mol) 
in THF (50 mL) at 0 °C was added dropwise to a solution (S)-malic acid (2-141) (24.7 g, 0.184 
mol) in THF (100 mL) at 0 °C over 20 min. After complete addition, the ice bath was removed and 
the mixture stirred for 12 h at r.t. Then, the reaction mixture was quenched by dropwise addition of 
MeOH (150 mL) at r.t. The solvent was removed under reduced pressure. The crude triol 2-147 
(22.0 g) was used for the next reaction without further purification.  
Rf = 0.42 (CH2Cl2/MeOH, 9:1); HRMS (ESI): m/z [M + Na]
+ calcd for C4H10O3: 129.0522; found: 
129.0522. 
 
(S)-1,2-O-Cyclohexylidene-1,2,4-butanetriol (2-148)  
 
 
To a solution of triol 2-147 (22.0 g, 0.207 mol) in cyclohexanone (53 mL, 0.519 mol) was added p-
toluenesulfonic acid (pTsOH·H2O) (0.78 g, 4.10 mmol) followed by stirring of the mixture at r.t. 
for 3 h. Then the reaction mixture was diluted with saturated NaHCO3 solution (55 mL) and H2O 
(50 mL). The aqueous layer was extracted with CH2Cl2 (3 × 55 mL). The combined organic layers 
were washed with saturated NaCl solution (45 mL), dried over Na2SO4, filtered, and concentrated 
Experimental Section                                                                                 125 
 
 
under reduced pressure. The residue was purified by flash chromatography (petroleum ether/ethyl 
acetate, 1:1) to give alcohol 2-148 (20.0 g, 58%, over two steps) as a colorless oil.  
Rf = 0.72 (petroleum ether/ethyl acetate, 6:4); []D
18 = –12.7 (c = 0.5, CH2Cl2); {Lit.
113 []D = –
15.4 (c = 2.0, acetone)}; 1H NMR (400 MHz, CDCl3): δ = 1.36–1.37 (m, 2H, CH2), 1.56–1.60 (m, 
8H, (CH2)4), 1.78 (q, J = 5.8 Hz, 2H, 3-H), 2.44 (br s, 1H, OH), 3.58 (dd, J = 7.3, 7.3 Hz, 1H, 1-H), 
3.78 (t, J = 6.2 Hz, 2H, 4-H), 4.05 (dd, J = 8.0, 5.9 Hz, 1H, 1-H), 4.21–4.27 (m, 1H, 2-H); 13C 
NMR (100 MHz, CDCl3): δ = 23.8 (CH2), 24.0 (CH2), 25.0 (CH2), 35.1 (CH2), 35.6 (C-3), 36.4 
(CH2), 60.6 (C-4), 69.0 (C-1), 74.9 (C-2), 109.7 (acetal C). HRMS (ESI): m/z [M + Na]
+ calcd for 
C10H18O3: 209.1147; found: 209.1147. 
 
(S)-2-(1,4-Dioxaspiro[4.5]decan-2-yl)acetaldehyde (2-149)  
 
 
To a solution of oxalyl chloride (6.95 mL, 80.5 mmol) in CH2Cl2 (20 mL) was slowly added DMSO 
(11.4 mL, 161 mmol) at –78 °C. After being stirred for 15 min at this temperature, a solution of 
alcohol 2-148 (10.0 g, 53.7 mmol) in CH2Cl2 (50 mL) was added to the mixture over a period of 15 
min. The reaction mixture was stirred at the same temperature for 1 h. Thereafter, Et3N (45.3 mL, 
322 mmol) was added dropwise. Then, the reaction mixture was brought to r.t. and stirred for 10 
min. It was diluted with H2O (100 mL) and extracted with CH2Cl2 (2 × 50 mL). The combined 
organic layers were washed with saturated NaCl solution (80 mL), dried over Na2SO4, filtered, and 
concentrated under reduced pressure to give aldehyde 2-149 (8.0 g, 81%) as a slightly brown oil. 
The aldehyde 2-149 was used for the next reaction without further purification.  
Rf = 0.87 (petroleum ether/ethyl acetate, 6:4); 1H NMR (400 MHz, CDCl3): δ = 1.33–1.40 (m, 2H, 
CH2), 1.51–1.58 (m, 8H, (CH2)4), 2.57–2.60 (m, 1H, 2-H), 2.81 (ddd, J = 17.1, 6.5, 1.8 Hz, 1H, 2-
H), 3.55 (dd, J = 8.3, 6.6 Hz, 1H, 3'-H), 4.14 (dd, J = 8.3, 6.0 Hz, 1H, 3'-H), 4.46–4.52 (m, 1H, 2'-
H), 9.77 (t, J = 1.6 Hz, 1H, CHO); 13C NMR (100 MHz, CDCl3): δ = 23.7 (CH2), 23.9 (CH2), 25.0 
















To a stirred solution of triphenylphosphine (54.1 g, 0.206 mol) in CH2Cl2 (70 mL) at 0 °C was 
added carbon tetrabromide (45.0 g, 0.136 mol) in small portions. After complete addition, the ice 
bath was removed and the reaction mixture stirred for 30 min at r.t. The reaction mixture was 
recooled to 0 °C before a solution of aldehyde 2-149 (10.0 g, 54.3 mmol) in CH2Cl2 (85 mL) was 
added dropwise over 15 min. After addition, the white suspension was stirred at r.t for 30 min. The 
reaction mixture was treated with hexane (250 mL) resulting of precipitation of phosphorus 
compounds. The obtained solid was removed by filtration of the mixture through a pad of celite and 
the filtrate concentrated under reduced pressure. The same procedure was repeated twice. Finally, 
the obtained oil was purified by flash chromatography (petroleum ether/ethyl acetate, 90:10) to give 
dibromide 2-150 (12.0 g, 65%) as a colorless oil.  
Rf = 0.72 (petroleum ether/ethyl acetate, 9:1); []D
19 = –3.91 (c = 0.8, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 1.39–1.40 (m, 2H, CH2), 1.56–1.62 (m, 8H, (CH2)4), 2.35–2.39 (m, 2H, 1'-H), 
3.60 (dd, J = 8.2, 6.4 Hz, 1H, 3-H), 4.03 (dd, J = 8.2, 6.1 Hz, 1H, 3-H), 4.15–4.21 (m, 1H, 2-H), 
6.49 (t, J = 7.1 Hz, 1H, 2'-H); 13C NMR (100 MHz, CDCl3): δ = 23.8, 23.9, 25.1, 35.0, 36.5 (5 × 





To a solution of Cp2ZrCl2 (19.25 g, 65.86 mmol) in THF (85 mL) at 0 °C was added DIBAL-H (1M 
hexane, 65.9 mL, 65.9 mmol) followed by stirring of the resulting white suspension of zirconocene 
hydrochloride at r.t. for 45 min. Thereafter, alkyne 2-140 (4.57 g, 23.5 mmol) in THF (10 mL) was 
added dropwise at 0 °C. The resulting mixture was heated for 1 h at 55 °C and then cooled to 0 °C 
before a solution of NBS (5.20 g, 29.4 mmol) in THF (15 mL) was added. After complete addition, 
the reaction mixture was stirred for another 30 min at 0 °C. The reaction mixture was carefully 
quenched with saturated NaHCO3 solution (15 mL) and extracted with ethyl acetate (3 × 50 mL). 
The combined organic layers were washed with saturated NaCl solution, dried over Na2SO4, filtered 
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and concentrated under reduced pressure to give vinyl bromide 2-152 (6.0 g, 93%; 4:1 mixture of 
regioisomers). The crude brown oil was used for the next reaction without chromatography.  
Rf = 0.92 (petroleum ether/ethyl acetate, 8:2); 1H NMR (400 MHz, CDCl3): δ = 1.34–1.38 (m, 3H, 
CH2), 1.52–1.61 (m, 13H, CH2), 2.21–2.35 (m, 5H, 3-CH3, 1'-H), 3.54 (dd, J = 7.9, 6.5 Hz, 1.4H, 3-
H), 4.03 (dd, J = 8.1, 6.0 Hz, 1.3H, 3-H), 4.08–4.14 (m, 1.5H, 2-H), 5.85 (td, J = 7.7, 1.2 Hz, 1H, 
2'-H, major), 6.00–6.05 (m, 0.2H, 2'-H, minor); 13C NMR (100 MHz, CDCl3): δ = 23.4 (CH3), 23.8 
(CH2), 24.0 (C-1'), 25.1, 33.9, 35.0, 36.5 (4 × CH2), 68.3 (C-3), 74.3 (C-2), 109.7 (C-5), 121.7 (C-





A solution of acetal 2-152 (1.24 g, 4.50 mmol) in a mixture of AcOH/H2O (1:1, 16 mL) was stirred 
for 12 h at r.t. Thereafter, the reaction mixture was diluted with saturated NaHCO3 solution (25 mL) 
and extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were washed with saturated 
NaCl solution (25 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
regioisomers were separated by flash chromatography (petroleum ether/ethyl acetate, 3:7) to give 
diol 2-153 (0.37 g, 42%) and a small amount of minor isomer (68 mg, 8%) as colorless oils.  
Rf = 0.45 (petroleum ether/ethyl acetate, 2:8); []D
21 = –5.44 (c = 0.8, CH2Cl2); 1H NMR (400 
MHz, C6D6): δ = 1.83–1.93 (m, 2H, 3-H), 2.00 (s, 3H, 5-CH3), 2.85 ( br s, 2H, OH), 3.20 (dd, J = 
11.1, 7.1 Hz, 1H, 1-H), 3.32 (dd, J = 11.1, 2.5 Hz, 1H, 1-H), 3.41–3.46 (m, 1H, 2-H), 5.88 (td, J = 
7.8, 1.2 Hz, 1H, 4-H); 13C NMR (100 MHz, C6D6): δ = 23.3 (CH3), 33.5 (C-3), 66.0 (C-1), 71.4 (C-






A solution of diol 2-153 (0.25 g, 1.28 mmol) in CH2Cl2 (10 mL) at r.t. was treated with pyridine 
(0.2 mL, 2.61 mmol), DMAP (55 mg, 0.45 mmol) and trityl chloride (0.72 g, 2.61 mmol). The 
resulting mixture was stirred for 2 h at r.t. Thereafter, the reaction mixture was diluted with water 
(20 mL) and the layers were separated. The aqueous layer was extracted with CH2Cl2 (2 × 10 mL). 
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The combined organic layers were washed with saturated NaCl solution (15 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by flash 
chromatography (petroleum ether/ethyl acetate, 7:3) to give trityl ether 2-155 (0.34 g, 59%) as a 
colorless oil.  
Rf = 0.54 (petroleum ether/ethyl acetate, 8:2); []D
22 = –2.29 (c = 1.04, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 2.15–2.28 (m, 5H, CH3, 3-H), 3.10 (dd, J = 9.5, 6.6 Hz, 1H, 1-H), 3.20 (dd, J = 
9.4, 4.0 Hz, 1H, 1-H), 3.47 (br s, 1H, OH), 3.74–3.80 (m, 1H, 2-H), 5.80 (td, J = 7.7, 1.3 Hz, 1H, 4-
H), 7.23–7.34 (m, 10H, ArH), 7.41–7.46 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 23.3 
(CH3), 33.7 (C-3), 66.8 (C-1), 70.1 (C-2), 86.8 (CPh3), 121.4 (C-5), 127.2 (Ar C), 127.6 (C-4), 






To a solution of alcohol 2-155 (1.10 g, 2.51 mmol) in CH2Cl2 (10 mL) at 0 °C were added 2,6-
lutidine (0.58 mL, 5.03 mmol) and TIPSOTf (0.74 mL, 2.76 mmol) dropwise. The resulting mixture 
was stirred for 1 h at 0 °C before it was diluted with water (15 mL) and the mixture was extracted 
with CH2Cl2 (2 × 10 mL). The combined organic layers were washed with saturated NaHCO3 
solution (15 mL), saturated NaCl solution (15 mL), dried with anhydrous Na2SO4, filtered and 
concentered under reduced pressure. The residue was purified by flash chromatography (petroleum 
ether/ethyl acetate, 95:5) to give silyl ether 2-156 (1.29 g, 86%) as a colorless oil.  
Rf = 0.77 (petroleum ether/ Et2O, 9:1); []D
22 = –1.08 (c = 0.55, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.79–0.84 (m, 1H, Si(CH(CH3)2)3), 0.92–0.94 (m, 20H, Si(CH(CH3)2)3), 2.15 (s, 3H, 
CH3), 2.35–2.47 (m, 2H, 3-H), 2.97 (dd, J = 8.9, 7.3 Hz, 1H, 1-H), 3.03 (dd, J = 9.0, 4.2 Hz, 1H, 1-
H), 3.91–3.96 (m, 1H, 2-H), 5.83 (td, J = 7.1, 1.2 Hz, 1H, 4-H), 7.17–7.27 (m, 10H, ArH), 7.36–
7.40 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 12.3 (Si(CH(CH3)2)3), 18.0 (Si(CH(CH3)2)), 
23.5 (CH3), 35.2 (C-3), 66.4 (C-1), 70.8 (C-2), 86.5 (CPh3), 120.5 (C-5), 127.0, 127.7 (2 × Ar C), 
128.3 (C-4), 128.7, 144.0 (2 × Ar C); HRMS (ESI): m/z [M + Na]+ calcd for C34H45BrO2Si: 











To a solution of trityl ether 2-156 (1.29 g, 2.17 mmol) in CH2Cl2 (15 mL) at 0 °C were added 
Et3SiH (1.04 mL, 6.51 mmol) and BF3·OEt2 (0.54 mL, 4.34 mmol) dropwise. The resulting mixture 
was stirred for 1 h at the same temperature before it was diluted with saturated NaHCO3 solution 
(10 mL). The layers were separated and the organic layer was extracted with CH2Cl2 (3 × 10 mL). 
The combined organic layers were washed with saturated NaCl solution (10 mL), dried with 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by flash 
chromatography (petroleum ether/ethyl acetate, 7:3) to give alcohol 2-157 (0.57 g, 75%) as a 
colorless oil.  
Rf = 0.37 (petroleum ether/ethyl acetate, 8:2); []D
20 = –3.02 (c = 0.21, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 1.06–1.08 (m, 21H, Si(CH(CH3)2)3), 1.76 (br s, 1H, OH), 2.20–2.27 (m, 4H, 
CH3, 3-H), 2.34–2.42 (m, 1H, 3-H), 3.50 (dd, J = 11.1, 3.8 Hz, 1H, 1-H), 3.60 (dd, J = 11.0, 3.8 Hz, 
1H, 1-H), 3.87–3.92 (m, 1H, 2-H), 5.82–5.86 (m, 1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = 12.4 
(Si(CH(CH3)2)3), 18.0 (Si(CH(CH3)2)3), 23.3 (CH3), 34.1 (C-3), 65.2 (C-1), 71.7 (C-2), 121.5 (C-5), 





To a mixture of IBX (1.37 g, 4.90 mmol) in DMSO (8 mL) was added alcohol 2-157 (0.53 g, 1.50 
mmol) in CH2Cl2 (10 mL) at 0 °C. After complete addition, the ice bath was removed and the 
mixture stirred for 5 h at r.t. The suspension was diluted with CH2Cl2 (20 mL) and filtered through 
a pad of celite. The filtrate was washed with saturated NaHCO3 solution (10 ml), saturated NaCl 
solution (5 mL), dried over Na2SO4, filtered and concentrated under reduced pressure to give 
aldehyde 2-158 (0.40 g, 76%) as yellow oil that was used for the next reaction without further 
purification.  
Rf = 0.69 (petroleum ether/ethyl acetate, 7:3); 1H NMR (400 MHz, CDCl3): δ = 1.05–1.11 (m, 21H, 
Si(CH(CH3)2)3), 2.21 (s, 3H, 5-CH3), 2.34–2.47 (m, 2H, 3-H), 4.12 (dt, J = 5.7, 1.8 Hz, 1H, 2-H), 
5.90 (t, J = 7.2 Hz, 1H, 4-H), 9.64 (d, J = 1.8 Hz, 1H, CHO); 13C NMR (100 MHz, CDCl3): δ = 
12.1 (Si(CH(CH3)2)3), 17.8 (Si(CH(CH3)2)3), 23.4 (CH3), 33.7 (C-3), 125.9 (C-2), 128.2 (C-5), 
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To a solution of aldehyde 2-158 (0.5 g, 1.43 mmol) in THF (10 mL) at 0 °C was added CH3MgBr 
(3M in Et2O, 0.71 mL, 2.14 mmol) dropwise. After addition, the white suspension was stirred for 
30 min at 0 °C. Then, the reaction was quenched with saturated NH4Cl solution (5 mL) and the 
layers were separated. The aqueous layer was extracted with ethyl acetate (3 × 10 mL). The 
combined organic layers were washed with statured NaCl solution (15 mL), dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was purified by flash 
chromatography (petroleum ether/Et2O, 6:4) to give of alcohol 2-159 (0.40 g, 76%) as a colorless 
oil.  
Rf = 0.41 (petroleum ether/Et2O, 7:3); 1H NMR (400 MHz, CDCl3): δ = 1.04 (s, Si(CH(CH3)2)3, 
major), 1.07–1.08 (m, Si(CH(CH3)2)3, minor), 1.12 (d, J = 6.3 Hz, 1-H, minor), 1.18 (d, J = 6.2 Hz, 
1-H, major), 2.15–2.27 (m, 7-H, 4-H, minor), 2.40–2.47 (m, 4-H, major), 3.61–3.70 (m, 2-H, 3-H 
minor), 3.80–3.86 (m, 3-H, major), 5.84–5.90 (m, 1H, 5-H); 13C NMR (100 MHz, CDCl3): δ = 12.3 
(Si(CH(CH3)2)3), 12.7 (C-1, minor) 12.8 (C-1, major), 17.7 (Si(CH(CH3)2)3, major), 18.1 
(Si(CH(CH3)2)3, minor), 23.4 (C-7, minor and major), 31.9 (C-4, minor), 34.1 (C-4, major), 68.7 
(C-2, major), 70.3 (C-2, minor), 75.3 (C-3, minor), 75.6 (C-3, major), 120.5 (C-6, minor), 121.3 (C-
6, major), 127.6 (C-5, major), 128.7 (C-5, minor); HRMS (ESI): m/z [M + Na]+ calcd for 





To a stirred solution of alcohol 2-159 (0.40 g, 1.09 mmol) in CH2Cl2 (10 mL) at 0 °C were added 
DMP (0.92 g, 2.18 mmol) and NaHCO3 (0.27 g, 3.28 mmol). Thereafter, the reaction mixture was 
stirred for 1 h at r.t. The reaction mixture was treated with saturated NaHCO3 solution (10 mL). The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (2 × 10 mL). The combined 
organic layers were washed with saturated NaCl solution (10 mL), dried over Na2SO4, filtered, and 
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concentrated under reduced pressure. The crude material was purified by flash chromatography 
(petroleum ether/ethyl acetate, 8:2) to give methyl ketone 2-160 (0.30 g, 75%) as a colorless oil.  
Rf = 0.43 (petroleum ether/ethyl acetate, 9:1); []D
22 = +1.88 (c = 0.25, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 1.02–1.07 (m, 21H, Si(CH(CH3)2)3), 2.18–2.19 (m, 6H, 1-H, 7-H), 2.27–2.33 (m, 
1H, 4-H), 2.40–2.47 (m, 1H, 4-H), 4.17 (t, J = 5.6 Hz, 1H, 3-H), 5.88 (t, J = 7.1 Hz, 1H, 5-H); 13C 
NMR (100 MHz, CDCl3): δ = 12.2 (Si(CH(CH3)2)3), 17.9 (Si(CH(CH3)2)3), 23.4 (C-7 or C-1), 25.5 
(C-1 or C-7), 35.4 (C-4), 78.1 (C-3), 122.0 (C-6), 126.1 (C-5), 211.8 (C-2); HRMS (ESI): m/z [M + 
Na]+ calcd for C16H31BrO2Si: 385.1169; found: 385.1169. 
 
Hex-5-enoic acid (2-161)109 
 
 
To a stirred solution of chromium trioxide (11.23 g, 112 mmol) in aqueous sulfuric acid (2M, 134 
mL, 270 mmol) at –5 °C was added 5-hexen-1-ol 2-146 (3.0 g, 29.5 mmol) in acetone (100 mL) 
over 30 min. The resulting black suspension was stirred for 12 h at –5 °C. Thereafter, the reaction 
mixture was diluted with diethyl ether (100 mL) and the layers were separated. The organic layer 
was washed with aqueous NaOH solution (1M, 2 × 35 mL) and again the layers were separated. 
The combined aqueous layers were acidified with sulfuric acid (6M, 20 mL), and then extracted 
with diethyl ether (3 × 25 mL). The combined organic layers were washed with saturated NaCl 
solution (15 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
acid was purified by flash chromatography (petroleum ether/ethyl acetate, 7:3) to give acid 2-161 
(1.85 g, 54%) as a colorless liquid.  
Rf = 0.26 (petroleum ether/ethyl acetate, 8:2); 1H NMR (400 MHz, CDCl3): δ = 1.73 (tt, apparent q, 
J = 7.5 Hz, 2H, 3–H), 2.12 (m, 2H, 4-H), 2.38 (t, J = 7.5 Hz, 2H, 2-H), 5.01–5.08 (m, 2H, 6-H), 
5.77 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H, 5-H); 13C NMR (100 MHz, CDCl3): δ = 23.7 (C-3), 32.9 (C-
4), 33.1 (C-2), 115.2 (C-6), 137.5 (C-5), 179.3 (C-1). 
 
(4S)-Benzyl-3-(hex-5-enoyl)-2-oxazolidinone (2-163) 110,151 
 
 
To a slurry of 5-hexenoic acid 2-161 (15.0 g, 131 mmol) in THF (80 mL) was added Et3N (25.6 
mL, 184 mmol) at 0 °C and the mixture was stirred for 30 min. Then, pivaloyl chloride (17.8 mL, 
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145 mmol) was added dropwise over 5 min at 0 °C. The resulting white suspension was stirred for 1 
h at r.t. To a second flask, charged with (S)-4-benzyloxazolidin-2-one 2-162 (13.9 g, 118 mmol) in 
THF (125 mL) was added n-BuLi (2.5 M in hexane, 57.8 mL, 145 mmol) at –78 °C over 20 min. 
The resulting orange suspension was stirred at –78 °C for 1 h before the solution of the mixed 
anhydride in THF was added in a dropwise fashion. Thereafter, the reaction mixture was stirred for 
1 h at –78 °C and then brought to r.t. The reaction mixture was treated with a saturated NH4Cl 
solution (85 mL). Then, the layers were separated and the aqueous layer was extracted with ethyl 
acetate (2 × 75 mL). The combined organic layers were washed with saturated NaCl solution (50 
mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was 
purified by flash chromatography (petroleum ether/ethyl acetate, 8:2) to give acylated 
oxazolidinone 2-163 (19.5 g, 54%) as a colorless oil.  
Rf = 0.56 (petroleum ether/ethyl acetate, 1:1); []D
20 = +68.0 (c = 2, CH2Cl2); {Lit.
110 []D
23 = 
+56.7 (c = 1.2, CHCl3)}; 1H NMR (400 MHz, CDCl3): δ = 1.76–1.84 (m, 2H, 3'-H), 2.16 (q, J = 7.3 
Hz, 2H, 4'-H), 2.76 (dd, J = 13.4, 9.6 Hz, 1H, 5-H), 2.87–3.02 (m, 2H, 2'-H), 3.30 (dd, J =13.3, 3.2 
Hz, 1H, 5-H), 4.10–4.21 (m, 2H, CH2Ph), 4.63–4.68 (m, 1H, 4-H), 4.98 (d, J = 10.1 Hz, 1H, 6'-H), 
5.05 (d, J = 17.1 Hz, 1H, 6'-H), 5.82 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H, 5'-H), 7.21–7.35 (m, 5H, 
ArH); 13C NMR (100 MHz, CDCl3): δ = 23.3 (C-3'), 32.9 (C-4'), 34.8 (C-2'), 37.9 (C-5), 55.1 (C-
4), 66.1 (CH2Ph), 115.3 (C-6'), 127.3, 128.9, 129.4, 135.2 (4 × Ar C), 135.8 (C-5'), 153.4 (C-2), 





To a solution of N-acyloxazolidinone 2-163 (13.47 g, 49.28 mmol) in THF (80 mL) at –78 ° C was 
added a solution of NaHMDS (2M in THF, 37.0 mL, 73.9 mmol) over 30 min. The reaction mixture 
was stirred for 1 h at –78 °C before iodomethane (35 mL, 246 mmol) was added dropwise within 15 
min. The resulting yellow mixture was stirred for another 1 h at –78 °C and another 30 min at r.t. 
Thereafter, the reaction mixture was diluted with AcOH (4 mL) and water (60 mL). The layers were 
separated and the aqueous layer was extracted with ethyl acetate (2  80 mL). The combined 
organic layers were washed with saturated NaCl solution, dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The crude product was purified by flash chromatography gel 
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(petroleum ether/ethyl acetate, 9:1) to give methylated acid derivative 2-165 (11.82 g, 83%) as a 
colorless oil.  
Rf = 0.38 (petroleum ether/ethyl acetate, 9:1); []D
20 = +91.5 (c = 1.05, CH2Cl2); {Lit.
110 []D
23 = 
+78.3 (c = 1.7, CHCl3)}; 1H NMR (400 MHz, CDCl3): δ = 1.23 (d, J = 6.8 Hz, 3H, 2-CH3), 1.47–
1.55 (m, 1H, 3'-H), 1.83–1.92 (m, 1H, 3'-H), 2.09 (q, J = 6.9 Hz, 2H, 4'-H), 2.77 (dd, J = 13.4, 9.6 
Hz, 1H, 5-H), 3.27 (dd, J = 13.4, 3.2 Hz, 1H, 5-H), 3.68–3.77 (m, 1H, 2'-H), 4.14–4.21 (m, 2H, 
CH2Ph), 4.63–4.69 (m, 1H, 4-H), 4.95 (d, J = 10.2 Hz, 1H, 6'-H), 5.03 (d, J = 17.1 Hz, 1H, 6'-H), 
5.73–5.83 (m, 1H, 5'-H), 7.20–7.21 (m, 2H, ArH), 7.30–7.34 (m, 3H, ArH); 13C NMR (100 MHz, 
CDCl3): δ = 17.4 (2-CH3), 31.5 (C-4'), 32.4 (C-3'), 37.2 (C-2'), 37.9 (C-5), 55.3 (C-4), 66.0 
(CH2Ph), 114.9 (C-6'), 127.3, 128.9, 129.4, 135.3 (4 × Ar C), 138.1 (C-5'), 153.0 (C-2), 177.1 (C-





To a stirred solution of N-acyloxazolidinone 2-165 (11.82 g, 41.13 mmol) in THF (80 mL) and 
MeOH (1.58 mL, 49.36 mmol) was added a solution of lithium borohydride (4M in THF, 30.9 mL, 
75.9 mmol) at 0 °C over 15 min. The resulting mixture was stirred for 2 h at r.t. Thereafter, the 
reaction mixture was quenched with aqueous NaOH (2M, 40 mL). The aqueous layer was extracted 
with diethyl ether (2  50 mL) and the combined organic layers were washed with a saturated NaCl 
solution (35 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure.  
The residue was purified by flash chromatography (petroleum ether/diethyl ether, 90:10) to give 
primary alcohol 2-166 (2.92 g, 62%) as a colorless oil.  
Rf = 0.27 (petroleum ether/ethyl acetate, 9:1); []D
20 = –11.2 (c = 3.0, CH2Cl2); {Lit.
152 []D
20 = –
13.3 (c = 1.81, CH2Cl2)}; 1H NMR (400 MHz, CDCl3): δ = 0.93 (d, J = 6.7 Hz, 3H, 2-CH3), 1.16–
1.26 (m, 1H, 3-H), 1.43 (br s, 1H, OH), 1.47–1.55 (m, 1H, 3-H), 1.60–1.68 (m, 1H, 2-H), 2.00–2.17 
(m, 2H, 4-H), 3.44 (dd, J = 10.5, 6.5 Hz, 1H, 1-H), 3.50 (dd, J = 10.5, 5.8 Hz, 1H, 1-H), 4.95 (dd, J 
= 10.1, 1.8 Hz, 1H, 6-H), 5.03 (dd, J = 17.1, 1.8 Hz, 1H, 6-H), 5.81 (ddt, J = 17.0, 10.1, 6.7 Hz, 1H, 
5-H); 13C NMR (100 MHz, CDCl3): δ = 16.4 (2-CH3), 31.1 (C-4), 32.3 (C-3), 35.2 (C-2), 68.2 (C-










A solution of primary alcohol 2-166 (1.1 g, 9.63 mmol) in CH2Cl2 (10 mL) and pyridine (10 mL) at 
r.t. was treated with trityl chloride (4.0 g, 14.44 mmol) and DMAP (1.17 g, 9.63 mmol). The 
resulting mixture was stirred for 2 h at 40 °C. Thereafter, the reaction mixture was diluted with 
water (85 mL) and the layers were separated. The aqueous layer was extracted with CH2Cl2 (2 × 40 
mL). The combined organic layers were washed with saturated NaCl solution (35 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by flash 
chromatography (petroleum ether/ethyl acetate, 9:1) to give trityl ether 2-167 (2.65 g, 77%) as a 
colorless oil.  
Rf = 0.84 (petroleum ether/ethyl acetate, 9:1); []D
20 = +7.6 (c = 1, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.93 (d, J = 6.8 Hz, 3H, 2-CH3), 1.20–1.25 (m, 1H, 3-H), 1.49–1.55 (m, 1H, 3-H), 
1.72–1.77 (m, 1H, 2-H), 1.93–1.99 (m, 2H, 4-H), 2.84–2.97 (m, 1H, 1-H), 4.87–4.95 (m, 2H, 6-H), 
5.72–5.79 (m, 1H, 5-H), 7.24–7.29 (m, 5H, ArH), 7.41–7.44 (m, 10H, ArH); 13C NMR (100 MHz, 
CDCl3): δ = 17.4 (2-CH3), 31.2 (C-4), 32.9 (C-3), 33.4 (C-2), 68.1 (C-1), 86.1 (CPh3), 114.2 (C-6), 
126.8, 127.6, 128.8 (3 × Ar C), 139.1 (C-5), 144.5 (Ar C); HRMS (ESI): m/z [M + Na]+ calcd for 
C26H28O: 379.20162 ; found: 379.20162. 
 
Methyl (S,E)-6-methyl-7-(trityloxy)hept-2-enoate (2-169) 
 
 
A solution of alkene 2-167 (1.5 g, 4.21 mmol) and methyl acrylate (1.5 mL, 16.84 mmol) in toluene 
(15 mL) was deoxygenated by bubbling argon through the solution for 2–5 min. Then, Grubbs II 
catalyst (0.17 g, 0.21 mmol, 5 mol%) in toluene (6 mL) was added dropwise at r.t. The dark red 
suspension was heated at 85 °C for 8 h. After the reaction mixture had cooled down to r.t., the 
solvent was removed under reduced pressure. The residue was purified by flash chromatography 
(petroleum ether/ethyl acetate, 7:3) to give enoate 2-169 (1.45 g, 83%) as an off brown oil.  
Rf = 0.26 (petroleum ether/ethyl acetate, 9:1); []D
20 = +6.0 (c = 1, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.96 (d, J = 6.7 Hz, 3H, 6-CH3), 1.23–1.34 (m, 1H, 5-H), 1.58–1.62 (m, 1H, 5-H), 
1.63–1.78 (m, 1H, 6-H), 2.10–2.15 (m, 2H, 7-H), 2.90–3.01 (m, 2H, 4-H), 3.71 (s, 3H, OCH3), 5.82 
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(dt, J = 15.6 Hz, 1H, 2-H), 6.90–6.70 (m, 1H, 3-H), 7.20–7.31 (m, 10H, ArH), 7.42–7.44 (m, 5H, 
ArH); 13C NMR (100 MHz, CDCl3): δ = 17.2 (6-CH3), 29.6 (C-4), 31.9 (C-5), 33.3 (C-6), 51.4 
(OCH3), 67.7 (C-7), 86.1 (CPh3), 126.8, 127.7, 128.7, 144.4 (4 × Ar C), 167.1 (C=O); HRMS 
(ESI): m/z [M + Na]+ calcd for C28H30O3: 437.20872; found: 379.20905. 
 
Methyl (2R,3S,6S)-2,3-dihydroxy-6-methyl-7-(trityloxy)heptanoate (2-170) 
 
 
To a stirred solution of enoate 2-169 (100 mg, 0.24 mmol) in t-BuOH/H2O (3:1, 5 mL) was added 
AD-mix  (0.33 g) and methyl sulfonamide (23 mg, 0.24 mmol) at 0 °C. The yellow suspension 
was stirred for 8 h at r.t. After that, the reaction mixture was quenched with sodium thiosulfate 
solution (5 mL) and the aqueous phase was extracted with ethyl acetate (3  5 mL). The combined 
organic layers were washed with saturated NaCl solution (5 mL), dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was purified by flash chromatography (petroleum 
ether/ethyl acetate, 6:4) to give dihydroxy ester 2-170 (60 mg, 55%) as a colorless oil.  
Rf = 0.43 (petroleum ether/ethyl acetate, 1:1); []D
20 = –12.4 (c = 1, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.95 (d, J = 6.7 Hz, 3H, 6-CH3), 1.50–1.58 (m, 3H, 5-H, 4-H), 1.75–1.87 (m, 2H, 4-H, 
6-H), 2.92–3.01 (m, 2H, 7-H), 3.81 (s, 4H, OCH3, 2-H), 4.04–4.06 (m, 1H, 3-H), 7.20–7.30 (m, 
10H, ArH), 7.43–7.45 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 17.3 (6-CH3), 29.4 (C-4), 
31.1 (C-5), 33.7 (C-6), 52.8 (OCH3), 68.0 (C-7), 72.7 (C-2), 73.1 (C-3), 86.1 (CPh3), 126.8, 127.6, 
128.7, 144.4 (4 × Ar C), 174.0 (C=O); HRMS (ESI): m/z [M + Na]+ calcd for C28H32O5: 






2,2-Dimethoxypropane (0.18 mL, 1.50 mmol) and p-toluenesulfonic acid (pTsOH·H2O) (7 mg) 
were added to a stirred solution of dihydroxy ester 2-170 (0.56 g, 1.24 mmol) in acetone (12 mL) at 
r.t. followed by stirring of the mixture for 5 h. The reaction mixture was diluted with saturated 
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NaHCO3 solution (8 mL) and H2O (15 mL). The aqueous phase was extracted with ethyl acetate (3 
 10 mL). The combined organic layers were washed with saturated NaCl solution (15 mL), dried 
over Na2SO4, filtered, and concentrated under reduced pressure. The crude acetal was purified by 
flash chromatography (petroleum ether/ethyl acetate, 8:2) to give protected dihydroxy ester 2-171 
(0.42 g, 68%) as a colorless oil.  
Rf = 0.26 (petroleum ether/ethyl acetate, 9:1); []D
20 = –8.1 (c = 1, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.92 (d, J = 6.7 Hz, 3H, 3'-CH3), 1.27–1.30 (m, 1H, 1'-H), 1.35 (s, 3H, C(CH3)2), 1.37 
(s, 3H, C(CH3)2), 1.51–1.73 (4H, 2'-H, 1'-H, 3'-H), 2.84–2.88 (m, 2H, 4'-H), 3.60 (s, 3H, OCH3), 






To a mixture of N,O-dimethylhydroxylamine hydrochloride (0.25 g, 2.43 mmol) in CH2Cl2 (50 mL) 
at –20 °C was added a solution of trimethylaluminum (2M in hexane, 1.2 mL, 6.80 mmol) over 5 
min. Then the mixture was stirred for 30 min at the same temperature before the dropwise addition 
of dihydroxy ester 2-171 (0.42 g, 0.86 mmol) in CH2Cl2 (5 mL). After addition, the cooling bath 
was removed and the mixture stirred for 2 h at r.t. Thereafter, the reaction mixture was carefully 
quenched with water (10 mL) at –10 °C. The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were washed with saturated NaCl 
solution (25 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure to give a 
mixture of 2-172/173 (1:1) as a colorless oil. Again, the crude mixture 2-172/173 (0.37 g, 0.76 
mmol) was dissolved in acetone (8 mL) to which were added 2,2-dimethoxypropane (0.1 mL, 0.10 
mmol) and p-toluenesulfonic acid (pTsOH·H2O) (2 mg) followed by stirring of the mixture at r.t for 
1 h. The reaction mixture was diluted with saturated NaHCO3 solution (5 mL) and H2O (10 mL). 
The aqueous phase was extracted with ethyl acetate (3  15 mL). The combined organic layers were 
washed with saturated NaCl solution (10 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The crude acetal was purified by flash chromatography (petroleum ether/ethyl 
acetate, 7:3) to give dihydroxy ester 2-172 (0.24 g, 60%) as a colorless oil.  
Rf = 0.62 (petroleum ether/ethyl acetate, 9:1); []D
20 = –5.6 (c = 0.5, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.92 (d, J = 6.7 Hz, 3H, 3'-CH3), 1.22–1.27 (m, 1H, 3'-H), 1.42 (s, 6H, C(CH3)2), 1.50–
Experimental Section                                                                                 137 
 
 
1.75 (m, 4H, 1'-H, 2'-H), 2.84–2.93 (m, 2H, 4'-H), 3.17 (s, 3H, OCH3), 3.65 (s, 3H, CH3), 4.30–4.40 
(m, 2H, 4-H, 5-H), 7.17–7.27 (m, 10H, ArH), 7.40–7.41 (m, 5H, ArH); 13C NMR (100 MHz, 
CDCl3): δ = 17.2 (3'-CH3), 26.1 (C(CH3)2), 27.4 (C(CH3)2), 29.5 (C-1' or C-2'), 30.4 (C-2' or C-1'), 
33.9 (C-3'), 68.2 (C-7), 86.1 (CPh3), 110.4 (C(CH3)2), 126.7, 127.6, 128.7, 144.4 (4 × Ar C); 





To a solution of amide 2-172 (110 mg, 0.21 mmol) in Et2O (5 mL) at −78 °C was added DIBAL-H 
(1.0 M in hexane, 0.42 mL, 0.42 mmol) dropwise. The reaction mixture was stirred for 1 h at the 
same temperature. Then the reaction mixture was quenched with methanol (2 mL), and saturated 
NH4Cl solution (5 mL). The layers were separated and the aqueous phase was extracted with diethyl 
ether (2  8 mL). The combined organic layers were washed with saturated NaCl solution (5 mL), 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The aldehyde 2-174 (85 mg, 
87%) was obtained as a yellow oil which was used without flash chromatography.  
Rf = 0.73 (petroleum ether/ethyl acetate, 1:1); 1H NMR (400 MHz, CDCl3): δ = 0.93 (d, J = 6.7 Hz, 
3'-CH3), 1.36 (s, 3H, (C(CH3)2), 1.42 (s, 3H, (C(CH3)2), 1.50–1.55 (m, 5H, 1'-H, 2'-H, 3'-H), 2.87–
2.90 (m, 2H, 4'-H), 3.85–3.95 (m, 2H, 4-H, 5-H), 7.16–7.27 (m, 10H, ArH), 7.40–7.41 (m, 5H, 
ArH); 13C NMR (100 MHz, CDCl3): δ = 17.2 (3'-CH3), 25.5 (C(CH3)2), 26.1 (C(CH3)2), 29.3 (C-
2'), 30.8 (C-1'), 33.3 (C-3'), 67.8 (C-4'), 84.8 (C-4 or C-5), 86.1 (C-5 or C-4), 110.8 (C(CH3)2), 





To a suspension of NaH (60% dispersion in mineral oil, 2.0 g, 51 mmol) in THF (10 mL) was 
added a solution of alcohol 2-166 (2.92 g, 25.6 mmol) in THF (15 mL) at 0 °C. The white 
suspension was stirred for 30 min before tetrabutylammonium iodide (TBAI, 0.94 g, 2.55 mmol) 
and 4-methoxybenzyl chloride (5.2 mL, 38.4 mmol) were added at 0 °C. The reaction mixture was 
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then stirred for 18 h at r.t. Thereafter, the reaction mixture was diluted with H2O (45 mL). The 
aqueous phase was extracted with ethyl acetate (2  30 mL). The combined organic layers were 
washed with saturated NaCl solution (20 mL), dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash chromatography (petroleum ether/ethyl acetate, 
9:1) to give PMB ether 2-175 (4.5 g, 75%) as a colorless oil.  
Rf = 0.61 (petroleum ether/ethyl acetate, 9:1); []D
20 = +3.24 (c = 2.0, CH2Cl2); {Lit.
153 []D
20 = 
+3.0 (c = 1, CHCl3)}; 1H NMR (400 MHz, CDCl3): δ = 0.92 (d, J = 6.7 Hz, 3H, 2-CH3), 1.15–1.24 
(m, 1H, 3-H), 1.48–1.57 (m, 1H, 3-H), 1.72–1.81 (m, 1H, 2-H), 1.96–2.14 (m, 2H, 4-H), 3.22 (dd, J 
= 9.0, 6.6 Hz, 1H, 1-H), 3.28 (dd, J = 9.1, 6.1 Hz, 1H, 1-H), 3.80 (s, 3H, OCH3), 4.42 (s, 2H, 
CH2Ar), 4.93 (dd, J = 10.1, 2.0 Hz, 1H, 6-H), 5.01 (dd, J = 17.1, 1.9 Hz, 1H, 6-H), 5.80 (ddt, J = 
16.8, 10.2, 6.6 Hz, 1H, 5-H), 6.88 (d, J = 8.6 Hz, 2H, ArH), 7.25 (d, J = 8.6 Hz, 2H, ArH); 13C 
NMR (100 MHz, CDCl3): δ = 16.9 (2-CH3), 31.1 (C-4), 32.8 (C-3), 55.2 (OCH3), 72.6 (CH2Ar), 
75.5 (C-1), 113.7, 114.2, 129.0, 130.8 (4 × Ar C), 139.0 (C-5), 159.0 (Ar C(OMe)); HRMS (ESI): 
m/z [M + Na]+ calcd for C15H22O2: 257.1512; found: 257.1512. 
 
Methyl (S,E)-7-((4-methoxybenzyl)oxy)-6-methylhept-2-enoate (2-176) 
 
 
A solution of alkene 2-175 (1.0 g, 4.26 mmol) and methyl acrylate (1.46 mL, 17.1 mmol) in toluene 
(12 mL) was deoxygenated by bubbling argon through the solution for 2–3 min. Then, Grubbs II 
catalyst (0.18 g, 0.21 mmol, 5 mol%) in toluene (4 mL) was added dropwise at r.t. The dark red 
suspension was heated at 85 °C for 8 h. After the reaction mixture had cooled down to r.t., the 
solvent was removed under reduced pressure. The residue was purified by flash chromatography 
(petroleum ether/ethyl acetate, 8:2) to give enoate 2-176 (1.18 g, 95%) as an off brown oil.  
Rf = 0.33 (petroleum ether/ethyl acetate, 9:1); []D
20 = –1.65 (c = 1, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.92 (d, J = 6.7 Hz, 3H, 6-CH3), 1.24–1.33 (m, 1H, 5-H), 1.58–1.67 (m, 1H, 5-H), 
1.75–1.80 (m, 1H, 6-H), 2.13–2.29 (m, 2H, 4-H), 3.27 (dd, J = 6.3, 1.9 Hz, 2H, 7-H), 3.73 (s, 3H, 
OCH3), 3.81 (s, 3H, ArOCH3), 4.43 (s, 2H, CH2Ar), 5.82 (dt, J = 15.7, 1.6 Hz, 1H, 2-H), 6.87 (d, J 
= 8.6 Hz, 2H, ArH), 6.93–7.01 (m, 1H, 2-H), 7.25 (d, J = 8.6 Hz, 2H, ArH); 13C NMR (100 MHz, 
CDCl3): δ = 16.8 (6-CH3), 29.6 (C-4), 31.8 (C-5), 32.9 (C-6), 51.3 (OCH3), 55.2 (OCH3), 72.6 
(CH2Ar), 75.1 (C-7), 113.7 (Ar C), 120.8 (C-3), 129.1 (Ar C), 130.6 (Ar C), 149.6 (C-2), 159.0 (Ar-
C), 167.1 (C-1); HRMS (ESI): m/z [M + Na]+ calcd for C17H24O4: 315.1570; found: 315.1570. 
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Methyl (2R,3S,6S)-2,3-dihydroxy-7-((4-methoxybenzyl)oxy)-6-methylheptanoate (2-177) 
 
 
To a stirred solution of enoate 2-176 (1.18 g, 4.03 mmol) in t-BuOH/H2O (3:1, 40 mL) was added 
solid of AD-mix  (5.65 g) and methyl sulfonamide (0.95 g, 10.1 mmol) at 0 °C. The yellow 
suspension was stirred for 36 h at r.t. After that, the reaction mixture was quenched with sodium 
thiosulfate solution (25 mL) and the aqueous phase was extracted with ethyl acetate (3  16 mL). 
The combined organic layers were washed with saturated NaCl solution (20 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by flash 
chromatography (petroleum ether/ethyl acetate, 6:4) to give dihydroxy ester 2-177 (0.84 g, 64%) as 
a colorless oil.  
Rf = 0.34 (petroleum ether/ethyl acetate, 1:1); []D
19 = –19.75 (c = 2, CH2Cl2), 1H NMR (400 MHz, 
CDCl3): δ = 0.91 (d, J = 6.7 Hz, 3H, 6-CH3), 1.31–1.37 (m, 1H, 5-H), 1.47–1.58 (m, 2H, 4-H, 5-H), 
1.63–1.70 (m, 1H, 4-H), 1.75–1.83 (m, 1H, 6-H), 3.25 (dd, J = 6.4, 1.8 Hz, 2H, 7-H), 3.79 (s, 3H, 
OCH3), 3.81 (s, 3H, OCH3), 3.83–3.87 (m, 1H, 3-H), 4.07 (d, J = 2.1 Hz, 1H, 2-H), 4.41 (s, 2H, 
CH2Ar), 6.87 (d, J = 8.6 Hz, 2H, ArH), 7.23 (d, J = 7.8 Hz, 2H, ArH); 13C NMR (100 MHz, 
CDCl3): δ = 17.1 (6-CH3), 29.9 (C-4), 31.0 (C-5), 33.2 (C-6), 43.4 (C-3), 52.8 (OCH3), 55.3 
(OCH3), 72.7 (CH2Ar), 73.2 (C-2), 75.4 (C-7), 113.7, 129.2, 130.6, 159.1 (4 × Ar C), 174.0 (C-1); 






2,2-Dimethoxypropane (0.38 mL, 3.11 mmol) and p-toluenesulfonic acid (pTsOH·H2O) (3 mg, 0.02 
mmol) were added to a stirred solution of dihydroxy ester 2-177 (0.84 g, 2.57 mmol) in acetone (10 
mL) at r.t. followed by stirring of the mixture for 2 h. The reaction mixture was diluted with 
saturated NaHCO3 solution (5 mL) and H2O (10 mL). The aqueous phase was extracted with ethyl 
acetate (3  5 mL). The combined organic layers were washed with saturated NaCl solution (10 
mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude acetal was 
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purified by flash chromatography (petroleum ether/ethyl acetate, 8:2) to give protected dihydroxy 
ester 2-178 (0.67 g, 71%) as a colorless oil.  
Rf = 0.55 (petroleum ether/ethyl acetate, 8:2); []D
20 = –13.28 (c = 0.5, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 0.92 (d, J = 6.7 Hz, 3H, 3'-CH3), 1.26–1.36 (m, 1H, 1'-H), 1.42 (s, 3H, C(CH3)2), 
1.45 (s, 3H, C(CH3)2), 1.50–1.59 (m, 1H, 2'-H), 1.67–1.81 (m, 3H, 1'-H, 3'-H, 2'-H), 3.22–3.30 (m, 
2H, 4'-H), 3.76 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 4.08–4.12 (m, 2H, 4-H, 5-H), 4.42 (s, 2H, 
CH2Ar), 6.87 (d, J = 8.6 Hz, 2H, ArH), 7.25 (d, J = 8.6 Hz, 2H, ArH); 13C NMR (100 MHz, 
CDCl3): δ = 16.9 (3'-CH3), 25.6 (C(CH3)2), 27.2 (C(CH3)2), 29.5 (C-1' or C-2'), 30.9 (C-2' or C-1'), 
33.4 (C-3'), 52.3 (OCH3), 55.2 (OCH3), 72.6 (CH2Ar), 75.4 (C-4'), 79.0 (C-4), 79.2 (C-5), 110.8, 
113.7, 129.1, 130.7 (4 × Ar C), 159.1 (C-2), 171.3 (CO2Me); HRMS (ESI): m/z [M + Na]
+ calcd for 






To a solution of LiAlH4 (0.10 g, 2.61 mmol) in THF (3 mL) at 0 °C was added a solution of methyl 
ester 2-178 (0.64 g, 1.74 mmol) in THF (8 mL). After complete addition, the resulting suspension 
was stirred at r.t. for 2 h. The reaction mixture was quenched by adding H2O (5 mL) and 15% 
aqueous NaOH (2 mL). The white suspension was filtered through a pad of celite, which was rinsed 
with ethyl acetate (10 mL). The obtained filtrate was dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was purified by flash chromatography (petroleum ether/ethyl 
acetate, 5:5) to give primary alcohol 2-179 (0.57 g, 96%) as a colorless oil.  
Rf = 0.23 (petroleum ether/ethyl acetate, 7:3); []D
21 = –14.64 (c = 2, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 0.93 (d, J = 6.7 Hz, 3H, 3'-CH3), 1.29–1.40 (m, 6H, C(CH3)2, 2'-H), 1.46–1.53 
(m, 2H, 2'-H, 1'-H), 1.71–1.79 (m, 1H, 1'-H), 1.93–1.96 (m, 1H, 3'-H), 3.26 (dd, J = 17.9, 9.0 Hz, 
2H, 4'-H), 3.54–3.61 (m, 1H, CH2OH), 3.69–3.79 (m, 5H, 5-H, 4-H, OCH3), 3.81–3.86 (m, 1H, 
CH2OH), 4.41 (s, 2H, CH2Ar), 6.87 (d, J = 8.6 Hz, 2H, ArH), 7.25 (d, J = 8.6 Hz, 2H, ArH); 13C 
NMR (100 MHz, CDCl3): δ = 17.0 (3'-CH3), 27.0 (C(CH3)2), 27.3 (C(CH3)2), 29.8 (C-2'), 30.5 (C-
1'), 33.5 (C-3'), 55.2 (OCH3), 62.0 (CH2OH), 72.6 (CH2Ar), 75.3 (C-4'), 77.0 (C-4 or C-5), 81.7 (C-
5 or C-4), 108.5, 113.7, 129.1, 130.7 (4 × Ar C), 159.0 (C-2); HRMS (ESI): m/z [M + Na]+ calcd 
for C19H30O5: 361.1988; found: 361.1988. 
 
 







To a solution of oxalyl chloride (0.21 mL, 2.48 mmol) in CH2Cl2 (5 mL) was slowly added DMSO 
(0.35 mL, 4.96 mmol) at –78 °C. After being stirred for 15 min at this temperature, a solution of 
alcohol 2-179 (0.56 g, 1.65 mmol) in CH2Cl2 (8 mL) was added over a period of 5 min. The 
reaction mixture was stirred at the same temperature for 1 h. Thereafter, Et3N (1.3 mL, 9.92 mmol) 
was added dropwise. Then the reaction mixture was warmed to r.t. The mixture was diluted with 
H2O (10 mL) and the layers were separated. The aqueous layer was extracted with CH2Cl2 (2 × 8 
mL). The combined organic layers were washed with saturated NaCl solution (10 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The aldehyde 2-180 (0.53 g, 95%) was 
used for the next step without chromatography.  
Rf = 0.55 (petroleum ether/ethyl acetate, 7:3); []D
19 = –3.40 (c = 1.5, CH2Cl2); 
1H NMR (400 
MHz, CDCl3): δ = 0.91 (d, J = 6.7 Hz, 3H, 3'-CH3), 1.25–1.46 (m, 8H, C(CH3)2, 2'-H), 1.48–1.77 
(m, 3H, 3'-H, 1'-H), 3.21–3.29 (m, 2H, 4'-H), 3.79 (s, 3H, OCH3), 3.88–3.93 (m, 1H, 4-H), 3.98–
4.03 (m, 1H, 5-H), 4.41 (s, 2H, CH2Ar), 6.86 (d, J = 8.6 Hz, 2H, ArH), 7.23 (d, J = 7.7 Hz, 2H, 
ArH), 9.70 (s, 1H, CHO); 13C NMR (100 MHz, CDCl3): δ = 16.9 (3'-CH3), 26.1 (C(CH3)2), 27.0 
(C(CH3)2), 29.4 (C-2'), 30.8 (C-1'), 33.3 (C-3'), 55.2 (OCH3), 72.6 (CH2Ar), 75.2 (C-4'), 77.1 (C-5), 
84.8 (C-4), 110.8, 113.7, 129.1, 130.7 (4 × Ar C), 159.0 (C-2), 201.1 (CHO); HRMS (ESI): m/z [M 
+ CH3OH + Na]





To a stirred solution of vinyl bromide 2-139 (25 mg, 0.06 mmol) in THF (0.5 mL) at –78 °C was 
added a solution of t-BuLi (1.7 M in pentane, 0.05 mL, 0.1 mmol) over 5 min. The reaction mixture 
was stirred at –78 °C for 1 h, before the addition of 2-180 (40 mg, 0.1 mmol) in THF (0.3 mL) 
dropwise. After addition, the reaction mixture was stirred at –78 °C for 30 min. Then the reaction 
mixture was stirred for 2 h at r.t. The reaction mixture was diluted with saturated NH4Cl solution (3 
mL). The layers were separated and the aqueous layer was extracted with ethyl acetate (2 × 3 mL). 
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The combined organic layers were washed with saturated NaCl solution (2 mL), dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The debrominated crude was purified by flash 
chromatography (petroleum ether/diethyl ether, 8:2) to give debrominated 2-184 (10 mg, 51%) as a 
major compound.  
Rf = 0.7 (petroleum ether/diethyl ether, 9:1); 1H NMR (400 MHz, CDCl3): δ = 1.05–1.04 (m, 21H, 
Si(CH(CH3)2)3), 1.52–1.62 (m, 6H, 2 × CH3), 1.68 (t, J = 1.5 Hz, 3H, 3-CH3), 2.27–2.41 (m, 2H, 5-
H), 4.66 (dd, J = 8.6, 5.5 Hz, 1H, 4-H), 5.20–5.31 (m, 2H, 6-H, 7-H), 5.44–5.50 (m, 1H, 2-H); 13C 
NMR (100 MHz, CDCl3): δ = 12.4 (Si(CH(CH3)2), 13.2 (C-1), 17.4 (3-CH3), 17.9 (Si(CH(CH3)2)3), 
18.0 (Si(CH(CH3)2)3), 29.7 (C-8), 34.0 (C-5), 69.5 (C-4), 119.6 (C-2), 125.2 (C-7), 126.2 (C-6), 
138.0 (C-3). 
 
C1-C12 fragment (2-185) 
 
Vinyl bromide 2-156 (0.15 g, 0.25 mmol) was dried by dissolving it in a mixture of benzene/toluene 
(3 mL, 1:1) followed by evaporation of the solvents using a rotavapor and placing it under high 
vacuum for 1 h. Thereafter, THF (1.5 mL) was added under an argon atmosphere and the reaction 
flask was cooled to –78 °C. Then, s-BuLi (1.4M in cyclohexane, 0.21 mL, 0.30 mmol) was added 
dropwise and the reaction mixture stirred for 30 min at –78 °C before aldehyde 2-180 (0.14 g, 0.43 
mmol), dissolved in THF (1.5 mL), was added dropwise. After complete addition, the reaction 
mixture was stirred for 2 h at –78 °C and at r.t. for 1 h. Finally, the reaction mixture was treated 
with saturated NH4Cl solution (5 mL). The layers were separated and the aqueous layer was 
extracted with ethyl acetate (2 × 8 mL). The combined organic layers were washed with saturated 
NaCl solution (5 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. The 
crude allylic alcohol 2-185 (86 mg, dr = 10:4) was used for the next reaction without 















To a solution of alcohol 2-186 (70 mg, 0.08 mmol) in CH2Cl2 (5 mL) at 0 °C were added DMP (70 
mg, 0.16 mmol) and NaHCO3 (20 mg, 0.24 mmol). After addition, the cooling bath was removed 
and the mixture stirred for 2 h at r.t. Then the reaction mixture was diluted with saturated NaHCO3 
solution (5 mL). The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 × 5 
mL). The combined organic layers were washed with saturated NaCl solution (8 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (petroleum ether/ethyl acetate, 85:15) to give enone 2-187 (50 mg, 71%) as a 
colorless oil.  
Rf = 0.48 (petroleum ether/ethyl acetate, 9:1); []D
19 = –6.85 (c = 0.52, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 0.90 (d, J = 6.7 Hz, 3H, 2-CH3), 0.94–0.96 (m, 21H, Si(CH(CH3)2)3), 1.25–1.30 
(m, 1H, 3-H), 1.30 (s, 3H, C(CH3)2), 1.37–1.44 (m, 4H, C(CH3)2, 3-H), 1.50–1.53 (m, 1H, 4-H), 
1.56–1.60 (m, 1H, 4-H), 1.68–1.73 (m, 1H, 2-H), 1.80 (s, 3H, 8-CH3), 2.70–2.73 (m, 2H, 10-H), 
2.97 (t, J = 8.3 Hz, 1H, 12-H), 3.10–3.20 (m, 2H, 12-H, 1-H), 3.26 (dd, J = 9.0, 5.8 Hz, 1H, 1-H), 
3.77 (s, 3H, OCH3), 4.10–4.18 (m, 1H, 11-H), 4.22–4.26 (m, 1H, 5-H), 4.34 (d, J = 7.4 Hz, 1H, 6-
H), 4.48 (d, J = 1.8 Hz, 2H, CH2Ar), 6.86 (d, J = 8.6 Hz, 2H, ArH), 6.97 (t, J = 6.4 Hz, 1H, 9-H), 
7.17–7.27 (m, 12H, ArH), 7.38–7.41 (m, 5H, ArH); 13C NMR (100 MHz, CDCl3): δ = 11.8 (8-
CH3), 12.3 (Si(CH(CH3)2)3), 16.9 (2-CH3), 18.0 (Si(CH(CH3)2)3), 26.2 (C(CH3)2), 27.2 (C(CH3)2), 
29.7 (C-3), 30.6 (C-4), 33.4 (C-2), 34.8 (C-1), 55.2 (OCH3), 66.3 (C-12), 70.3 (C-11), 72.6 
(CH2Ar), 75.5 (C-1), 78.0 (C-5 or C-6), 80.3 (C-6 or C-5), 86.6 (CPh3), 109.8 (C(CH3)2), 113.7, 
127.0, 127.7, 128.6, 129.0, 130.8 (6 × Ar), 137.7 (C-8), 142.5 (C-9), 143.9 (Ar C), 159.0 (Ar C), 

















To a solution of LiAlH4 (1.98 g, 52.29 mmol) in THF (5 mL) at 0 °C was added methyl ester 3-63 
(4.50 g, 26.1 mmol) in THF (50 mL) dropwise. The reaction mixture was heated at 50 °C for 3 h. 
Thereafter, the reaction mixture was cooled to r.t. and then treated with 10% NaOH (20 mL), and 
water (5 mL). The resulting white suspension was filtered through a pad of celite, which was 
washed with hot ethyl acetate (35 mL), the filtrate was concentrated under pressure. The alcohol 
residue was purified by flash chromatography (petroleum ether/ethyl acetate, 60:40) to afford 
alcohol 3-52 (3.40 g, 89%) as a colorless oil.  
Rf = 0.4 (petroleum ether/ethyl acetate, 1:1), 1H NMR (400 MHz, CDCl3): δ = 1.25–1.34 (m, 1H, 
3'-H), 1.41–1.68 (m, 8H, 5'-H, 4'-H, 3'-H, 3-H, 2-H), 1.77–1.78 (m, 1H, 2-H), 2.68 (s, 1H, OH), 
3.22–3.28 (m, 1H, 3-H), 3.40 (dt, J = 11.3, 2.8 Hz, 1H, 6'-H), 3.54–3.63 (m, 2H, 1-H), 3.94–3.98 
(m, 1H, 6'-H); 13C NMR (100 MHz, CDCl3): δ = 23.5 (C-4'), 25.8 (C-5'), 29.3 (C-2'), 31.9 (C-3'), 
33.7 (C-3), 63.0 (C-1), 68.5 (C-6'), 78.0 (C-2); HRMS (ESI): calculated for [C8H16O2+Na]
+: 
167.1042; found: 167.1042. 
 
Methyl (E)-3-(tetrahydro-2H-pyran-2-yl)acrylate (3-61) 
 
 
To a solution of oxalyl chloride (4.37 ml, 51.7 mmol) in CH2Cl2 (100 ml) at –78 °C was added 
DMSO (7.64 ml, 107 mmol) dissolved in CH2Cl2 (10 mL) dropwise. The solution was stirred for 15 
min at–78 °C before the addition of tetrahydropyran-2-methanol (3-58) (5.0 ml, 43 mmol) in 
CH2Cl2 (25 ml). After addition, the reaction mixture was stirred for 1 h at –78 °C. After that Et3N 
(29.8 ml, 101 mmol) was added dropwise at –78 °C and then the reaction mixture was warmed to 0 
°C. Then, ylene 3-62 (18.0 g, 54.0 mmol) was added portionwise to the reaction mixture. The white 
suspension was stirred for 1 h at r.t. The reaction mixture was quenched with H2O (50 mL) and then 
the layer were separated. The aqueous layer was extracted with CH2Cl2 (2 × 60 mL). The combined 
organic layers were washed with saturated NaCl solution (20 mL), dried over Na2SO4, filtered, and 
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concentrated under reduced pressure. The crude ester was purified by flash chromatography 
(petroleum ether/ethyl acetate, 65:35) to give methyl acrylate 3-61 (5.4 g, 73%) as a colorless oil.  
Rf = 0.7 (petroleum ether/ethyl acetate, 7:3), 1H NMR (400 MHz, CDCl3): δ = 1.27–1.37 (m, 1H, 
3'-H), 1.50–1.57 (m, 3H, 5'-H, 4'-H), 1.67–1.72 (m, 1H, 5'-H), 1.84–1.87 (m, 1H, 3'-H), 3.47 (m, 
1H, 6'-H), 3.71 (s, 3H, OCH3), 3.91–4.04 (m, 2H, 2'-H, 6'-H), 6.00 (dd, J = 15.8, 1.8 Hz, 1H, 2-H), 
6.88 (dd, J = 15.8, 4.2 Hz, 1H, 3-H); 13C NMR (100 MHz, CDCl3): δ = 23.4 (C-5'), 25.6 (C-4'), 
31.4 (C-3'), 51.5 (OCH3), 68.3 (C-6'), 76.1 (C-2'), 119.3 (C-2), 148.4 (C-3), 167.1 (CO2Me).  
 
Methyl 3-(tetrahydro-2H-pyran-2-yl)propanoate (3-63) 
 
 
To a stirred solution of ester 3-61 (0.86 g, 5.05 mmol) in MeOH (10 mL) was added 10 mole% of 
Pd/C (86 mg). The suspension was kept under hydrogen atmosphere (Shaker hydrogenation 
apparatus) for 8 h. The reaction mixture was filtered through celite and filtrate concentrated under 
reduced pressure. The crude ester was purified by flash chromatography (petroleum ether/ethyl 
acetate, 60:40) to give methyl ester 3-63 (0.6 g, 68%) as a colorless oil.  
Rf = 0.7 (petroleum ether/ethyl acetate, 7:3), 1H NMR (400MHz, CDCl3): δ = 1.21–1.28 (m, 1H, 3-
H), 1.42–1.56 (m, 4H, 4'-H, 5'-H), 1.68–1.80 (m, 3H, 3 (or) 2-H, 3'-H), 2.35–2.40 (m, 2H, 2 (or) 3-
H), 3.20–3.22 (m, 2'-H), 3.31–3.37 (m, 1H, 6'-H), 3.63 (s, 3H, OCH3), 3.90–3.94 (m, 1H, 6'-H); 13C 
NMR (100 MHz, CDCl3): δ = 23.3 (C-4'), 26.0 (C-5'), 30.1 (C-3 or C-4), 31.4 (C-4 (or) C-3), 31.7 
(C-3'), 51.4 (OCH3), 68.3 (C-6'), 76.6 (C-2'), 174.2 (CO2Me); HRMS (ESI): calculated for 
[C9H14O3+Na]





Methyl ester 3-63 (0.2 g, 1.2 mmol) was dissolved in ammonia solution (7 N in MeOH, 10 mL). 
The reaction mixture was heated in a Parr bomb vessel for 2 days at 75 °C. Then, the mixture was 
slowly brought to r.t., and the solvent removed under reduced pressure. The crude amide was 
146                                                    Experimental Section 
 
 
washed with diethyl ether (2 × 15 mL), and dried under high vacuum for overnight to give 3-66 
(0.12 g, 66% yield) as a white solid.  
Rf = 0.38 (dichloromethane/MeOH, 9:1); 1H NMR (400 MHz, CDCl3): δ = 1.25–1.32 (m, 1H, 3'-
H), 1.45–1.60 (m, 4H, 5'-H, 4'-H), 1.66–1.72 (m, 1H, 5'-H), 1.78–1.84 (m, 2H, 2-H), 2.32–2.37 (m, 
2H, 3-H), 3.25–3.30 (m, 1H, 2'-H), 3.40 (dt, J = 11.1, 3.0 Hz, 1H, 6'-H), 3.93–3.97 (m, 1H, 6'-H), 
5.48 (br s, 2H, NH2); 13C NMR (100 MHz, CDCl3): δ = 23.4 (C-4'), 26.0 (C-5'), 31.8 (C-3'), 31.9 
(C-2'), 32.0 (C-3), 68.4 (C-6'), 77.0 (CH2), 175.7 (C=O); HRMS (ESI): calculated for 
[C8H15NO2+Na]











17.1 NMR Spectra for important compounds 
Additional spectra are included in the supporting information of the published papers from 
this work and are available free of charge via Internet at DOI: 10.1002/ajoc.201600455 (Asian 
J.Org. Chem).  
 
Chapter I. Total Synthesis of Lingzhiol and some Analogs via Wittig Reaction on an 
Oxocyclopentane Carboxylate. Asian J. Org. Chem. 2017, 6, 108–117  
 
Chapter II. Synthesis of a C1-C12 Fragment of Gulmirecin B 
 































































































































1H NMR (400 MHz) spectrum of alkylated α-ketoester 1-93 in CDCl3 (0.5 – 7.5 ppm)  
 




































































13C NMR (100 MHz) spectrum of alkylated α–ketoester 1-93 in CDCl3 (10 – 220 ppm)  
Appendix    149  
 
 


































































































































1H NMR (400 MHz) spectrum of alkene exo–1-89 in CDCl3 (0.5 – 7.5 ppm)  
 








































































13C NMR (100 MHz) spectrum of alkene exo–1-89 in CDCl3 (0 – 180 ppm)  




7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shift (ppm)





















































































































































1H NMR (400 MHz) spectrum of epoxide 1-88 (7/3 ration of d.r) in CDCl3 (0.5 – 7.5 ppm)  
 



























































































13C NMR (100 MHz) spectrum of epoxide 1-88 (d.r =7;3) in CDCl3 (0 – 180 ppm)  
Appendix    151  
 
 














































































































































1H NMR (400 MHz) spectrum of allyl alcohol 1-94 in CDCl3 (0.5 – 7.5 ppm)  
 








































































13C NMR (100 MHz) spectrum of allyl alcohol 1-94 in CDCl3 (0 – 180 ppm)  






























































































































































1H NMR (400 MHz) spectrum of epoxide 1-87 in CDCl3 (0.5 – 7.5 ppm)  
 


















































































































13C NMR (400 MHz) spectrum of epoxide 1-87 in CDCl3 (10 – 180 ppm)  
Appendix    153  
 
 



















































































































1H NMR (400 MHz) spectrum of acetate 1-95 in CDCl3 (0.5 – 7.5 ppm)  
 















































































13C NMR (100 MHz) spectrum of acetate 1-95 in CDCl3 (0 – 180 ppm)  





























































































































1H NMR (400 MHz) spectrum of epoxide 1-97a in CDCl3 (0.5 – 7.5 ppm)  
 













































































13C NMR (100 MHz) spectrum of epoxide 1-97a in CDCl3 (0 – 180 ppm)  





4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0













































6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0




































































6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5





























































bc = bond corrrelation
 
















4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
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1H NMR (400 MHz) spectrum of epoxide 1-97b in CDCl3 (0.5 – 7.5 ppm)  
 

























































































































1H NMR (400 MHz) spectrum of epoxide 1-97b in CDCl3 (1.0 – 5.0 ppm)  
















































































































4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0

















































4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0









































































6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5



















































































4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
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1H NMR (400 MHz) spectrum of allyl alcohol 1-61 in CDCl3 (0.5 – 7.5 ppm)  
 








































































13C NMR (100 MHz) spectrum of allyl alcohol 1-61 in CDCl3 (0 – 180 ppm)  






































































































































1H NMR (400 MHz) spectrum of epoxide 1-62 in CDCl3 (0.5 – 7.5 ppm)  
 






































































13C NMR (100 MHz) spectrum of epoxide 1-62 in CDCl3 (0 – 180 ppm)  
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1H NMR (400 MHz) spectrum of polycycle 1-63 in CDCl3 (0.5 – 7.5 ppm)  
 
































































13C NMR (100 MHz) spectrum of polycycle 1-63 in CDCl3 (0 – 190 ppm)  
































































































































1H NMR (400 MHz) spectrum of acetate 1-99 in CDCl3 (0.5 – 7.5 ppm)  
 







































































13C NMR (100 MHz) spectrum of acetate 1-99 in CDCl3 (0 – 190 ppm)  
Appendix    169  
 
 













































































































1H NMR (400 MHz) spectrum of phenone 1-68 in CDCl3 (0.5 – 7.5 ppm)  
 








































































13C NMR (100 MHz) spectrum of phenone 1-68 in CDCl3 (10 – 200 ppm)  




















































































































1H NMR (400 MHz) spectrum of hydroxyketone 1-100 in CDCl3 (0.5 – 7.5 ppm)  
 

































































13C NMR (100 MHz) spectrum of hydroxyketone 1-100 in CDCl3 (10 – 200 ppm)  
Appendix    171  
 
 








































































































1H NMR (400 MHz) spectrum of lingzhiol [(±)–1-1] in (CD3)2CO (0.5 – 12.0 ppm)  
 



















































































































1H NMR (400 MHz) spectrum of lingzhiol [(±)–1-1] in (CD3)2CO (1.5 – 5.5 ppm)  



































































13C NMR (100 MHz) spectrum of lingzhiol [(±)–1-1] in (CD3)2CO (10 – 210 ppm)  
 






















































































































1H NMR (400 MHz) spectrum of hydroquinone 1-101 in CD3OD (0.5 – 7.5 ppm)  
Appendix    173  
 
 








































































































































1H NMR (400 MHz) spectrum of hydroquinone 1-101 in CD3OD (1.5 – 4.5 ppm)  
 
































































13C NMR (100 MHz) spectrum of hydroquinone 1-101 in CD3OD (10 – 190 ppm) 














































































































1H NMR (400 MHz) spectrum of quinone 1-102 in CDCl3 (0.5 – 7.5 ppm)  
 
















































































































1H NMR (400 MHz) spectrum of quinone 1-102 in CDCl3 (1.5 – 5.5 ppm)  
Appendix    175  
 
 


























































13C NMR (100 MHz) spectrum of quinone 1-102 in CDCl3 (10 – 190 ppm)  
 

























































































































1H NMR (400 MHz) spectrum of lingzhiol analog 1-103 in CD3OD (0.5 – 7.5 ppm)  















































































































































1H NMR (400 MHz) spectrum of lingzhiol analog (phenol) 1-103 in CD3OD (1.0 – 5.5 ppm)  
 





























































13C NMR (100 MHz) spectrum of lingzhiol analog 1-103 in CD3OD (10 – 190 ppm)  











5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0





















































5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0









































































6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5



































































bc = bond correlation
4 bc
 

















































































































1H NMR (400 MHz) spectrum of ketone 1-104 in CDCl3 (0.5 – 7.5 ppm)  
 

































































13C NMR (100 MHz) spectrum of ketone 1-104 in CDCl3 (0.5 – 7.5 ppm)  




7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5



















1H NMR (400 MHz) spectrum of bis-Weinreb amide 2-99 in CDCl3 (0.5 – 7.5 ppm) 
 






























13C NMR (100 MHz) spectrum of bis-Weinreb amide 2-99 in CDCl3 (10 – 220 ppm) 
 




7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5


































1H NMR (400 MHz) spectrum of ketone 2-104 in CDCl3 (0.5 – 7.5 ppm) 






























13C NMR (100 MHz) spectrum of ketone 2-104 in CDCl3 (10 – 220 ppm) 
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7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)









































































































1H NMR (400 MHz) spectrum of mono alkylation 2-106 in CDCl3 (0.5 – 7.5 ppm) 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10
















































































13C NMR (100 MHz) spectrum of mono alkylation 2-106 in CDCl3 (10 – 220 ppm) 
 




7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)


















































































































1H NMR (400 MHz) spectrum of vinyl triflate 2-107 in CDCl3 (0.5 – 7.5 ppm) 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10


















































































13C NMR (100 MHz) spectrum of vinyl triflate 2-107 in CDCl3 (10 – 220 ppm) 
 
Appendix    185  
 
 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5


































































































































1H NMR (400 MHz) spectrum of alcohols 2-108 in CDCl3 (0.5 – 7.5 ppm) 
 





































































































13C NMR (100 MHz) spectrum of alcohols 2-108 in CDCl3 (10 – 220 ppm) 
 




7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)



































































































































































































1H NMR (400 MHz) spectrum of alcohol 2-109c in CDCl3 (0.5 – 7.5 ppm) 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10





































































































13C NMR (100 MHz) spectrum of alcohol 2-109c in CDCl3 (10 – 220 ppm) 
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)









































































































































































































1H NMR (400 MHz) spectrum of trityl ether 2-110c in CDCl3 (0.5 – 7.5 ppm) 
 









































































































13C NMR (100 MHz) spectrum of trityl ether 2-110c in CDCl3 (10 – 220 ppm) 
 




7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)



















































































































































1H NMR (400 MHz) spectrum of vinyl triflate 2-111 in CDCl3 (0.5 – 8 ppm) 
 
144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24







































































































































































13C NMR (100 MHz) spectrum of vinyl triflate 2-111 in CDCl3 (15 – 200 ppm) 
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)












































































































1H NMR (400 MHz) spectrum of diene 2-113 in CDCl3 (0.5 – 8 ppm) 
 



























































































13C NMR (100 MHz) spectrum of diene 2-113 in CDCl3 (15 – 150 ppm)  
 




7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)




















































































1H NMR (400 MHz) spectrum of ketone 2-114 in CDCl3 (0.5 – 8 ppm) 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10
















































































13C NMR (100 MHz) spectrum of ketone 2-114 in CDCl3 (15 – 220 ppm)  
 
Appendix    191  
 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)























































































1H NMR (400 MHz) spectrum of alcohols 2-115 in CDCl3 (0.5 – 8 ppm) 
 
168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16














































































































13C NMR (100 MHz) spectrum of alcohols 2-115 in CDCl3 (20 – 160 ppm)  
 




7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5





































































































































1H NMR (400 MHz) spectrum of ketone 2-116 in CDCl3 (0.5 – 8 ppm) 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20


















































































13C NMR (100 MHz) spectrum of alcohol 2-116 in CDCl3 (15 – 220 ppm)  
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)














































































































































































1H NMR (400 MHz) spectrum of exo/endo-2-117 in CDCl3 (0.5 – 8 ppm) 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)




























































































































































1H NMR (400 MHz) spectrum of (E/Z)-2-118 in CDCl3 (0.5 – 8 ppm) 
 




190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20





















































































































13C NMR (100 MHz) spectrum of (E/Z)-2-118 in CDCl3 (15 – 200 ppm)  
 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
























































































1H NMR (400 MHz) spectrum of hydrazone 2-129 in CDCl3 (0.5 – 8 ppm) 
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168 160 152 144 136 128 120 112 104 96 88 80 72 64 56 48 40 32 24 16





















































































13C NMR (100 MHz) spectrum of hydrazone 2-129 in CDCl3 (15 – 175 ppm) 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
Chemical Shif t (ppm)















































































































1H NMR (400 MHz) spectrum of exo-2-131 in CDCl3 (0.5 – 8 ppm) 
 




210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20











































































































13C NMR (100 MHz) spectrum of exo-2-131 in CDCl3 (15 – 220 ppm) 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shif t (ppm)


































































1H NMR (400 MHz) spectrum of enone 2-135 in CDCl3 (0 – 8 ppm) 
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190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0


























































































13C NMR (100 MHz) spectrum of enone 2-130 in CDCl3 (0 – 200 ppm) 
 































































































1H NMR (400 MHz) spectrum of acetal 2-148 in CDCl3 (0.5 – 7.5 ppm) 




















































































































































































































































































































































































































































































































































































































































































































































































13C NMR (100 MHz) spectrum of acetal 2-149 in CDCl3 (10 – 140 ppm)  
Chemical Shift (ppm)












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1H NMR (400 MHz) spectrum of aldehyde 2-149 in CDCl3 (0.5 – 10.0 ppm)  









































































































































































































































































































































































































































































































































































































































































































































































































13C NMR (100 MHz) spectrum of aldehyde 2-149 in CDCl3 (5 – 205 ppm)  
Chemical Shift (ppm)




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1H NMR (400 MHz) spectrum of dibromoalkene 2-150 in CDCl3 (0.5 – 7.5 ppm)  












































































































































































































































































































































































































































































































































































































































































































































































































































































13C NMR (100 MHz) spectrum of dibromoalkene 2-150 in CDCl3 (10 – 140 ppm)  
Chemical Shift (ppm)












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1H NMR (400 MHz) spectrum of alkyne 2-140 in CDCl3 (0.5 – 7.5 ppm)  






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1H NMR (400 MHz) spectrum of alkyne 2-140 in CDCl3 (1.0 – 4.5 ppm)  
Chemical Shift (ppm)



























































































































































































































































































































































































































































































































































































































































































































































































































































































13C NMR (100 MHz) spectrum of alkyne 2-140 in CDCl3 (0 – 130 ppm)  











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1H NMR (400 MHz) spectrum of vinyl bromide 2-152 in CDCl3 (0.5 – 7.5 ppm)  
Chemical Shift (ppm)
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